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Abstract 
The growing adoption of Electronic Health Record (EHR) systems has resulted in an 
unprecedented amount of data. This availability of data has also opened up the opportunity to 
utilize EHRs for providing more customized care for each patient by considering individual 
variability, which is the goal of precision medicine. In this context, patient similarity (PS) 
analytics have been introduced to facilitate data analysis through investigating the similarities 
in patients’ data, and, ultimately, to help improve the healthcare system.  
This dissertation is presented in six chapters and focuses on employing PS analytics in 
data-rich intensive care units. Chapter 1 provides a review of the literature and summarizes 
studies describing approaches for predicting patients’ future health status based on EHR and 
PS. Chapter 2 demonstrates the informativeness of missing data in patient profiles and 
introduces missing data indicators to use this information in mortality prediction. The results 
demonstrate that including indicators with observed measurements in a set of well-known 
prediction models (logistic regression, decision tree, and random forest) can improve the 
predictive accuracy. 
Chapter 3 builds upon the previous results and utilizes these missing indicators to reveal 
patient subpopulations based on their similarity in laboratory test ordering being used for 
them. In this chapter, the Density-based Spatial Clustering of Applications with Noise 
method, was employed to group the patients into clusters using the indicators generated in 
the previous study. Results confirmed that missing indicators capture the laboratory-test-
  vi 
ordering patterns that are informative and can be used to identify similar patient 
subpopulations. 
Chapter 4 investigates the performance of a multifaceted PS metric constructed by utilizing 
appropriate similarity metrics for specific clinical variables (e.g. vital signs, ICD-9, etc.). The 
proposed PS metric was evaluated in a 30-day post-discharge mortality prediction problem. 
Results demonstrate that PS-based prediction models with the new PS metric outperformed 
population-based prediction models. Moreover, the multifaceted PS metric significantly 
outperformed cosine and Euclidean PS metric in k-nearest neighbors setting.  
Chapter 5 takes the previous results into consideration and looks for potential 
subpopulations among septic patients. Sepsis is one of the most common causes of death in 
Canada. The focus of this chapter is on longitudinal EHR data which are a collection of 
observations of measurements made chronologically for each patient. This chapter employs 
Functional Principal Component Analysis to derive the dominant modes of variation in septic 
patients’ EHR's. Results confirm that including temporal data in the analysis can help in 
identifying subgroups of septic patients. 
Finally, Chapter 6 provides a discussion of results from previous chapters. The results 
indicate the informativeness of missing data and how PS can help in improving the 
performance of predictive modeling. Moreover, results show that utilizing the temporal 
information in PS calculation improves patient stratification. Finally, the discussion identifies 
limitations and directions for future research. 
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Introduction 
The growing amount of Electronic Health Record (EHR) data has provided the opportunity 
to utilize it for improving healthcare systems and patient outcomes. A recent initiative for 
fulfilling these objectives is precision medicine, the goal of which is to provide treatment and 
prevention strategies that take individual variability into consideration (Collins et al. 2015). 
Patient Similarity (PS) analytics, a novel approach to precision medicine, focuses on 
investigating the similarities in patients’ data so as to provide more customized care 
(Parimbelli et al. 2018). This dissertation is concerned with the application of PS analytics 
among Intensive Care Unit (ICU) patients. It first demonstrates the informativeness of 
missing data among the heterogeneous populations of ICU patients particularly with respect 
to predictive modeling. It then utilizes the proposed data representation to identify patient 
subpopulations based on the similarities in laboratory tests ordered for each patient. After 
that, it shifts its focus to defining a multifaceted PS metric in which similarity scores from 
various metrics—specific to the variable under examination—are aggregated to build the 
final score. Finally, this dissertation takes the findings from previous sections into 
consideration and looks for potential subpopulations among septic patients, with a special 
focus on the longitudinal data collected for this patient cohort. 
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The purpose of this chapter is three-fold: first it presents an overview of the background 
concepts used throughout the dissertation, and then lays out the dissertation’s organization.  
The background section begins with a discussion of the availability of EHR data and their 
potential secondary uses, followed by their challenges in practice. Then, the discussion is 
narrowed down to the application of EHR data in health analytics in population-based and 
personalized applications. With personalized health analytics in mind, PS analytics and its 
promise are introduced. Then, the focus is brought to ICUs, where PS analytics can play an 
important role. After establishing the background for this thesis, a comprehensive review of 
the literature on PS analytics is provided, which forms the core of this thesis. Finally, the 
rationale, arching objectives, and the outline for the rest of this thesis are discussed.  
1.1 Background 
1.1.1 Electronic Health Records and their Secondary Uses 
Along with strategies that have been employed to develop and adopt health information 
technology and EHRs (Coiera 2009; Morrison et al. 2011), billions of dollars of investments 
in this field, such as the nearly 2 billion dollar funding allocated by the Health Information 
Technology for Economic and Clinical Health (HITECH) Act in the United States 
(Blumenthal 2010), have accelerated the adoption of EHR systems and resulted in an 
unprecedented amount of data. According to the International Organization for 
Standardization (2005), an EHR is a “repository of information regarding the health status of 
a subject of care, in computer processable form, stored and transmitted securely and 
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accessible by multiple authorized users, having a standardized or commonly agreed logical 
information model that is independent of EHR systems and whose primary purpose is the 
support of continuing, efficient and quality integrated health care.” This availability of data 
has also opened up the opportunity to utilize EHR for secondary uses like assessing the 
efficiency of health care systems, research for expanding knowledge about diseases and 
treatments, improving public health and health services, etc. According to the American 
Medical Informatics Association (Safran et al. 2007), “Secondary use of health data can 
enhance health care experiences for individuals, expand knowledge about disease and 
appropriate treatments, strengthen understanding about effectiveness and efficiency of health 
care systems, support public health and security goals, and aid businesses in meeting 
customers' needs.”  Studies have also demonstrated that EHR can help in improving the 
quality of care (Kern et al. 2013; Cebul et al. 2011; Campanella et al. 2016) and reducing 
medical errors (Ammenwerth et al. 2008; Devine et al. 2010; Campanella et al. 2016).  
1.1.2 EHR Data Challenges 
EHR data consist of structured/coded and unstructured data. Each category also includes 
various data types for different purposes (Hayrinen et al. 2008). This wide range of data 
types highlights the challenges in EHR secondary uses (Jensen et al. 2012). Moreover, since 
EHR data have not been collected particularly for research purposes, the task of mining these 
data is not trivial due to the following challenges.  
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Incomplete data: EHR data comprise a variety of incomplete information and 
measurements. Since most standard analytical methods require complete data, missing data 
can be problematic. 
Volume and dimensionality: EHRs include enormous amounts of administrative data, 
ancillary clinical data and clinical text reported as numerous variables (Jensen et al. 2012). 
The amount of the data gets even bigger with continuous-monitoring systems. Mining this 
amount of data can be complex and computationally challenging. 
Data complexity:  EHR data consist of information about thousands of variables and their 
underlying relations; therefore, EHR data are highly complex. 
Data quality: Administrative data often refers to billing codes, which will then be used for 
financial reimbursement and sometimes suffer from biases since the amount of 
reimbursement depends on the assigned codes (Jensen et al. 2012). For instance, it has been 
observed that using a diagnosis-related group patient classification system for payment 
system increases secondary diagnoses (Serden et al. 2003). Ancillary clinical data also suffer 
from errors in measurement, collection and data entry processes (Koppel 2009). Clinical text 
has its own sources of imprecision, including lack of normal grammar, and is rich in spelling 
and typing errors (Meystre et al. 2008). 
Temporal data: The temporal nature of EHR data holds the promise to provide more-
detailed data (Singh 2015). However, longitudinal EHR data mining is still in its early stages, 
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and exploring patient trajectories can be complex and computationally demanding (Jensen et 
al. 2012). 
Irregular sampling: EHR data are only recorded when a patient visits a hospital or during 
a healthcare period, which causes varying time intervals between measurements. When using 
non-temporal methods to analyse EHR data, this challenge is well-handled by aggregating 
data over the time window of interest (Singh et al. 2015). However, longitudinal analysis of 
the data can be challenging and requires accounting for dependency of repeated measures 
within the same individual.  
1.1.3 Precision and Population-based Analytics  
With the emergence of the ever-growing amount of EHR data, it is becoming much more 
demanding for clinicians to examine that data in depth and derive actionable insights from 
the overlapping biomedical structures and body-system interactions. Therefore, in recent 
decades, health analytics has been widely utilizing EHR data in the following applications to 
achieve the goals of secondary uses of EHR data. 
Predictive modeling: In the past, medicine was largely a reactive field—a disease is 
treated, when it has been diagnosed (Miner et al. 2014). However, a move toward proactive 
medicine has been initiated (Hood et al. 2009). One particular pathway to proactive medicine 
employs predictive analytics, for instance, to attempt to accurately derive insights from 
available health data to predict disease progression and provide recommendations to optimize 
patient outcomes. Predictive modeling utilizes statistical and machine learning methods to 
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learn from clinical data and subsequently to predict patients’ future health outcomes. Among 
the areas for prediction are graft survival in heart-lung transplants (Oztekin et al. 2009), 
cancer survival (Delen et al. 2005; Zolbanin et al. 2015; Gupta et al. 2014) and future 
hospital admissions (Peck et al. 2013; Li et al. 2009).  
Patient stratification: Many clinical research studies and clinical trials largely rely on the 
identification of a homogeneous study population (Jensen et al. 2012). Moreover, patient 
stratification has been widely used to study risk factors, outcomes and prognoses within 
population groups to uncover underlying attributes (Hu et al. 2016a; Bose et al. 2018). 
Patient stratification analytics employs clustering methods to group patients based on their 
characteristics and similarities (Jensen et al. 2012).  
Care pathway exploration: After disease diagnosis, clinicians come up with a care 
plan—which is a sequence of medical interventions known as a care pathway— using their 
knowledge and the available evidence to control or improve the patient’s health status (Hu et 
al. 2016a). Although effective care plans hold the promise to provide best-care scenarios, 
developing and optimizing them is a challenging task. Care pathway analytics has been used 
to identify the most desirable and effective care plan by deriving and exploring care 
pathways and their associated outcomes, based on EHR data. This approach has been used to 
analyze pediatric asthma care (Basole et al. 2015), congestive heart failure care plans (Perer 
et al. 2013; Gotz et al. 2012a), and vasopressor intervention (Wu et al. 2017). 
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In general, there are two major streams in the aforementioned health analytics: population-
based analytics and precision medicine analytics. 
1.1.3.1 Population-Based Analytics 
Many evidence-based studies have been done on large populations to answer a wide range of 
health-related questions, including the second version of the Acute Physiology and Chronic 
Health Evaluation (APACHE-II) (Knaus et al. 1985), the Framingham heart failure risk 
assessment (McKee et al. 1971), and a study done in southern England to devise a diabetes 
risk score for predicting undetected type 2 diabetes (Griffin et al. 2000). These studies 
provide statistically rigorous results for an average patient. However, they are also relatively 
expensive, time-consuming and prone to population selection bias (Miner et al. 2014). For 
instance, most of these studies are mainly concerned with patients who seek care. 
Additionally, one of the major challenges in evidence-based medicine is multimorbidity, 
which limits generalizing a study to many patients (Campbell-Scherer 2010; Gotz et al. 
2012b).  
Typically, evidence-based medicine utilizes guidelines derived from studies on a large 
population and provides “the average best choice” (Bellazzi et al. 2011). Therefore, 
physicians cannot solely rely on the evidence from the mean of the population when facing 
an individual with special conditions; instead, they must base their recommendations on the 
characteristics of that particular patient. For instance, many patients have been placed on 
Statins, even though only one patient among 50 may benefit (Mukherjee et al. 2002), and 
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certain types of patients may actually be harmed by the drug (Schork 2015; Currie et al. 
2006). If medical researchers can sub-divide the general population into more homogeneous 
sub-groups, they should be able to find similarities among people and tailor their treatments 
accordingly. In other words, clinicians should be able to take individual characteristics into 
consideration. 
1.1.3.2 Precision Medicine Analytics 
Today, personalized medicine, which can be defined as “the tailoring of a treatment to an 
individual based on their unique characteristics” is gaining a lot of attention (Miner et al. 
2014). The treatments may be a medication, an exercise, or any other intervention within the 
field of health. According to the National Research Council, precision medicine is a newer 
term for personalized medicine. The National Institutes of Health defines precision medicine 
as “an emerging approach for disease treatment and prevention that takes into account 
individual variability in genes, environment, and lifestyle for each person.” In fact, there is a 
considerable overlap between the terms precision medicine and personalized medicine. 
Personalized medicine implies the design of a unique treatment for an individual. In order to 
avoid the misinterpretation, that treatment must be developed uniquely for an individual. In 
the US, the President’s Council of Advisors on Science and Technology clarified this 
definition, by stating that precision medicine “does not literally mean the creation of drugs or 
medical devices that are unique to a patient, but rather the ability to classify individuals into 
sub-populations that differ in their susceptibility to a particular disease or their response to a 
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specific treatment” (PCAST 2008 ). Therefore, precision medicine may lead to non-
personalized treatment (Khoury 2016). Another term often used in these discussions is 
genomic medicine; that is, “the use of information from genomes and their derivatives (RNA, 
proteins, and metabolites) to guide medical decision making.” (Ginsburg et al. 2009). 
Unfortunately, personalized medicine, precision medicine, and genomic medicine have 
frequently been used interchangeably in the literature. However, the first two terms are 
broader than genomic medicine (Snyderman 2012). Although genomic medicine has 
undeniable advances and offers the promise to facilitate the move toward personalized 
medicine, more time is needed to translate these advances into health benefits and overcome 
the challenges in the practical implementation of this promise (Conti et al. 2010). One 
approach toward precision medicine is to consider the clinical similarity of patients, then 
tailor health analytics based on a cohort of such similar patients to one index patient by 
utilizing existing EHRs. Therefore, PS analytics can be embedded in health analytics to make 
personalized predictions. This approach can best manage a real-world patient with a complex 
health status and comorbidity. 
1.1.4 Intensive Care Units and ICU Databases 
ICUs provide care to acutely and severely ill patients and were primarily introduced in the 
1950s, with a basis in World War II (Rodriguez 2001b) and a poliomyelitis epidemic in 
Denmark (Reisner-Senelar 2011). Recent studies have shown that these units target diverse 
critically ill patient populations and that close monitoring of these patients has generated an 
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enormous amount of data (Johnson et al. 2016a). Although ICUs have a higher number of 
staff in comparison to other departments (Johnson et al. 2016a), analysis and interpretation of 
this amount of data is challenging for clinicians and must be handled by data analysis 
methods. Therefore, ICU clinicians have adopted EHR systems for collecting and storing 
data (Ghassemi et al. 2015), resulting in ICU databases such as the APACHE Outcomes 
database (Celi et al. 2013), the Philips eICU database (Pollard et al. 2018) and the 
Multiparameter Intelligent Monitoring in Intensive Care (MIMIC) database—recently, 
renamed the Medical Information Mart for Intensive Care (Saeed et al. 2011; Johnson et al. 
2016b). 
In this thesis, the freely accessible MIMIC-III database (Johnson et al. 2016b)—an update 
of the MIMIC-II database—is used. This database, which was released in 2015, has detailed 
information on 53,423 distinct hospital admissions to the critical care units at the Beth Israel 
Deaconess Medical Center in Boston, between 2001 and 2012 (Johnson et al. 2016b). The 
records in this database contain data from various sources, from temporal physiological 
measurements to free-text hospital discharge summaries. The out-of-hospital death dates 
were also collected from the Social Security Administration Death Master File. The data in 
this database were de-identified according to the Health Insurance Portability and 
Accountability Act (HIPPA) standards. MIMIC-III is a relational database and has 26 tables 
that are linked by various identifiers. In this database, the top primary ninth version of the 
International Classification of Disease (ICD-9) discharge codes are: 414.01 (“Coronary 
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atherosclerosis of native coronary artery”, 0.39.9 (Unspecified septicemia’) and 419.071 
(“Subendocardial infarction, initial episode of care”), accounting for 7.1%, 4.2% and 3.6% of 
all hospital admissions, respectively. Overall, there are three classes of tables in this 
database: (i) tables that track patient stays in the hospital, e.g. ADMISSION; (ii) dictionary 
tables, which are look-up tables that map codes to their definitions; (iii) tables that store 
information about patient care, such as clinical measurements and billing information.  
1.2 Patient Similarity Literature Review 
In recent years, the amount of literature on PS analytics has grown enormously. Three recent 
review studies (Parimbelli et al. 2018; Sharafoddini et al. 2017; Brown 2016) point out PS 
analytics’ position as a core topic in precision medicine, stress its potential to fulfill its 
promise, and note its likelihood of remaining a trending topic in this area. Application of PS 
analytics has not been limited to a particular medical problem; various approaches have been 
taken on different EHR databases to improve medication targeting, subgroup discovery, and 
patient outcome prediction. However, some areas such as treatment targeting, missing patient 
data treatment, and longitudinal EHR data analysis have received only limited attention from 
the research community. Therefore, future research efforts in these areas are required to 
accelerate the impact of PS analytics on healthcare. In the next two subsections, a more in-
depth review of the literature in terms of the preprocessing techniques (particularly predictors 
extracting and missing data treatments) and PS modelling is provided to identify potential 
gaps in this research area. 
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1.2.1  Predictor Extraction and Missing Data Treatment in PS Analytics 
Studies 
Predictor extraction from raw EHR data has been one unavoidable component of PS 
analytics research. The variety in raw EHR formats (such as recorded signals, textual reports 
and laboratory measurement) has resulted in many approaches in predictor extraction. While 
for cross-sectional variables such as age and gender the actual value has been used, different 
transformation techniques have been employed to represent longitudinal/time series data. 
These techniques range from simple summary statistics from longitudinal data within a 
particular time window (such as minimum, average, maximum) (Henriques et al. 2015; Lee 
et al. 2015; Panahiazar et al. 2015) to more-complex transformations such as wavelets (Sun 
et al. 2010b; Sun et al. 2010a; Henriques et al. 2015; Lee et al. 2015a; Panahiazar et al. 
2015). For instance, Sun et al. and Saeed et al. ( 2010b; 2006b), respectively, utilized 
Daubechies-4 and Harr wavelet transformations for representing patient vital signs, and 
concluded that wavelet coefficients are better in representing temporal data. Sun et al. (Sun et 
al. 2010b), derived two sets of predictors: Daubechies-4 wavelet coefficients and statistical 
coefficients (mean and variance) from two-hour measurements of vital signs. They defined a 
Mahalanobis distance by solving an optimization problem aiming at minimizing the within-
class squared distances and maximizing between-class squared distances. This similarity 
metric was used to retrieve the three most-similar patients in their k-NN Classifier. This 
study showed that wavelet predictors are better representations of temporal measurements. 
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Recently, natural language processing techniques for extracting predictors from raw EHR 
have received attention from researchers in PS analytics (Saeed et al. 2006a; Wang et al. 
2012a; Wang et al. 2015). In particular, the Term Frequency-Inverse Document Frequency 
(TF-IDF) technique has repeatedly been utilized to produce predictors. This method extracts 
the predictors in three steps: first, a list of the entire observed predictors with a certain value 
in the whole training data set is prepared and named the bag of predictors. For instance, a 
diagnosis code and a discrete glucose serum level can both be considered members in the bag 
of predictors. Then, the ratio of the number of times a predictor appears in a given patient 
profile, 𝑛𝑝 (where p is the predictor), to the total number of predictors in the patient profile, 
𝑛, will be calculated: 
 𝑇𝐹 =
𝑛𝑝
𝑛
 (1.1) 
For TF calculation, a normal clinical event such as a heart rate between 60 to 100 beats 
may be very common in a patient’s profile during a stay in the hospital, and consequently has 
a fairly high TF value. Therefore, IDF is defined as follows to overcome this challenge: 
 𝐼𝐷𝐹 = log2
𝑁
𝑁𝑝
 (1.2) 
where 𝑁 is the number of patient profiles in the training set, and 𝑁𝑝 is the number of patient 
profiles that contain the predictor 𝑝. Again, a normal clinical observation arguably appears in 
every patient’s profile during his or her stay, and consequently the ratio (𝑁/𝑁𝑝) would be 
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close to one, and the IDF value would be close to zero for that particular predictor. 
Therefore, the IDF value is low for common clinical observations and high for rare 
observations. Finally, the TF-IDF value is defined as the simple product of TF and IDF as 
shown below: 
 𝑇𝐹_𝐼𝐷𝐹 =
𝑛𝑝
𝑛
× log2
𝑁
𝑁𝑝
 (1.3) 
Applying this technique to derive predictors could help boost the accuracy of similarity 
assessment for patients with rare conditions; that is, the IDF coding favours patients with rare 
conditions. Wang et al. (2012a) represented patient profiles using the TF-IDF method and 
utilized three bags of predictors: diagnosis codes, medication codes and lab tests. 
Additionally, Saeed et al. (2006a) employed IDF to identify patients with rare conditions. 
While feature extraction has been of interest in PS analytics, missing data in EHR, which is 
one of the most-common challenges in this area to date, has received scant attention in the 
research literature. Most studies choose to omit patients’ data entirely when missingness 
(some missing records) is a feature, and a few studies simply imputed the missing data with 
the average value for that particular variable (Sharafoddini et al. 2017). Sun et al. (2010a) 
took this challenge more seriously and used linear regression to predict missing values based 
on the available values. Since missing data in clinical contexts are considerable and 
inevitable (Weiskopf et al. 2013a; Wells et al. 2013; Little et al. 2012), this lack of evidence 
on missing data treatment in PS analytics highlights a research gap in this area and indicates 
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a need to address the missing data challenge so as to establish an appropriate ground for PS 
analytics. 
1.2.2 The PS Modelling Algorithms 
1.2.2.1 Neighbourhood-based methods 
While various modelling techniques have been used in PS analytics, neighbourhood-based 
methods have received more attention in recent years. The very first study on these methods 
goes back to 1998 (Jurisica et al.). Neighbourhood techniques refer to studies in which a 
group of patients similar to a new patient is retrieved and a prognosis, diagnosis or 
recommendation is provided by a model trained on the data from those similar patients. This 
category of techniques is comparable to memory-based techniques in collaborative filtering, 
in which a new product or a movie is suggested to the customer based on the history of 
similar consumers (Su et al. 2009). One of the most common methods in this category is k-
nearest neighbors (KNN). The overall structure of these techniques is demonstrated in Figure 
1-1. 
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Figure 1-1 An overview of neighbourhood-based PS analytics. 
As can be seen in Figure 1-1, the similarity metric is one of the main components in these 
methods. Various types of similarity metrics including absolute distance (Chattopadhyay et 
al. 2008), Euclidean distance and its family (Bobrowski 2006; Henriques et al. 2015; David 
et al. 2011; Park et al. 2006; Hielscher et al. 2014), Mahalanobis distance and its family (Sun 
et al. 2010b; David et al. 2011; Wang et al. 2012a; Wang et al. 2015; Lowsky et al. 2013; 
Han et al. 2015; Sun et al. 2010a), correlation-based similarity metric (Saeed et al. 2006a) 
and cosine similarity metric (Lee et al. 2015a) have been employed in the literature which 
will be discussed in more detail in this section. 
An early example of research into neighbourhood-based PS modeling is the study by 
Bobrowski (2006) in which a linear data transformation mapped patients to a space in which 
similar patients are closer to each other, and the distance between different patients is greater. 
Then, a KNN model with the Euclidean distance was employed on the mapped data. This 
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two-level PS analytics procedure outperformed the classic KNN. However, the optimal 
number of similar patients (k) remained unanswered in this study. Around the same time, 
Park et al. (2006) investigated the optimal number of similar patients for an index patient. 
The proposed statistical case-based reasoning technique in this study consists of two major 
steps. First, the distribution of pair-wise distances in the training set was derived, and then an 
optimum cut-off which defined a distance threshold was found using a grid search. These 
techniques not only outperformed the one-size fits-all logistic regression (LR), decision tree 
(DT) and KNN, but also the conventional case-based reasoning technique. David et al. 
(2011) employed the Euclidean distance metric in their PS analytics. They first assigned 
random weights to their predictors, then mapped the data to a weighted space. In the next 
step, the Euclidian distance was used to identify patients similar to an index patient within a 
particular threshold. Last, they mapped the data to a lower-dimensional space using singular 
value decomposition (SVD) and examined the discriminative power of the weights. These 
steps were repeated several times to achieve a set of discriminative weights. Unfortunately, 
no comparison method was used in this study, and they only reported the level of agreement 
between their algorithm results and data labeled by a reviewer. 
While some studies utilized only a simple distance metric such as absolute difference 
(Chattopadhyay et al. 2008), other researchers focused on more-complex distance/similarity 
calculation techniques. Sun et al. (2010b) defined a Mahalanobis distance optimized to 
minimize within-class distances and maximize between-class distances. The proposed metric 
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outperformed the conventional Euclidean metric. When they tested the proposed 
Mahalanobis distance on a lower dimensional space mapped by Principal Component 
Analysis (PCA) (Sun et al. 2010b) and linear discriminant analysis (Sun et al. 2010a), it 
outperformed the other models. 
Recently, a number of researchers have started working on integrating multiple PS metrics 
learned separately without the need to share the data that have been used to calculate them. In 
other words, in these methods each care facility requires to share the output labels from the 
identified neighborhood for an index patient not the raw data used for similarity calculations. 
These techniques are very helpful when a number of health facilities want to share insights 
without sharing their patient data. Wang et al. (2011) used this approach and defined a 
quadratic optimization problem aiming to minimize in-class scatterness and maximize 
between-class distances for the weighted sum of the similarity matrices. In another study, 
they proposed a Mahalanobis PS metric learned from a human expert’s ideas (Wang et al. 
2012a). In this study, they first calculated the pair-wise Euclidean distances and then applied 
the expert’s idea on these PS scores by using a similarity matrix and dissimilarity matrix. To 
incorporate expert’s knowledge, two matrices are defined based on the expert’s opinion: 
similarity matrix and dissimilarity matrix. The (𝑖, 𝑗)-th entry of these matrices will be -1, if 
patient 𝑖 and 𝑗 are similar/dissimilar. Otherwise, the entry is equal to the number of patients 
that are similar/dissimilar to the patient 𝑖 based on the expert opinion. If expert knowledge is 
available, these matrices are considered in the global optimization problem. In the same vein, 
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Wang et al. (2015) introduced a two-fold objective function for PS learning: a part focused 
on humans’ expert knowledge and the other based on the available EHR data. In this study, 
the proposed two-fold PS metric outperformed the one based only on patient data. Similarly, 
Huai et al. (2018) considered the idea of learning PS without directly accessing the EHR data 
in their uncorrelated PS learning method. In this study, PS learning was formulated as a 
maximum likelihood problem in which two regularization terms were considered for assuring 
the selection of the most relevant and uncorrelated features. The proposed PS metric 
outperformed all competing metrics, including cosine and Euclidean in a KNN setting. 
Unlike previous studies, that by Lowsky et al. (2013) demonstrated that in survival 
probability prediction using a Kaplan-Meier survival curve, neighbourhood-based PS 
analytics based on the Mahalanobis distance do not show a consistent advantage over the 
Cox model as the baseline. They also found that more-complex models such as Random 
Survival Forest (Ishwaran et al. 2008) outperformed the proposed PS analytics in all 
scenarios.  
A number of authors have considered using PS analytics in feature selection and predictive 
modelling. Hielscher et al. (2014) utilized a two-step PS analytics. They first split the 
training data set into two data sets based on gender. Then, after performing correlation-based 
feature selection to identify the most important features for each group, they used KNN and 
weighted KNN to predict liver fat concentration level for new patients. In this study, 
weighted KNN outperformed the conventional KNN, and it was found that feature selection, 
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by reducing dimensionality, helps predictive modelling performance. Moreover, the fact that 
only a few of the most-predictive predictors within each subgroup were common highlights 
the efficiency of PS analytics and customized predictors. Han et al. (2015) followed the same 
approach for diabetes. They first retrieved a cohort of similar patients using a Mahalanobis 
distance and then selected a subset of predictors common between the new patient and the 
cohort of similar patients. Then, an LR model was trained on the cohort of similar patients to 
make predictions for the new patients. They acknowledged that personalized predictive 
modeling can perform better than conventional models. In their further exploration using 
clustering analysis on the risk factors, they found that patients with similar risk factors were 
grouped together and also that a large number of risk factors were not identified by their 
global model, whereas the PS-based model highlighted them. These results acknowledged 
the importance of using PS analytics in feature selection and modeling in clinical 
applications. 
A Mahalanobis distance metric has also been used in unsupervised settings for finding 
similar patient subpopulations. Panahiazar et al. (2015) utilized this method for 
recommending medication to patients with a history of heart failure. Hierarchical clustering 
was used to find a subpopulation of similar patients, and the cluster was labeled by the most 
commonly used medication in that group. Then, for a new patient, the medication of the most 
similar cluster was recommended. 
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Besides PS measures such as Mahalanobis that have been widely used in the literature, 
some researchers have focused on similarity metrics such as correlation-based (Saeed et al. 
2006a) and cosine similarity metrics. Lee et al. (2015a) examined the performance of PS-
based predictive modelling in comparison to one-size fits-all methods in a systematic set of 
experiments using cosine similarity metrics. They compared the performance of personalized 
and global KNN, LR, and DT models. In all experiments, the PS settings not only 
outperformed the global setting but also the well-known medical scoring systems. It was also 
demonstrated that the size of the cohort of similar patients matters; a very small cohort can 
suffer from small sample size effect and decrease the performance. This study did not 
compare the performance of cosine metric to other metrics. 
1.2.2.2 Other methods 
Other non-conventional PS metrics have also been introduced in the literature. For instance, 
one study (Houeland 2011b) devised a PS metric by combining Euclidean distance and 
random forest. A random forest with decision trees with the height of five (16 terminal 
nodes) was trained first. Then, in the first stage of PS calculation, a cohort of similar patients 
(half of the size of the training set) to an index patient was retrieved using Euclidean 
distance. In the second stage, PS was further investigated using the random forest. Patients 
were sorted based on the number of trees in which they were assigned to the same node as 
the index patient. Then the data from the most similar patients in the second stage were used 
for prediction. This method outperformed the simple Euclidean distance. 
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While some researchers argue that the computational burden of neighbourhood-based PS 
analytics increases as the number of patients increases and requires more memory, a group of 
researchers have introduced the idea of implementing all steps of PS analytics ranging from 
predictor extraction to PS calculation in a database using Structured Query Language (SQL), 
which will be independent of Random Access Memory (RAM) size (Wiese et al. 2018; 
Tashkandi et al. 2018). In a comprehensive evaluation framework, this study demonstrated 
that PS calculation is more time-efficient in the database systems than the data mining tools 
(ELKI and Apache Mahout). Investigating the performance of cosine similarity and 
Euclidean distance, it was shown that Euclidean distance calculation is more time-consuming 
in the databased systems. 
Although the literature (Perlman et al. 2011) suggests using various similarity metrics for 
different variables (for instance an ECG similarity metric, age similarity metric, and gender 
similarity metric)—because using just one similarity metric for all predictors may miss 
information relevant to prediction—only one study (Gottlieb et al. 2013) has taken this into 
consideration and defined eight similarity metrics between hospitalizations and two for ICD 
codes. All these similarity scores then formed the hospitalization-discharge code 
associations. Then, the researchers combined these measures into 16 hospitalization-
discharge code associations.  
PS has also been used with other types of similarity. Zhang et al. (2014b) combined PS 
analytics with drug similarity analytics to provide personalized drug recommendations on 
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hypercholesterolemia treatment. Three sets of Jaccard similarities were considered in this 
study: a) patient-patient similarity based on ICD-9 codes b) drug-drug similarity based on 
chemical structure and c) patient-drug similarity based on the ICD-9 diagnosis codes of 
patients and ICD-9 format drug indications from the MEDI database. Then, a label-
propagation algorithm was employed to measure the efficiency of each of the available four 
drugs for a given patient in three settings: employing PS, drug similarity, and a combination 
of both similarities. The latter setting outperformed the others, suggesting that combining PS 
with drug similarity can help achieve personalized medicine. 
Some studies have used predictive modeling for PS calculation. Wang (2015) introduced 
an Adaptive Semi-Supervised Recursive Tree Partitioning (ART) method to calculate 
pairwise PS with less computational burden. In this method, the tree is constructed based on 
two objective functions: a term based on expert knowledge and a term based on information 
from EHR data. This study also provided a kernelized tree-construction framework. The 
proposed method performed better than all methods they compared it with. 
Zhang et al. (2018) utilized a Gaussian process in which a kernel function measured the 
similarity between the available patient data and that of new patients and reported a weighted 
average of all retrieved diagnoses. In this study, the inverse of similarity scores was used as 
the weights. The proposed method outperformed not only linear regression and DT, but also 
ranked the highest in the Alzheimer’s Disease Big Data DREAM Challenge. 
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With the availability of big EHR databases, PS analytics has received attention from 
researchers in the deep learning field. To date, several researchers have investigated the idea 
of measuring PS via a deep neural network. Zhu et al. (2017) employed medical concept 
embedding (word2vec) to demonstrate the medication events, and then a convolutional 
neural network (CNN) was modified to derive pair-wise PS scores. In their network, patients’ 
features are filtered through the convolutional layer, and then feature maps demonstrating 
patients’ clinical characteristics are used for measuring PS. Suo and colleagues (Suo et al. 
2017) also employed CNNs for PS calculation from ICD-9 codes. Their time-fusion CNN 
also learned the local temporal relationships between the codes and accounts for the time 
intervals between the codes. The proposed method outperformed the conventional PS metrics 
in KNN, weighted sampling, and personalized LR settings. 
The evidence reviewed in this section suggests that PS analytics can often outperform one-
size fits-all models. The contradictory evidence to this hypothesis suggests the need 
for further investigation of PS analytics' performance compared to population-based 
analytics. Together these studies provide insights into how PS can be employed in various 
stages of modelling. There remain several domains in PS that would benefit from further 
research, such as PS visualization, missing data treatment, and longitudinal data processing. 
1.3 Thesis Rationale 
As described in sub-section 1.1 Background, PS analytics is an emerging field and has 
repeatedly been used in various applications. While many studies have been done in this area, 
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most of them still suffer from poor handling of missing data and longitudinal data, and lack 
of interpretability in their PS calculation. There has been some research on missing data 
treatment in EHR databases; however, in-depth research is lacking on the potential 
informativeness of this missingness and how it can be converted to useful information. 
Therefore, a move away from traditional missing data treatment toward more-informative 
methods is needed. Moreover, studies on PS calculation have shown remarkable results in 
predicting outcomes; however, such predictive performance has been achieved at the expense 
of trading off the explainability of the method. In particular, studies in which deep learning 
has been used to calculate PS suffer from lack of interpretability and transparency.  Although 
researchers in the field of explainable artificial intelligence are working on making these 
networks more interpretable, we should bear in mind that one of the PS analytics promises is 
to help clinicians in their decision making. Therefore, any PS calculation must be able to 
answer at least one question for clinicians: “why are these two patients similar?”. Besides 
interpretability of PS calculation, there is also a need for more research on methods for 
including longitudinal data in PS analytics. Therefore, the overall goal of this thesis is to 
learn more from missing data in EHRs and use this information to identify patient 
subpopulations, introduce an explainable multifaceted PS metric, and take PS analytics into 
application, with a special focus on longitudinal data processing. Moreover, this thesis 
utilizes data from ICU patients, since there is a wealth of high-resolution data available in 
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many ICUs and PS analytics can be helpful in deriving insights from these complex and 
heterogenous ICU patient data. 
1.4 Thesis Organization 
1.4.1 Thesis Outline 
The six chapters of this thesis comprise this introduction; four studies, all written in the form 
of journal or conference papers; and a general conclusion. To date, the first two studies have 
already been published, and the other two are very close to being submitted. The first study 
(Chapter 2) focuses on missing data, one of the main challenges in working with EHR data. 
This study, by utilizing a new data representation method (missingness indicators), 
investigates the informativeness of missing data in ICU EHR and how we can learn from 
missing data and use them in predictive modeling (Sharafoddini et al. 2019). The second 
study (Chapter 3) builds upon the first and utilizes the missingness indicators to capture 
laboratory-test-ordering patterns in ICU and uses this information to find subpopulations of 
similar patients in the ICU (Sharafoddini et al. 2018). The third study (Chapter 4) takes PS 
analytics further and introduces a multifaceted PS metric by which the PS is explainable. The 
proposed metric considers ICU PS from different aspects and investigates whether PS 
analytics is always a better alternative to population-based analytics. This study focuses on 
30-day ICU mortality prediction. The last study (Chapter 5) applies all findings 
from the previous studies to a specific application, with a special focus on longitudinal 
data, and investigates the possibility of having subpopulations in septic patients. 
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Finally, Chapter 6 summarizes the findings from the four studies and discusses their 
limitations. This chapter also provides some possible future directions for interested 
researchers.   
1.4.2 Overarching Objectives 
Although each of the aforementioned studies had its own distinct objectives, the overarching 
goals of this thesis are to: 
1. Explore the informativeness of missing data in an ICU database and introduce a new 
data representation that can measure PS in terms of missingness (Chapter 2). 
2. Utilize missingness similarity in the context of PS analytics to identify 
subpopulations of ICU patients with similar laboratory test ordering patterns (Chapter 
3). 
3. Aggregate various aspects of PS in one PS metric to capture the similarity of ICU 
patients from different perspectives (vital signs, laboratory tests, etc.) in order to 
improve 30-days post-discharge mortality prediction (Chapter 4).  
4. Utilize the multifaceted PS to investigate the heterogeneity of a cohort of ICU septic 
patients and identify groups of similar patients while including the vital signs 
trajectories in PS calculation (Chapter 5). 
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A New Insight Into Missing Data in Intensive Care Unit Patient 
Profiles: Observational Study 
This chapter investigates the informativeness of missing data in patient profiles and 
introduces a new data representation technique that can be used in PS similarity calculations 
for evaluating similarity in terms of missingness. This chapter was originally published in 
January 2019 and revisions have been made to the current copy based on the thesis 
committee’s reviews. The full citation is as follows: Sharafoddini, A., Dubin, J. A., Maslove, 
D. M., & Lee, J. (2019). A New Insight Into Missing Data in Intensive Care Unit Patient 
Profiles: Observational Study. JMIR Med Inform, 7(1), e11605. doi:10.2196/11605 
 
2.1 Abstract 
Background: The data missing from patient profiles in intensive care units (ICUs) are 
substantial and unavoidable. However, this incompleteness is not always random or because 
of imperfections in the data collection process. 
Objective: This study aimed to investigate the potential hidden information in data missing 
from electronic health records (EHRs) in an ICU and examine whether the presence or 
missingness of a variable itself can convey information about the patient health status. 
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Methods: Daily retrieval of laboratory test (LT) measurements from the Medical 
Information Mart for Intensive Care III database was set as our reference for defining 
complete patient profiles. Missingness indicators were introduced as a way of representing 
presence or absence of the LTs in a patient profile. Thereafter, various feature selection 
methods (filter and embedded feature selection methods) were used to examine the predictive 
power of missingness indicators. Finally, a set of well-known prediction models (logistic 
regression [LR], decision tree, and random forest) were used to evaluate whether the absence 
status itself of a variable recording can provide predictive power. We also examined the 
utility of missingness indicators in improving predictive performance when used with 
observed laboratory measurements as model input. The outcome of interest was in-hospital 
mortality and mortality at 30 days after ICU discharge. 
Results: Regardless of mortality type or ICU day, more than 40% of the predictors 
selected by feature selection methods were missingness indicators. Notably, employing 
missingness indicators as the only predictors achieved reasonable mortality prediction on all 
days and for all mortality types (for instance, in 30-day mortality prediction with LR, we 
achieved area under the curve of the receiver operating characteristic [AUROC] of 
0.6836±0.012). Including indicators with observed measurements in the prediction models 
also improved the AUROC; the maximum improvement was 0.0426. Indicators also 
improved the AUROC for Simplified Acute Physiology Score II model—a well-known ICU 
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severity of illness score—confirming the additive information of the indicators (AUROC of 
0.8045±0.0109 for 30-day mortality prediction for LR). 
Conclusions: Our study demonstrated that the presence or absence of LT measurements is 
informative and can be considered a potential predictor of in-hospital and 30-day mortality. 
The comparative analysis of prediction models also showed statistically significant prediction 
improvement when indicators were included. Moreover, missing data might reflect the 
opinions of examining clinicians. Therefore, the absence of measurements can be informative 
in ICUs and has predictive power beyond the measured data themselves. This initial case 
study shows promise for more in-depth analysis of missing data and its informativeness in 
ICUs. Future studies are needed to generalize these results. 
Keywords: Electronic Health Records; Clinical Laboratory Tests; Imputation Methods; 
Feature Selection Methods; Machine Learning; Mortality Prediction. 
2.2 Introduction 
2.2.1 Background 
The increased adoption of electronic health record (EHR) systems has boosted interest in the 
secondary use of EHR data (Weiskopf et al. 2013c). Although the literature has introduced 
various dimensions for EHR data quality, completeness and correctness have been reported 
as the fundamental dimensions (Weiskopf et al. 2013c; Chan et al. 2010). Although these 
issues can also be observed in paper-based records, EHR brought us the opportunity to 
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identify them faster and helped us with addressing them. The data missing from clinical 
contexts are substantial (Weiskopf et al. 2013a; Wells et al. 2013) and unavoidable (Little et 
al. 2012); many studies have focused on resolving this issue (Sterne et al. 2009; Haukoos et 
al. 2007; Newgard et al. 2007). Although many researchers treat missing data as a challenge 
(Pringle et al. 1995; Thiru et al. 2016; Forster et al. 2008; Jones et al. 1986; Porcheret et al. 
2004; Soto et al. 2002; Tang et al. 1999; Jensen et al. 2009; Botsis et al. 2010; Sharafoddini 
et al. 2017), others continue to debate whether lack of completeness also provides useful 
information (Wells et al. 2013; Rusanov et al. 2014; Weiskopf et al. 2013b; Agniel et al. 
2018). Researchers do agree that a part of this incompleteness is not random or because of 
imperfections in the data collection process (Kuhn et al. 2013; Agniel et al. 2018). Recently, 
Angiel et al. (2018) demonstrated that the laboratory ordering time (ie, the interval between 2 
orders of a laboratory test; LT) for some LT is more informative than the actual values in 
predicting 3-year survival. Our study focuses on systematically investigating the implications 
or possible value of lack of data, particularly in intensive care units (ICUs) and proposes a 
representation method for missing data to capture hidden information. In general, two 
reasons are given for missing data in EHRs: 
• No intention to collect: the clinical variable was never measured because there was no 
clinical indication to do so—the patient was not suffering from a relevant symptom or 
comorbidity (Wells et al. 2013), or it could not be measured (Rusanov et al. 2014). 
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• Intention to collect: records are missing although the variables were measured (Wells 
et al. 2013). 
Therefore, the health care process (e.g., clinicians’ decision to order a test and nurse data 
entry) affects the recorded EHR and can cause incompleteness in data. 
Incomplete EHR data can complicate or prohibit the data analysis process, as many 
machine learning (ML) algorithms assume that there are no missing data in the dataset or 
require users to clean the data in the preprocessing stage and so provide a complete dataset. 
Therefore, from a research perspective, the ideal situation is to increase the amount and 
accuracy of EHR documentation by employing approaches that focus on intention to collect, 
such as reducing the error in data entry or increasing data documentation in terms of 
resolution. Although the current amount of testing and bloodwork has been reported as 
actually redundant in ICUs (Lee et al. 2015b; Oliveira et al. 2014; Cismondi et al. 2013) and 
requires extra time and work from clinicians (Wells et al. 2013), these approaches suffer 
from their own shortcomings. Besides analytical methods that can handle missing data (that 
are missing at random) such as decision trees (DTs) or mixed-effects models for longitudinal 
data, other approaches usually assume missing data are missing completely at random. In 
general, the literature proposes 3 analytical approaches: complete case analysis (CCA) or 
deletion, available case analysis (ACA), and imputation. 
CCA starts with the list of variables included in the analysis and discards records with 
missing data on any of the variables. However, this subsample might not be a random sample 
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of the population. Although researchers argue that sample selection based on the predefined 
eligibility criteria in randomized clinical trials can limit the external generalizability of these 
studies (Rothwell 2005), CCA in studies using EHR data can also potentially threaten the 
external validity of a study (Rusanov et al. 2014) and cause bias as the literature shows a 
statistically significant relationship between severity of illness and data completeness 
(Weiskopf et al. 2013b). For example, a study (Rusanov et al. 2014) on 10,000 EHRs from 
patients receiving anesthetic service showed that patients with an anesthesiologists physical 
status (ASA) (Delegates 2014) class 4 fitness rating had 5.05 more days with laboratory 
results and 6.85 more days with medication orders than patients with ASA class 1, suggesting 
more data are recorded for sicker patients than healthier patients. Thus, imposing complete 
case requirements when using EHR data for secondary use can cause bias toward selecting 
patients with more severe conditions (or several comorbidities). Despite this drawback, CCA 
has been identified as the leading approach in studies on ICU data (Vesin et al. 2013). That 
said, CCA provides valid inference only when data are missing completely at random 
(MCAR), which is unlikely in practice (Fitzmaurice et al. 2011). 
The ACA (or pairwise deletion) utilizes all available data for a given analysis. In other 
words, it maximizes the availability of data by an analysis-by-analysis basis (Baraldi et al. 
2010). The advantage of this method is that more data are included in each analysis than with 
CCA. It also allows for valid inference by likelihood-based models when missing data are 
ignorable—often the case when the data are missing at random (MAR) (Fitzmaurice et al. 
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2011). In each analysis, the ACA method utilizes the data points that are needed for that 
particular analysis. For instance, in correlation analysis to measure the correlation for each 
pair of variables, ACA uses the data points that have the information for those variables in 
each analysis resulting in varying samples. Although ACA is an improvement to CCA 
(Baraldi et al. 2010), it also has limitations. As different samples are being used in each 
analysis, not only is comparison of various analyses impossible (Stockdale et al. 2016) but 
also, using different samples for estimating the parameters of interest has occasionally led to 
biased or mathematically inconsistent results (Myers 2011; Pigott 2010; Roth 1994). 
Imputation methods, which try to draw inferences from incomplete data, rely on knowing 
the mechanism of missingness, which cannot be validated from the available data. Single 
imputation methods suffer from 2 problems. First, an inference based on imputed data can be 
biased if the underlying assumptions are not valid. Second, because imputed data are 
assumed to be true, the model’s statistical precision is overstated. Multiple imputation 
methods, in spite of their promising performance, rely on parametric assumptions that, if not 
valid, can lead to incorrect imputation. Due to these limitations, imputation methods should 
be used with caution, and checking underlying assumptions with clinicians is highly 
recommended (Little et al. 2012). However, Gorelick (2006) in a simulation study, 
demonstrated that either CCA or imputation could cause bias in predictive modeling, and that 
assuming missing values to be normal when missingness rates are high and substituting them 
with normal values would also cause substantial bias. In brief, if primary assumptions are not 
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fully satisfied, neither considering complete or available cases nor imputing missing data is 
likely to yield reliable results. Furthermore, these statistical methods on their own are not 
sufficient to capture the hidden information about the patient health status and care process in 
the complex EHR data. Alternatively, we can try to learn from what is missing rather than 
only dealing with missingness as a deficiency. 
2.2.2 Objectives 
This case study provides evidence that ‘missing data’ in ICU might be missing because of the 
patient’s health status or health care process and introduces a new method for representing 
patient profiles. In this representation, auxiliary variables, called indicators, are used to 
represent the presence or absence of a measurement and might convey the possible hidden 
information in the missing data. Then, by employing various analytical methods, this study 
attempts to demonstrate the informativeness of missing data. In the rest of the study, the 
term missing data is used to describe not-at-random missing information in patient profiles. 
In other words, the potential informativeness of data that has not been recorded by choice is 
of interest. 
2.3 Methods 
2.3.1 Measurement Protocol and Data Collection 
As patient monitoring strongly relies on clinical needs, no universal standards for ICU data 
completeness have been established (Schulman et al. 2010; Asiimwe et al. 2014; Cardona-
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Morrell et al. 2015). However, a study by Frassica in 2005 published a list of the top 80% of 
LTs common to all ICU patients within a university teaching hospital. We revised this list 
based on the presence of these tests in our database and updated it with input from an ICU 
clinician to reflect current practices (Table 2-1). 
Table 2-1 Thirty six laboratory tests used in investigating informativeness of missing 
data. 
Variable Category Variables 
Top 80% laboratory tests and 
profiles common to all ICUs 
(Frassica 2003) reviewed and 
revised by domain expert 
Alanine Aminotransferase (ALT); Alkaline Phosphatase (ALK);  Aspartate 
Aminotransferase (AST); Arterial blood gases: pH, PCO2, PO2, Base Excess 
(BE); Basic metabolic panel: Sodium (Na), Potassium (K), Chloride (Cl), 
Bicarbonate (HCO3), Anion Gap (AG), Blood Glucose (BG), Blood Urea 
Nitrogen (BUN), Creatinine (Cr); Complete blood count: White blood 
cells (WBCs), red blood cells (RBCs), Hemoglobin (HGB),  
Hematocrit (HCT), Mean corpuscular volume (MCV),  
Mean corpuscular hemoglobin(MCH), Mean corpuscular hemoglobin 
concentration (MCHC), Red cell distribution width (RDW), Platelet count 
(PLT), Absolute Monocytes (MO), Absolute Eosinophils (EO), Absolute 
Basophils (BA), Absolute  Lymphocytes (LY), Absolute Neutrophils (NE); 
Lactate (Lac); Calcium (Ca); Magnesium (Mg); Phosphorus/ Phosphate (Phos); 
Partial Thromboplastin Time (PTT); Prothrombin Time (PT); Total Bilirubin 
(TBil). 
 
The data for this study were collected from the Medical Information Mart for Intensive 
Care III (MIMIC-III) (Johnson et al. 2016b) database which contains data from 38,597 
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distinct adult patients admitted to the Beth Israel Deaconess Medical Center in Boston, 
Massachusetts, between 2001 and 2012. For patient cohort selection, a tailored version of the 
generalized cohort selection heuristics for retrospective EHR studies introduced by Harrell et 
al. (2016) was used. The data for first admission to 1 of the 5 ICUs—medical ICU, surgical 
ICU, cardiac care unit, cardiac surgery recovery unit, and trauma surgical ICU—were 
extracted for adult patients (aged 15 years or older). Included patients must have had at least 
one data point in any of the variable categories during the first, second, and third days of 
their ICU stay. 
2.3.2 Data Preprocessing and Missing Data Representation 
Each day’s extracted data were mapped into a matrix with columns for measurements and 
rows for patients. Therefore, we had a column for each daily measurement of LTs, resulting 
in 36 columns for LTs.  An auxiliary matrix was generated to store binary values reflecting 
the presence (0) or absence (1) of measurements. Since many well-performing ML 
algorithms are designed to work with a complete data matrix, two methods—Predictive 
Mean Matching (PMM) (Little 1988) and Hot Deck (HD)—were used to impute missing 
laboratory test measurements. PMM is a commonly used and well-accepted imputation 
method in public health research (Zhou et al. 2001) and is also robust against model 
misspecification (Buuren 2012). HD imputation is used commonly in applied data analysis 
when missing data exist (Andridge et al. 2010). 
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Given that imputed values are indistinguishable to the ML algorithm from true values, we 
combined the original matrix and auxiliary matrix to form an augmented matrix that directly 
indicates where values were imputed. This was done to mitigate the risk of treating imputed 
values the same as actual values, in a setting where the underlying reason for missing data is 
not fully known (Figure 2-1). Missing data indicators in this augmented matrix might also 
provide extra information about the reliability of the values (actual and imputed values) and 
potentially preserve any meaningful missing data patterns. Missingness indicators have been 
used as a method of handling missing data in epidemiological and clinical studies. However, 
in the current use of indicators, missing values are set to a fixed value (0 or the normal value 
for the variable) and the indicators are used as dummy variables in analytical models to 
indicate that a value was missing (Abraham et al. 2004; Groenwold et al. 2012). Studies have 
shown that this method causes bias as the missing values are imputed with a single value 
(Knol et al. 2010). In our study, we are not using indicators as dummy variables; instead, we 
are introducing them as a source of information to be used besides imputation methods. 
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Figure 2-1 An example of the augmented data matrix, the imputed data matrix 
(imputed values are underlined and italicized) and the auxiliary matrix (containing the 
missingness indicators: 0-present, 1-absent). 
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2.3.3 Validation 
Several validation techniques are available in medical research. In this study, for all 
experiments where applicable, we used cross-validation technique (10-fold cross-validation). 
We also repeated the cross-validation procedure several times (20 times) to acquire more 
stable results as suggested in the literature (Steyerberg 2009). 
2.3.4 Assessments 
2.3.4.1 Exploratory Analysis 
First, the trends of missingness among LTs were visualized for comparison. Afterward, 
pairwise correlation among indicators, using Phi coefficient, was done to explore the general 
behavior of missingness. The Elixhauser (1998) and the Charlson (1987) comorbidity indices 
are the most common comorbidity scores in clinical applications. The literature has shown 
that the Elixhauser Comorbidity Index (ECI) in general has the best performance in 
predicting mortality (Menendez et al. 2014; Southern et al. 2004; Farley et al. 2006; 
Sharabiani et al. 2012). This better performance can be the result of (1) including new 
comorbidities in ECI, (2) the differences in the coding of variables common between both 
indices, or (3) a combination of the first and second factors (Southern et al. 2004). The 
Simplified Acute Physiology Score II (SAPS-II) (Le Gall et al. 1993) scoring system that has 
been widely used by most ICUs for predicting illness severity was also chosen. Therefore, 
the association of missingness rates with ECI and SAPS-II was investigated using Spearman 
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correlation. Besides the clinical information, SAPS-II also has the information about type of 
admission (scheduled surgical, medical, or unscheduled surgical) and presence of 3 chronic 
diseases (metastatic cancer, hematologic malignancy, and AIDS). 
2.3.4.2 Feature Selection 
After exploratory analyses, we assessed the importance of the indicators as potential 
predictors. First, we used feature selection methods, which are widely used to determine 
which predictors should be used in a model, particularly for high-dimensional data (Kuhn et 
al. 2013). Two copies of the augmented matrix (derived from HD and PMM imputation) 
were fed to various feature selection methods. Our study considered in-hospital and 30-day 
post-discharge mortality as outcomes. Overall, we used 2 categories of supervised feature 
selection methods described below. 
 First, filter techniques evaluated the importance of a predictor by looking at data 
properties. Filter methods, in general, use a metric to identify irrelevant features and filter out 
the redundant predictors form the data matrix (Saeys et al. 2007). We selected 3 different 
metrics: LR beta value, Relief algorithm (Robnik-Šikonja et al. 2003), and Information Gain 
(InfGain) (Peng et al. 2005). The Relief algorithm examines the relevance of predictors based 
on their power to distinguish between similar patients with the same and different outcome. 
InfGain measures the reduction in entropy of the class variable achieved by partitioning the 
data based on the index predictor; relevant predictors receive a high InfGain value (Mitchell 
1997). This ensemble of the scoring methods was then used to determine the normalized 
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informativeness of all predictors. Aggregating these methods in one score provides a tool for 
comparing predictors from different aspects.  
Second, we used embedded techniques to search for the optimal set of predictors. In these 
techniques, feature selection is embedded in the model’s construction and interacts with the 
classifier. Least absolute shrinkage and selection operator (LASSO), used in this study, is a 
penalizing method in this category. LASSO regression in its objective functions considers a 
penalty that equals to the sum of the absolute values of the coefficients. As absolute function 
(L1 norm) is not differentiable, the estimated coefficients are close to 0, and some will be 
exactly 0 resulting in an automatic variable selection. For this and the next experiments, 10-
fold cross-validation with 20 repeats was used (leading to 200 repetitions in total). This 
number of repetitions is recommended to achieve desired accuracy for prediction 
performance estimation (Steyerberg 2009). 
2.3.4.3 Predictive Modeling 
In the last assessment, we first trained group of classification models, including DT, logistic 
regression (LR), and random forest (RF), on the indicator and imputed data matrices and 
evaluate their performance for predicting desired outcomes using the area under the curve of 
the receiver operating characteristic (AUROC) validation metric. Thereafter, new models 
were trained using the augmented data matrix and their performance was compared with that 
of the original to determine whether the indicators have predictive power and can boost the 
models’ predictive accuracy. We also investigated the predictive performance of SAPS-II 
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score, and then we added indicators to these scores to examine the impact of indicators 
beyond SAPS-II score. It is worth mentioning that in this assessment, the absolute accuracy 
of the models is not of our interest, instead, the relative improvement in the performance 
when including indicators as input. That is, achieving the best possible mortality prediction 
AUROC is not the objective of this study. 
2.4 Results 
2.4.1 Population 
The analyses of the first 24 hours after admission to ICU included 32,618 patients but 
decreased to 20,381 for the second 24-hour interval, as many patients were discharged after 
24 hours. The third 24-hour period included 13,670 patients. Of these groups, 10.99% 
(3586/32,618), 13.59% (2769/20,381), and 16.19% (2213/13,670) experienced death in-
hospital and 15.12% (4933/32,618), 18.26% (3722/20,381), and 21.32% (2915/ 13,670) 
experienced death within 30 days of discharge, respectively. Figure 2-2 demonstrates the 
retrospective study design. 
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Figure 2-2 The retrospective cohort study design. LOS: length of stay. 
2.4.2 Exploratory Analysis 
Missingness rates for LTs range from 1.36% (445/32,618) to 88.27% (12066/13,670) in the 
first 72 hours after admission. Figure 2-3 shows the missingness rate for LTs over 3 days. 
Absolute basophils (BA), absolute eosinophils (EO), absolute monocytes (MO), absolute 
lymphocytes (LY), absolute neutrophils (NE), alanine aminotransferase (ALT), alkaline 
phosphatase (ALK), aspartate aminotransferase (AST), total bilirubin (TBil), and lactate 
(Lac) were among the less-common LTs and were missing in the profiles of more than 60% 
of patients. 
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Figure 2-3 The average missingness rate among patients for laboratory tests in the 
first 72 hours of admission. 
We calculated the association between each indicator and the mortality flag. Although 
association values were small, on day 1, ALT, ALK, AST, and TBil stand out as the top LTs 
associated with both types of mortality. On days 2 and 3, partial pressure of carbon dioxide 
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(PCO2), partial pressure of oxygen (PO2) and base excess (BE) were the top LTs associated 
with both mortality types. Lac also joined the top tests on day two for 30-day mortality. 
Detailed association values are provided in Appendix C. 
Figure 2-4 visualizes the pairwise correlations among indicators. In total, 7 major groups 
of highly correlated (ρ ≥.95) indicators were observed in the results using Phi coefficient: (1) 
BA, MO, NE, EO, and LY; (2) mean corpuscular hemoglobin concentration (MCHC), red 
cell distribution width (RDW) mean corpuscular volume (MCV), red blood cell (RBC), and 
mean corpuscular hemoglobin (MCH); (3) BE, PCO2, and PO2; (4) TBil, ALT, AST, and 
ALK; (5) Blood urea nitrogen (BUN) and creatinine (Cr); (6) chloride (Cl) and bicarbonate 
(HCO3); (7) partial thromboplastin time (PTT) and prothrombin time (PT). 
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Figure 2-4 Visualization of the correlation matrix for variable indicators in first 72 
hours. 
The Spearman correlation between missingness rates and ECI was also calculated daily. 
Results show a statistically significant correlation between these variables (day 1: ρ=–.233; 
day 2: ρ=–.196; day 3: ρ=–.184; P<.001). The same assessment was done using SAPS-II. The 
results were in line with the previous one and demonstrate higher correlation (day 1: ρ=–
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.315; day 2: ρ=–.277; day 3=–.234; P<.001). These findings are interesting as they confirm 
that the missingness of data is associated with patient severity of illness. 
2.4.3 Feature Selection: Missing Data Indicators as Important Predictors 
Each of the imputation methods was applied to the original dataset, and the potential 
informativeness of missingness indicators in comparison with actual variables was 
investigated using an ensemble of the most representative filter selection methods (Aggarwal 
2014): LR beta value, relief, and InfGain. Table 2-2 shows the top 18 variables selected on 
each day based on the PMM-generated imputed matrix predicting 30-day mortality. BUN, 
RDW, and anion gap (AG) were among the top variables in all 3 days. Indicators for TBil, 
phosphate (Phos), calcium (Ca), and Lac were selected on the first day, whereas indicators 
for Lac, BE, PO2, and PCO2 were among the top features on the second and third days. PTT 
and pH indicators were also among the important indicators on the third day. 
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Table 2-2 The top 18 variables selected on each day after employing predictive mean 
matching imputation with regard to 30-day mortality. The ‘I’ at the beginning of the 
variables’ names means indicator. Numbers represent the ranking after aggregating the 
ranking results from the 3 different feature selection methods. 
Day 1 Day 2 Day 3 
Variable Score Variable Score Variable Score 
BUN 0.762397 AG 0.795419 RDW 0.748997 
RDW 0.680087 HCO3 0.783337 BUN 0.666667 
MCHC 0.668965 BUN 0.77677 HCO3 0.544964 
AG 0.540484 BE 0.609532 BE 0.540542 
I-Ca 0.436429 RDW 0.608711 pH 0.488433 
Cr 0.436071 I-PO2 0.587151 AG 0.450426 
HCO3 0.416741 I-PCO2 0.585947 I-Lac 0.418716 
PO2 0.404289 I-BE 0.585592 I-pH 0.40463 
MCV 0.386964 Cl 0.53158 Cr 0.400008 
I-Phos 0.374431 PT 0.462085 Phos 0.387661 
PTT 0.353913 Lac 0.461869 I-PCO2 0.387019 
HGB 0.342786 Cr 0.451999 I-PO2 0.386739 
pH 0.32767 PTT 0.424956 I-BE 0.385935 
Lac 0.320339 Na 0.422474 PCO2 0.367257 
BE 0.320299 Phos 0.419171 NE 0.360791 
I-Lac 0.318216 I-Lac 0.415475 MCV 0.351266 
PCO2 0.316668 MCV 0.368343 I-PTT 0.338352 
I-TBil 0.31277 MCHC 0.363146 Lac 0.331205 
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Similar results were observed when using the HD imputation method, except that ALT and 
Phos were also selected on the first and second day, respectively. Moreover, PTT and pH 
indicators were not among the important indicators on the third day. Detailed results of this 
assessment can be found in Appendix C. 
Results for in-hospital mortality were slightly different (Table 2-3). Although the selected 
indicators were almost the same as for 30-day mortality, more indicators were selected on the 
first day for in-hospital mortality, implying that indicators are more associated with in-
hospital mortality than 30-day mortality. Detailed results are available in Appendix C. 
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Table 2-3 The top 18 variables selected on each day after employing predictive mean 
matching imputation with regard to in-hospital mortality. The ‘I’ at the beginning of the 
variables names means indicator. Numbers represent the ranking after aggregating the 
ranking results from the 3 different feature selection methods. 
Day 1 Day 2 Day 3 
Variable Score Variable Score Variable Score 
BUN 0.825715 BUN 1 RDW 0.75246 
AG 0.668918 RDW 0.711852 BUN 0.635729 
RDW 0.573188 HCO3 0.684191 BE 0.633926 
HCO3 0.531746 AG 0.664339 HCO3 0.62367 
MCHC 0.507343 BE 0.528778 I-BE 0.595553 
PCO2 0.489483 MCHC 0.503805 I-PCO2 0.595238 
Cr 0.480181 PT 0.453111 I-PO2 0.594924 
BE 0.452599 Cl 0.429405 pH 0.556242 
I-LAC 0.436382 I-LAC 0.425279 Phos 0.494694 
LAC 0.415773 Cr 0.395266 AG 0.492864 
HGB 0.414263 I-PO2 0.382404 I-pH 0.470007 
pH 0.402466 I-PCO2 0.381737 I-LAC 0.469215 
I-TBil 0.399363 I-BE 0.381448 Cr 0.415249 
I-Ca 0.395278 PTT 0.357339 LAC 0.396136 
I-ALT 0.376004 Phos 0.352738 NE 0.338372 
I-AST 0.375944 Na 0.345109 PT 0.326491 
LY 0.375163 I-PT 0.333936 LY 0.319146 
I-ALK 0.366346 BG 0.320947 MCV 0.314868 
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To validate our previous results, we assessed the predictive power of the indicators using 
embedded feature selection methods. Each day, a LASSO model was trained on the 
augmented data from HD and PMM imputation using 10-fold cross-validation with 20 
repeats. In general, the AUROC of mortality prediction (in-hospital and 30-day 
postdischarge) and number of selected variables decreased from days 1 to 3 (Table 2-4). 
Moreover, prediction of in-hospital mortality resulted in higher AUROCs than 30-day 
mortality. Regardless of mortality type, on all days, more than 40% of the predictors selected 
by the best-performing model were indicators. Moreover, more than 61% of selected 
predictors were indicators on the third day. Sliding lambda to compromise the predictor 
number and model performance led to almost the same results. Generally, more than 40% of 
the selected predictors were indicators, and on the third day, this number increased to 61%. 
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Table 2-4 Results from feature selection by least absolute shrinkage and selection 
operator (LASSO) for 3 days (area under the curve of the receiver operating characteristics 
are reported with the SE). The best performing model refers to the model with a lambda 
value associated with minimum cross-validation error. The adjusted model refers to a 
LASSO model with the largest value of lambda such that the error remains within 1 SE of the 
minimum. 
Outcome Imputation 
method 
Day 1 Day 2 Day 3 
AUROC for best performing model 
30-day mortality HD 0.7858 (0.0033) 0.7685 (0.0041) 0.7302 (0.0043) 
PMM 0.7876 (0.0039) 0.7708 (0.0046) 0.7391 (0.0053) 
In-hospital 
mortality 
HD 0.7983 (0.0040) 0.7804 (0.0046) 0.7476 (0.0042) 
PMM 0.8007 ( 0.0047) 0.7838 ( 0.0049) 0.7582 (0.0054) 
Indicators among selected predictors by the best performing model, n (%) 
30-day mortality HD 43% (23/53) 48% (24/50 ) 70% (19/27 ) 
PMM 45% (26/58) 47% (26/55 ) 68% (17/25 ) 
In-hospital 
mortality 
HD 46% (28/61) 48% (29/61) 60% (21/35) 
PMM 47% (29/62) 49% (27/55) 62% (24/39) 
AUROC for adjusted model 
30-day mortality HD 0.7826 ± 0.0034 0.7646 ± 0.0043 0.7262 ± 0.0041 
PMM 0.7840 ± 0.0038 0.7667 ± 0.0045 0.7339 ± 0.0044 
In-hospital 
mortality 
HD 0.7944 ± 0.0043 0.7762 ± 0.0047 0.7439 ± 0.0041 
PMM 0.7961 ± 0.0049 0.7793 ± 0.0050 0.7536 ± 0.0045 
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Indicators among selected predictors by the adjusted model, n (%) 
30-day mortality HD 45% (20/44) 48% (16/33) 67% (22/33) 
PMM 45% (19/42) 52% (16/31) 62% (31/50) 
In-hospital 
mortality 
HD 47% (20/43) 42% (13/31) 64% (16/25) 
PMM 50% (18/36) 41% (11/27) 62% (16/26) 
 
Results in this section once more confirm the informativeness of missing data as 
missingness indicators have been selected by various feature selection methods. The high 
percentage of selected indicators also implies that the actual value of an LT is not always 
required in outcome prediction; instead, knowledge about whether the test was performed 
would suffice. 
2.4.4 Predictive Modeling: Missing Data Indicators in Predictive Modeling 
In the second assessment, we compared the performance of a set of 3 classification models 
(DT, LR, and RF) using the indicators, imputed and augmented data matrices, and SAPS-II 
score with or without indicators with 10-fold cross-validation over 20 repeats. We 
investigated whether including indicators can improve prediction and whether indicators 
alone have predictive power. For our LR, the iteratively reweighted least square method was 
used to fit the model. The complexity parameter (CP) for DT was tuned based on the model 
performance. On the basis of some preliminary model fitting, we set the CP value to vary 
from 0 (including all variables and having a large tree) to .02 for each model and then we 
picked the best performance model. In all models, the best-tuned model had a CP greater 
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than 0. Figure 2-5 shows the AUROC with 95% CI for all 3 days with regard to 30-day 
mortality (Appendix C provides the AUROC values for 30-day mortality and in-hospital 
mortality). 
 
 
Figure 2-5 The 95% confidence intervals of the AUROC for LR, DT and RF models 
on missingness indicators, SAPS-II score and actual variables with and without the 
missingness indicators. 
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Including indicators improved the AUROC in all modeling techniques, on average by 
0.0511; the maximum improvement was 0.1209 (Figure 2-5). AUROC has been 
demonstrated as an insensitive metric, for which an increase of 0.01 suggests meaningful 
improvement and is clinically of interest (Martens et al. 2016; Cook 2007; Pencina et al. 
2012). Although using only indicators demonstrated reasonable performance in all scenarios 
(AUROC=0.6019 [0.0862]>0.5), conventional scores such as SAPS II perform better 
(AUROC=0.6390 [0.0853]) on their own. Therefore, models trained only on indicators are 
not sufficient. However, including indicators with conventional scores can improve the 
performance (AUROC=0.7263 [0.0578]). The SAPS-II score has information for age, heart 
rate, systolic blood pressure, Glasgow coma scale, temperature, mechanical ventilation 
administration, partial pressure of oxygen in the arterial blood (PaO2), fraction of inspired 
oxygen (FiO2), urine output, BUN, sodium (Na), potassium (K), HCO3, TBil, white blood 
cells (WBCs), presence of chronic diseases, and type of admission. These results demonstrate 
that indicators have information beyond that included in SAPS-II. 
Figure 2-6 demonstrates the AUROC curves for LR 30-day mortality prediction on day 1. 
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Figure 2-6 The ROC curves for LR 30-day mortality prediction on day one. 
This combination of findings provides more support for the informativeness of missing 
data. Employing the missing indicators in mortality prediction modeling can improve the 
results in comparison to not including them. 
2.5 Discussion 
2.5.1 Principal Findings 
We used missingness indicators to represent missing information in patient profiles in ICU. 
The informativeness of these indicators was demonstrated in 3 sets of assessments. First, our 
exploratory analysis confirms that the missingness of data is associated with patient severity 
of illness or comorbidities. Afterward, by means of feature selection methods, the predictive 
power of the presence of an LT in the patient profile was found to be more than the actual 
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measured value. Finally, missingness indicators noticeably improved the performance of 
mortality prediction models. The high correlation observed among some of the variable 
indicators suggests that all the variables in a set are typically measured or ordered together. 
Therefore, if a patient is missing 1 variable of a set, he or she will likely be missing the 
others as well. This fact is well represented in all 7 groups. The first group comprises the 
differential WBC counts (BA, MO, NE, eosinophil; EO, and LY), which itemizes the number 
of basophils, monocytes, neutrophils, eosinophils, and lymphocytes among present WBCs. 
The second group (RDW, MCHC, MCV, RBC, and MCH) comprises tests that are used to 
measure the actual number of RBCs and their physical characteristics. The third group (BE, 
PCO2, and PO2) consists of blood gas components and focuses on oxygen and carbon 
dioxide pressure as well as excess or deficit of base levels in the blood. Tbil, ALT, AST, and 
ALK in the fourth group are liver enzymes (Gowda et al. 2009) that are ordered when a 
patient is suffering from or showing symptoms of a liver-related comorbidity. BUN and Cr 
mainly focus on kidney function. Bicarbonate; HCO3 and chloride; Cl are the primary 
measured anions in the blood. PT along with PTT are used for investigating hemostasis and 
are the starting points for looking into potential bleeding or clotting complications. 
Therefore, the presence of a clinical variable in a patient profile can represent a comorbidity 
in the patient. Although LTs are mainly ordered for diagnostic and prognostic reasons, 
studies have shown widely diverse test-ordering behavior among clinicians for similar 
symptoms (Wennberg 1984; Daniels et al. 1977; Solomon et al. 1998). Therefore, indicators 
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could also reflect the opinions, preconceptions, and biases of the treating clinicians. In other 
words, by using the missingness indicators, we are learning from practice patterns rather than 
physiologic patterns. Therefore, indicators as introduced in this study can then be used for 
modeling health care process in various applications such as clinical care, clinical research, 
health care economics, and health care policy (Agniel et al. 2018; Sharafoddini et al. 2018). 
Filter methods verified the importance of some indicators with regard to our outcomes. 
Results also demonstrated that indicators become more and more important on ICU days 2 
and 3 (Tables 2-2 and 2-3). This observation aligns with clinical practice in which ICU 
clinicians might try to get a complete dataset on day 1 to fully investigate the patient and 
understand the situation but are likely to be more selective with LT ordering on subsequent 
days. The Lac indicator was associated with 30-day and in-hospital mortality on the second 
and third day. Lactate is usually used as a biomarker for shock states. The literature has 
constantly reported an association between lactate levels and mortality rates among critically 
ill patients (Zhang et al. 2014c). Our study demonstrated that just the presence of this 
information could represent the severity of a patient’s illness, as patients with profound shock 
have a very high mortality rate in hospitals and ICUs (Levinson et al. 2011). Moreover, BUN 
(Beier et al. 2011; Cauthen et al. 2008; Kajimoto et al. 2015), RDW (Bazick et al. 2011; 
Hunziker et al. 2012; Patel et al. 2010; Purtle et al. 2014; Senol et al. 2013) and AG (Ahn et 
al. 2014; Kim et al. 2017; Lee et al. 2016; Sahu et al. 2006) have been repeatedly determined 
as a risk factor of all-cause mortality and their indicators received a high score in our 
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analysis. These results are consistent with those of Agniel et al’s (2018) who demonstrated 
that the presence of these tests have significant association with odds of 3-years survival. 
The LASSO model selected indicators among the clinical predictors of in-hospital 
mortality and 30-day mortality, implying the predictive power of indicators. More indicators 
than clinical variables were selected on the third day (60%-70% of selected predictors were 
indicators); the assessment demonstrates that indicators from the third day are more 
informative than those from the first, again supporting the idea that the practice patterns 
diverge later during ICU stays, so there is more variability in what gets measured. In other 
words, care on the first day is likely to be highly protocolized—all patients get the same tests 
regardless of their condition because their trajectory is still unclear. As time goes on, the 
patterns become more evident and ordering and prescribing practices change according to 
clinical need. This high percentage of selected indicators suggests that clinical variables are 
not always required in outcome prediction; instead, information about their presence would 
suffice. 
The last assessment demonstrated that models trained on indicators alone in some 
scenarios have reasonable performance (for instance, in 30-day mortality prediction with LR, 
we achieved AUROC of 0.6836 [0.012]). Reasonable performance in this study was defined 
as the AUROC above 0.6. These results imply that by considering missing data as noise or a 
random artifact, we can lose valuable information about patient outcomes. Moreover, 
indicators improved the AUROCs in most scenarios. Researchers in this field are looking for 
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predictors that can be included in the models to improve the prediction results. Having a low-
dimensional set of typical predictors plus these missing data indicators can actually lead to 
performance comparable with that achieved using typical predictors plus other potentially 
useful predictors identified a priori by medical researchers: First, in comparison with 
including extra numeric predictors, the computational load for performing mathematical 
calculations on binary values such as indicators is usually less. Second, binary data require 
less computational memory than numbers when performing data mining techniques. Finally, 
for some important clinical variables, storing the missing data indicators instead of the actual 
value better protects patient privacy while preserving predictive power. In other words, less 
privacy concern is expected in a situation when the type of test is disclosed rather than the 
actual test result. The comparative analyses on the predictive models showed that missing 
data indicators could improve the prediction models’ performance (please refer to Tables C4 
and C5 in Appendix C). Although literature considers a small increase (0.01) in AUROC 
meaningful and of clinical interest (because of insensitivity of AUROC) (Martens et al. 2016; 
Pencina et al. 2012), including the indicators in our study could improve the average 
AUROC by 0.0511. Thus, missing data indicators can be introduced as informative 
predictors and be used to learn from. In other words, these indicators can be representative of 
physicians’ and patients’ opinions during the health care process. Furthermore, the overall 
model performance decreased over time perhaps implying that patients’ data on the first 24-
hour has the highest level of information. The same pattern was also observed in the previous 
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assessment. According to these observations, we can infer that presence or absence of a 
variable can be used in predicting patients’ severity of illness. 
2.5.2 Strengths and Limitations of the Project 
A significant strength of this study is its new insight on missing data in a real-world ICU 
database. The results confirm the predictive power of some indicators and their advantage 
over actual values in predictive modeling. The findings further clarify the factors associated 
with lack of data collection such as the healthier status of a patient or practice patterns of 
clinicians. These insights, in turn, can be used to design models that consider missing data 
and benefit from the hidden information. On the basis of our results, missingness indicators 
can be introduced as potential predictors of ICU patients’ outcomes. 
Despite the strength, significance, and novel nature of this study, there also exist 
limitations that cannot be overlooked. First, because of the nature of ICUs, the amount of 
missing data in MIMIC is less than that from a general ward. Therefore, our study may not 
fully demonstrate the informativeness of these indicators. Moreover, adding the indicators of 
interest to the actual data matrix increases the dimension of the matrix and may become 
computationally burdensome. Using other imputation methods, the power of missing data 
indicators may vary but this was beyond the scope of our study, which focused on providing 
evidence on missing data informativeness. 
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2.5.3 Perspectives for Future Work 
Although our study demonstrates that missingness indicators are informative and have 
predictive power in mortality prediction in ICU, further studies are required to investigate 
their power in predicting other clinical outcomes. Future researchers can investigate the 
association between missingness patterns and patient diagnosis. They can also consider more 
sensitive criteria such as net reclassification or integrated discrimination improvements while 
preserving improvement in the AUROC as the first criterion. Moreover, as this study looked 
at the 3 days in the ICU independently, one can investigate if the missing data on a particular 
day are still informative given all the clinical and indicator variables from previous days. 
These future studies should also investigate the effect of missing rate on the predictive power 
of indicators. Another area of future work is examining the test-ordering behavior among 
clinicians, by using missingness indicators.  
While prediction uses data to guess a value, estimation utilizes data to guess parameters. This 
study focused on capabilities of missing indicators in prediction, however, they can result in 
bias in parameter estimation. Therefore, an open area of research is to investigate approaches 
for incorporating missing indicators in a way that better prediction performance can be 
achieved while minimizing bias in parameter estimation. Last but not least, future researchers 
can incorporate administrative data into their analyses. These data cover information about 
physician services, hospital services and can be used with missing indicators to understand 
the care practices in the hospital. 
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2.5.4 Conclusions 
Our study has demonstrated that the missingness of data itself might be informative in ICU 
and might have added predictive value beyond observed data alone. Moreover, indicators for 
variables with higher missingness rates had more predictive power. In practice, the lack of a 
set of symptoms might lead health professionals to conclude that a particular set of tests is 
not required at the current stage. Therefore, these missing data are not a random occurrence. 
This study showed that the number of comorbidities is associated with a decreased rate of 
missing data. Therefore, rudimentary treatments of missing data (eg, CCA) can cause bias 
toward sicker patients. The study is also notable because it provided new insight about the 
informativeness of missing data and described how this information could be used in 
predicting mortality. 
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Finding Similar Patient Subpopulations in the ICU Using 
Laboratory Test Ordering Patterns 
 
This chapter utilizes the missing indicators introduced in Chapter 2 to capture the laboratory 
test ordering patterns in ICU. Then these patterns are utilized to identify patient 
subpopulations in ICUs. This chapter was originally published in June 2018 and revisions 
have been made to the current copy based on the thesis committee’s reviews. The full citation 
is as follows: Sharafoddini, A., Dubin, J. A., & Lee, J. (2018). Finding Similar Patient 
Subpopulations in the ICU Using Laboratory Test Ordering Patterns. Paper presented at the 
Proceedings of the 2018 7th International Conference on Bioinformatics and Biomedical 
Science, Shenzhen, China.  
 
3.1 Abstract 
In this paper, we focus on phenotyping critically ill patients in intensive care units (ICUs). 
Various data types have been used to cluster patients. We introduce laboratory-test-ordering 
patterns as a source of information for finding clinically similar patients. We employed 
Density-Based Spatial Clustering of Applications with Noise (DBSCAN) clustering method 
to find patient subpopulations based on the first 24 hours of laboratory test ordered. The 
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DBSCAN identified 25 clusters, and we utilized t-Distributed Stochastic Neighbor 
Embedding (t-SNE) to visualize the subpopulations. Then, we evaluated the clinical 
interpretability of the clusters by using cluster characteristics and two outcomes: in-hospital 
mortality and 30-days post-discharge mortality. Our results demonstrate that laboratory-test-
ordering patterns are informative and can be used to identify patient subpopulations. 
Keywords: Phenotyping; Intensive Care Unit (ICU); DBSCAN clustering; t-SNE 
3.2 Introduction 
Intensive care units (ICUs) provide care to acutely ill patients and were primarily introduced 
in the 1950s (Rodriguez 2001a; Reisner-Senelar 2011). These units target diverse critically ill 
patient populations and that close monitoring of these patients has generated an enormous 
amount of data (Johnson et al. 2016a). Although ICUs have a higher number of staff than 
other departments (Johnson et al. 2016a), analysis and interpretation of this amount of data is 
challenging for clinicians and must be handled by data analysis methods. ICUs have a 
heterogeneous population with various health status dynamics and similar needs for constant 
care (Prin et al. 2012; 'Critical Care Statistics'). This heterogeneity adds to the importance of 
finding similar patients and detecting the underlying phenotypic groups. Recently, efforts 
have been made to phenotype patients, a term widely used in the literature with various 
meanings (Robinson 2012). We focus on phenotyping as in the study of identifying 
subpopulations of patients, suggested in (Shivade et al. 2014). Finding precise phenotypes 
from population-scale electronic health records is a core task in developing precision 
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medicine (Lasko et al. 2013). Traditionally, the task of phenotype discovery was based on 
one specific question using supervised learning; for instance, stratifying patients into five 
predefined heart failure risk levels. Although these methods were successful for decades, 
they are limited to only a set of predefined phenotypes and cannot help when the goal is new 
phenotype discovery (Lasko et al. 2013). Recently unsupervised learning methods 
(clustering) have been used to discover phenotypes from data. Many research groups have 
utilized these methods on varied information in EHRs data, such as demographics, vital signs 
(Pimentel et al. 2013), laboratory test results, and discharge summaries (Dai et al. 2017b), to 
identify patient subpopulations (Shivade et al. 2014). Owing to the sensitive nature of patient 
data, most of these groups have developed their own methods, resulting in a lack of standard 
tools (Shivade et al. 2014). 
Laboratory testing is a fundamental part of day-to-day practice in ICUs and it supports 
70% of the decision making in medicine (either for diagnosis or treatment) (Cadogan et al. 
2015). Laboratory tests may be ordered for various purposes, including diagnosis, treatment 
monitoring or severity scoring. However, the decision to order a test is influenced by many 
hospital-, caregiver-, patient- or disease-related factors. For instance, it has been observed 
that older and younger patients received less testing in comparison to middle-age patients in 
ICUs (Zimmerman et al. 1997) or more complete laboratory testing was performed for 
severely ill patients (Weiskopf et al. 2013b; Rusanov et al. 2014). In this work, we propose a 
data-driven framework for discovering patient subpopulations, using the laboratory test 
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ordering patterns from the EHR data. The presence or absence of a laboratory test may be a 
valuable indicator of patients’ characteristics (age group or ethnicity) or health status 
(symptoms or severity of illness). Therefore, such phenotype discovery can shed light on 
some characteristics, possibly even latent characteristics, of each subpopulation. Moreover, 
these phenotypes can help in customizing predictive modeling by training a model for each 
subpopulation instead of using a one-size-fits-all model. 
3.3 Methodology 
3.3.1 Data and Data Representation 
This study utilizes the freely accessible MIMIC-III (Medical Information Mart for Intensive 
Care) database (Johnson et al. 2016b)—an update of the MIMIC-II database—which was 
released in 2015. This database has detailed information on 38,597 distinct patients in the 
critical care units at the Beth Israel Deaconess Medical Center in Boston, between 2001 and 
2012 (Johnson et al. 2016b). Adult patients (age>=15 years) admitted to one of the five 
following ICUs were included in this study: medical ICU (MICU), surgical ICU (SICU), 
cardiac care unit (CCU), cardiac surgery recovery unit (CSRU), and trauma surgical ICU 
(TSICU). Therefore, we focused on the top 80% laboratory tests and profiles common to all 
ICUs (Frassica 2003) which were available in our database. Data for patients having at least 
one measurement for any of the following 36 laboratory tests in the first 24 hours of 
admission was extracted: Alanine Aminotransferase (ALT); Alkaline Phosphatase (ALP); 
Aspartate Aminotransferase (AST); Arterial blood gases: pH, PCO2, PO2, Base Excess (BE); 
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Basic metabolic panel: Sodium (Na), Potassium (K), Chloride (Cl), Bicarbonate (HCO3), 
Anion Gap (AG), Blood Glucose (BG), Blood Urea Nitrogen (BUN), Creatinine (Cr); 
Complete blood count: WBC, RBC, HGB, HCT, MCV, MCH, MCHC, RDW, Platelet count 
(PLT), Absolute MO no., Absolute EO no., Absolute BA no., Absolute LY no., Absolute NE 
no.; Lactate (Lac); Calcium (Ca); Magnesium (Mg); Phosphorus/ Phosphate (Phos); Partial 
Thromboplastin Time (PTT); Prothrombin Time (PT); Total Bilirubin (TBil). Therefore, 
whether a laboratory test was performed at least once in the first 24 hours constructs the 
laboratory ordering test patterns. 
3.3.2 Clustering 
Various clustering methods have been widely used to find subpopulations. However, many of 
these methods focus only on spherical-shaped clusters and are sensitive to the presence of 
noise or outliers (Ester et al. 1996). However, these limitations are more highlighted when 
working with EHR data in which information inaccuracy is frequently observed (Botsis et al. 
2010). DBSCAN (Ester et al. 1996), one of the most common clustering methods, utilizes the 
idea that the clusters are located where data have a high density and are separated by regions 
with a lower density of data (the density is evaluated based on two user-defined parameters). 
Unlike in other methods, clusters in DBSCAN can have any arbitrary shape and the 
algorithm is not sensitive to noise. DBSCAN received the ACM SIGKDD Test of Time 
Award due to its outstanding influence in data mining. 
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In this study, we will use DBSCAN to cluster the laboratory test ordering patterns, as it 
does not require the number of clusters to be set. However, it is important to acknowledge 
that the DBSCAN algorithm fails to identify clusters if density varies. Since DBSCAN uses a 
single global parameter epsilon (ɛ) to identify clusters, it is impossible to detect clusters with 
varied densities simultaneously. The only two parameters that must be tuned for DBSCAN 
are ɛ and minimum points (MinPts). MinPts (the minimum number of neighbors required to 
consider a point as a core point) is usually set to the dimensionality of data pulse one or 
higher. After setting MinPts, epsilon (the radius of the neighbourhood) can be set using k-
distance tuning method. In this method, first, the distance of each point from its k’th nearest 
neighbor is calculated. This distance is called kdist. After calculating and sorting kdists for 
all data points, the distance values will be plotted in a k-distance graph for a particular value 
of k. Then, the value for which the graph shows a strong bend—the knee point—will be 
chosen for epsilon.  
The DBSCAN algorithm also requires a distance metric to cluster patients.  Since our data 
are binary, we use the Jaccard distance (Deza et al. 2009) to calculate the similarity between 
points. 
3.3.3 Graphical Representation 
To visualize the data set, a dimensionality reduction algorithm, which creates two-
dimensional visualization of all data points is required. We have chosen t-Distributed 
Stochastic Neighbor Embedding (t-SNE) (Maaten et al. 2008), a dimensionality reduction 
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technique that is used for mapping high dimensional datasets into two-dimensional space in 
order to see the data structure. Numerous nonlinear dimensionality reduction methods have 
been introduced for data visualization while preserving the structure of data. However, t-SNE 
has been shown to perform better in preserving the structure of data than other widely used 
techniques (Maaten et al. 2008) such as Sammon mapping, curvilinear components analysis, 
Stochastic Neighbor Embedding, Isomap, Maximum Variance Unfolding, Locally Linear 
Embedding, and Laplacian Eigenmaps. 
Here, t-SNE starts with converting the pair-wise Jaccard distances (d) of a data point into 
probabilities (pji) that represent the probability that a data point (xi) will choose (xj) as its 
neighbor. For close data points, this probability is relatively high. Therefore, first, it centers a 
Gaussian distribution over xi and measures the density of other points under this Gaussian 
distribution. The joint probability of pji is calculated using pji = (pj|i + pi|j)/2N, where 
 Pj|i =
exp (−
𝑑(𝑥𝑖 − 𝑥𝑗 )
2
2σi
2 )
∑ exp (−
𝑑(𝑥𝑖 − 𝑥𝑘 )2
2σi
2 )k≠i
 (3.1) 
Similar conditional probability can be defined for the low-dimensional mappings of xi and 
xj, denoted as yi and yj. This probability measures the similarities of data points in low-
dimensional space. t-SNE utilizes a heavy-tailed Student-t distribution with one degree of 
freedom for low-dimensional spaces since it wants the dissimilar points to be too far apart in 
the map. 
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 qj|i =
(1 + 𝑑(𝑦𝑖 − 𝑦𝑗 )
2)
−1
∑ (1 + 𝑑(𝑦𝑖 − 𝑦𝑘  )2)−1k≠i
 (3.2) 
The goal is for qj|i to reflect pj|i as well as possible. t-SNE uses Kullback-Leiber 
divergence to measure the difference between these probabilities. Therefore, it moves the 
data points to minimize KL(P||Q) = ∑ ∑ pij log
pij
qij
j≠ii . Using gradient descent, the result is a 
map that reflects data points in a low-dimensional space while preserving their local 
structure. 
3.3.4 Evaluation Design 
One of the most challenging parts in cluster analysis as an exploratory analysis is the 
evaluation of results. In this work we employed two evaluation methods: (i) exploring the 
clinical characteristics of the clusters; and (ii) the silhouette index (Rousseeuw 1987), which 
evaluates the suitability of assigning a patient to a group rather than to another by 
considering cluster cohesion and cluster separation. Therefore, we employed silhouette 
index, which is a number between -1 and 1, to evaluate our clustering. Besides the total 
silhouette value for our proposed method, we calculated the silhouette index for each cluster 
by averaging the silhouette widths for the patients in that cluster. Silhouette values close to 
one indicate precise clustering, while small values close to zero represent observations that 
lie between two clusters. Negative values represent wrong patient assignment. 
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3.4 Results 
Based on the inclusion criteria, 32618 patients were retrieved from the MIMIC-III ICU 
database described in Section 3.3.1. To determine the parameters of DBSCAN, after testing 
various values for MinPts (including 37, 50, 100, 150, 200, 300, 400, 500) and observing 
little variation in clustering, we set MinPts to 37, which equals the dimensionality of data 
plus one. Then using the k-distance graph the radius associated with the sharp change was 
chosen as ɛ. Figure 3-1 shows the k-distance graph for k=37. The value of ɛ determined from 
this graph was 0.125.  
Utilizing DBSCAN with tuned parameters on the laboratory test ordering data resulted in 
25 clusters, with some data points as outliers (cluster 0). 
We represented each of the 32618 critically ill patients in a two-dimensional space using t-
SNE. Although the author of t-SNE has claimed that this algorithm is not very sensitive to 
the perplexity parameter (Maaten et al. 2008), there is evidence showing otherwise 
(Wattenberg et al. 2016). Therefore, first, we tested representing data with various values for 
perplexity: changing perplexity from 5 to 50 (as suggested by (Maaten et al. 2008)) and then 
testing it for higher values of 100, 150, and 200. Robust behaviors were observed from the 
topological aspect. However, the relative size of clusters and distance between them were 
unstable and meaningless, as was expected from literature (Wattenberg et al. 2016). 
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Figure 3-1 k-Distance graph (k=37) for tuning epsilon in DBSCAN. 
Figure 3-2 demonstrates the two-dimensional representation of patient data points with 
colored cluster assignment. The cluster populations range from 39 to 10486 patients. The in-
hospital mortality rate was from 0.83 to 27.95 while the 30-days hospital mortality rate was 
higher ranging from 1.65 to 33.29. The highest mortality rate was in cluster number 2 (light 
green), in which 92% of patients had an emergency admission. 
This cluster had the highest 30-days post-discharge mortality rate as well. We employed 
the Simplified Acute Physiology Score (SAPS-II) (Le Gall et al. 1993)—a well-known and 
widely-used ICU severity scoring system—to report the illness severity in each cluster. In 
Cluster #2, 49.2% of the patients received a SAPS-II score of 49, which equals the maximum 
SAPS-II score observed in the whole dataset. Interestingly, all the 36 laboratory tests listed 
above were ordered for all patients in this cluster, implying the severity of illness in this 
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cohort which resulted in higher mortality rate. Cluster #19 had the lowest mortality rates. The 
average number of tests per patient for this cluster was 3.4 (median=2, sd= 3.78). The second 
and third clusters with highest mortality rates were clusters #7 and 11, for which the average 
numbers of tests per patient were 35 and 31, respectively. The average age in clusters ranges 
from 49.21 to 67.44. The mortality rate in the younger cohort was approximately half of the 
mortality rate in the older cohort. Length of stay (LOS) ranges from 6.62 to 16.42, with a 
higher mortality rate associated with long LOS.  
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Figure 3-2 Clustering critically ill patients using laboratory test ordering patterns. 
DBSCAN clustering method with MinPts=37 and ɛ =0.125 was used. Data were mapped 
to a two-dimensional space using t-SNE with perplexity=30 and 1000 iteration. 
For each cluster, the population, gender distribution, average age, mortality rates, average 
number of tests performed per patient and the dominant primary ICD-9 codes for cluster are 
shown in Table 3-1. 
Dimension 1 
D
im
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o
n
 2
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Table 3-1 Population characteristics for each cluster. 
# Size Gender (%M) Age Mortality (%) LOS Average 
number 
of tests 
per 
patient 
Dominant ICD-9 diagnosis 
code In-Hospital 30-
days 
0 1096 54.74 63.42 13.78 18.89 12.13 28.16 41401 - Coronary 
atherosclerosis of native 
coronary artery 
1 8754 54.31 63.54 5.37 9.71 8.03 22.47 41071 - Subendocardial 
infarction, initial episode 
of care 
2 2472 55.66 61.53 27.95 33.29 14.52 36 0389 - Unspecified 
septicemia 
3 10486 60.91 64.73 8.27 11.18 10.98 25.27 41401 - Coronary 
atherosclerosis of native 
coronary artery 
4 1065 52.49 63.85 15.4 20.19 13.11 32 0389 - Unspecified 
septicemia 
5 237 48.95 64.75 10.13 21.52 9.9 32 0389 - Unspecified 
septicemia 
6 260 63.85 65.38 7.31 8.85 12.14 28.32 41401 - Coronary 
atherosclerosis of native 
coronary artery 
7 436 54.82 62.69 22.02 26.83 13.48 35 51881 - Acute respiratory 
failure 
8 346 52.89 61.13 11.27 14.45 10.5 28.5 0389 - Unspecified 
septicemia 
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9 146 43.15 64.73 13.7 20.55 11.12 30 0389 - Unspecified 
septicemia 
10 1444 52.29 65.9 5.89 12.12 8.36 26.84 0389 - Unspecified 
septicemia 
11 2301 59.76 60.95 21.82 25.9 15.47 31 0389 - Unspecified 
septicemia 
12 90 50 64.5 13.33 22.22 12.75 34 0389 - Unspecified 
septicemia 
13 1015 56.65 62.45 9.36 15.86 9.52 31 41071 - Subendocardial 
infarction, initial episode 
of care 
14 590 57.8 61.96 19.66 24.58 12.98 30 41071 - Subendocardial 
infarction, initial episode 
of care 
15 377 53.85 63.88 9.81 13.26 9.37 14.66 41071 - Subendocardial 
infarction, initial episode 
of care 
16 370 46.22 65 15.95 20.54 11.41 31 51881 - Acute respiratory 
failure 
17 39 61.54 49.21 7.69 7.69 6.62 10.28 41519 - Other pulmonary 
embolism and infarction 
18 121 63.64 66.44 0.83 1.65 9.36 28.87 41401 - Coronary 
atherosclerosis of native 
coronary artery 
19 467 51.18 62.75 19.49 23.34 7.26 3.4 41401 - Coronary 
atherosclerosis of native 
coronary artery 
20 70 42.86 61.63 4.29 8.57 11.08 33 03842 - Septicemia due to 
escherichia coli 
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21 145 75.86 66.76 2.07 4.14 9.69 30 41401 - Coronary 
atherosclerosis of native 
coronary artery 
22 53 58.49 59.95 16.98 22.64 12.14 32 20500 - Acute myeloid 
leukemia, without 
mention of having 
achieved remission 
23 103 41.75 64.49 18.45 20.39 8.78 28.85 51881 - Acute respiratory 
failure 
24 94 55.32 61.53 5.32 8.51 9.33 28.83 486 - Pneumonia, 
organism unspecified 
25 41 60.98 67.44 12.2 12.2 16.42 30 41401 - Coronary 
atherosclerosis of native 
coronary artery 
 
The total silhouette value was 0.81. Evaluating individual clusters, we observed that except 
for the group of outliers which received a silhouette value of -0.56, the average silhouette 
value for all clusters were positive. Figure 3-3 demonstrates the average silhouette values for 
all clusters. The interpretations of silhouette values are color coded based on the ranges 
proposed in (Kaufman et al. 2009). Green indicates that a strong structure has been found for 
that particular cluster. Yellow and red indicate reasonable and weak structures, respectively. 
Based on this interpretation, only three clusters had weak structure and alternative methods 
are suggested for them (cluster #6, 15, 18). Other clusters had acceptable structures. These 
results support the applicability of test-ordering patterns for patient phenotyping. 
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Figure 3-3  The average silhouette values for each cluster. Green, yellow and red 
respectively represent strong, reasonable and weak structures. 
3.5 Discussion 
Our results strongly support the introduction of lab ordering test as a source of information 
for phenotyping patients. Our approach can cluster patients into subpopulation following two 
rationales. 
First, lab ordering patterns are informative about physician’s opinion and biases. Various 
factors affect physicians’ decisions to order a test. One of these factors is whether a patient is 
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showing a symptom or not (Litchfleld et al. 2014; Wells et al. 2013). Therefore, these binary 
data can easily be used as an indicator of patients’ symptoms.  
Second, lab ordering patterns are informative about patient illness severity. Intensive care 
physicians tend to order more tests for patients who are severely ill, as they need to monitor 
them closely and comprehensively. Therefore, the number of tests being ordered can be 
associated with the severity of illness. 
These facts are well represented in our results. Clusters #2, 7 and 11 had higher mortality 
rates as an implication of severe health conditions. In these clusters, more than 30 lab tests 
(out of 36) were performed on average per patient.  
Our results are of interest from two aspects. While many phenotyping methods use huge 
amounts of data to find subpopulations, our method works in a 36-dimensional binary space. 
This will result in less computation burden and ease of implementing the method on personal 
computers. One trending research area is predicting modeling in health care. While many 
researchers are investing on one-fits-all models, a hierarchical approach where patients are 
first grouped into subpopulations and then models are trained on each group has been studied 
and showed promising results. Our approach can also contribute to this field as a fast and 
memory efficient way of subgrouping patients for predictive modelling. 
There are some limitations to this study. First, we limited our laboratory tests to the most 
common ones in ICUs and their availability in our database; therefore, abundant room 
remains for considering more-comprehensive lists. Second, this study focused on the 
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laboratory-test patterns of the first 24 hours of ICU admission; however, including data from 
all days of an ICU stay can provide information about the evolution of patient health status.  
3.6 Conclusion 
In this paper, we used laboratory test ordering patterns to discover subpopulations among 
critically ill patients. We used DBSCAN to reveal these subpopulations. t-SNE was utilized 
to represent results in a low-dimensional space. Our results demonstrate that lab ordering 
patterns are able to reveal information about patient health status and can be used to identify 
clinically meaningful subpopulations. Future researchers can focus on employing weighted 
distance for eliminating the effect of the lab tests that are routinely ordered as part of hospital 
protocols and highlighting laboratory tests that are more patient-specific and representative 
of their special health condition. These patterns can also be used with other methods to 
increase the performance of phenotyping patients. 
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Multifaceted Patient Similarity Metric 
This chapter builds upon the previous chapters and introduces a multifaceted PS metric that 
accounts for various EHR data and integrate different similarity metrics. This metric also 
considers the similarity in terms of missing data using the indicators introduced in Chapter 2. 
Various experiments are performed to evaluate the performance of the proposed metric in 
comparison to the conventional methods in mortality prediction application.  
4.1 Introduction 
In the past decade, with the emergence of precision medicine, patient similarity (PS) 
analytics has received special attention and become the core component of health analytics 
in, among other areas, predictive modeling, patient stratification, and clinical pathway 
analytics (Hu et al. 2016a). EHR data are present in a plethora of formats, including 
demographic data, vital signs, lab results, diagnosis/symptom/procedural codes, and 
clinicians’ notes, and reflect information about different aspects of patient health status. The 
volume of existing EHR data makes it difficult for physicians to assess the similarity of two 
patients. Therefore, health analytics has focused on devising similarity metrics, using various 
approaches (Jurisica et al. 1998; Bobrowski 2006; Park et al. 2006; Saeed et al. 2006a; 
Chattopadhyay et al. 2008; Han et al. 2015; Sun et al. 2010b; Sun et al. 2010a; David et al. 
2011; Wang et al. 2011; Campillo-Gimenez et al. 2013; Lowsky et al. 2013; Hielscher et al. 
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2014; Henriques et al. 2015; Lee et al. 2015a; Wang et al. 2015). Although studies have 
shown the utility of using PS in health analytics, assessing PS using one similarity metric for 
all the various clinical variables/predictors may not sufficiently capture the similarities.  
The ICD coding system is a widely used coding system for classifying diagnoses and 
procedures. MIMIC-III contains the ninth version of ICD codes (ICD-9 codes) for diagnosis 
and procedures. The ICD-9 coding system consists of a set of trees that represent the 
hierarchical relation between the codes. Whereas, higher-level nodes represent more general 
concepts, lower-level nodes are more detailed. Figure 4-1 shows a snippet of a hierarchy tree.  
427 Cardiac 
dysrhythmias
427.0 Tachycardia, 
paroxysmal 
supraventricular
427.3 Atrial 
fibrillation and 
flutter
427.4 Ventricular 
fibrillation and 
flutter
427.31 Atrial 
fibrillation
427.32 Atrial flutter
427.41 Ventricular 
fibrillation
...
 
Figure 4-1 A snippet of an ICD-9 hierarchy tree. 
ICD-9 codes have been used in healthcare analytics for various applications, including 30 
days post-discharge mortality prediction (Lee et al. 2015a). However, the ICD-9 codes are 
usually treated as a categorical variable, and the hierarchal nature of the codes is ignored. 
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The hierarchical nature of the ICD-9 code can be a potentially valuable source of 
information. For instance, considering the hierarchical nature of ICD-9 codes has led to 
better automated ICD-9 code assignment from discharge summaries (Perotte et al. 2014). 
Moreover, leveraging the hierarchy in the feature construction or model building or both 
significantly improved predictive modeling for chronic kidney disease and heart failure 
applications (Singh et al. 2014). Although Gottlieb et al. (Gottlieb et al. 2013) considered the 
hierarchy in their similarity assessment, the superiority of it over conventional methods 
remained undetermined. A recent study has also investigated the effect of leveraging the 
hierarchy in the similarity assessment. Girardi et al. (Girardi et al. 2016) proposed a new 
semantic similarity metric for ICD-10 codes in which the hierarchical characteristic was 
taken into consideration. They proposed the following measure for assessing the distance 
between two ICD codes in a hierarchy tree: 
 𝑑𝑖𝑠𝑡𝐼𝐶𝐷(𝐼𝐶𝐷1, 𝐼𝐶𝐷2) =
𝑀𝑖𝑛𝐸𝑑𝑔𝑒(𝐼𝐶𝐷1, 𝐼𝐶𝐷2)
𝑝(𝐼𝐶𝐷1) + 𝑝(𝐼𝐶𝐷2)
 (4.1) 
where MinEdge is the minimum number of edges between two ICD codes, and 𝑝(𝐼𝐶𝐷1) +
𝑝(𝐼𝐶𝐷2) denotes the longest path between the codes in the tree. They compared the proposed 
method to the Jaccard distance—a measure of the distance between sets—and Haase-Li 
(Haase et al. 2004; Yuhua et al. 2003) distance—a measure of the distance between 
individual hierarchical codes—, and it demonstrated better performance at detecting 
similarities.  
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Therefore, constructing a similarity score by utilizing appropriate similarity metrics for 
specific clinical variables can contribute to more accurate PS assessment and data retrieval in 
clinical care.  
4.1.1 Literature review 
Overall, various types of similarity metrics can be used in computing the similarity between 
patients. 
• Distance-based similarity metrics: Absolute distance (Chattopadhyay et al. 2008), 
Euclidean distance and its family (Bobrowski 2006; Henriques et al. 2015; David et al. 
2011; Park et al. 2006; Hielscher et al. 2014), Mahalanobis distance and its family (Sun et 
al. 2010b; David et al. 2011; Wang et al. 2012a; Wang et al. 2015; Lowsky et al. 2013; 
Han et al. 2015; Sun et al. 2010a). 
• Correlation-based similarity metrics (Saeed et al. 2006a) 
• Cosine-based similarity metrics (Lee et al. 2015a) 
• Model-based similarity metrics (Houeland 2011a; Zhu et al. 2017; Wang 2015; Zhang et 
al. 2018; Suo et al. 2017) 
Most of the current studies in PS analytics utilize one universal metric to assess the 
similarities among patients. However, researchers have recently focused on capturing 
multiple aspects of drug similarity (Zhang et al. 2014a; Gottlieb et al. 2011; Li et al. 2012; 
Moghadam et al. 2016; Yan et al. 2014)—including genetic (target proteins), phenotypic 
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(side effects) and chemical aspects—and disease similarities (Zhang et al. 2014a; Gottlieb et 
al. 2011; Li et al. 2016; Moghadam et al. 2016; Yan et al. 2014)—inclusive of disease 
symptom, ontology and gene aspects—by employing various metrics (Zhang et al. 2014a; 
Gottlieb et al. 2011) and combining the similarity scores to achieve one unified score.  
Although this kind of multifaceted similarity assessment is gaining attention in drug and 
disease similarities, only a very few studies exist on multifaceted PS assessment using EHR 
data. Gottlieb et al. (2013) utilized various similarity metrics for different variables: 
• ICD codes:  
o ICD similarity: 
 𝑆𝑖𝑚(𝐼𝐶𝐷1, 𝐼𝐶𝐷2) =
𝑁𝑒𝑎𝑟𝑒𝑠𝑡 𝐶𝑜𝑚𝑚𝑜𝑛 𝐴𝑛𝑐𝑒𝑠𝑡𝑜𝑟 (𝐼𝐶𝐷1, 𝐼𝐶𝐷2)
#𝑜𝑓 𝑙𝑒𝑣𝑒𝑙𝑠 𝑖𝑛 𝐼𝐶𝐷 ℎ𝑖𝑒𝑟𝑎𝑟𝑐ℎ𝑦
 (4.2) 
This metric uses the levels of ICD codes in the ICD coding hierarchy to calculate 
the similarity. For instance, for ICD codes 427.31 and 427.41 the nearest common 
ancestor is 427 (level 3) and the number of levels in the ICD-9 hierarchy is five. 
Therefore, the similarity between these two codes is 3/5. 
o Empirical co-occurrences between ICD codes 
This metric computes the number of co-occurrences of an ICD pair in patient 
profiles across the dataset as a measure of similarity between two codes. 
o Bipartite graph over ICD codes 
  
89 
To calculate the similarity score for two sets of ICD codes, this method constructs 
the bipartite graph over the codes in the two profiles in which an edge represents 
the similarity of two codes calculated based on one of the above methods. Then, 
the final similarity between two sets is calculated using maximal matching in 
graph theory.  
• Blood test and ECG records: Euclidean distance and absolute difference 
• Age: 
 𝑆𝑖𝑚(𝐴𝑔𝑒1, 𝐴𝑔𝑒2) =
|𝐴𝑔𝑒1 − 𝐴𝑔𝑒2|
max(𝐴𝑔𝑒1, 𝐴𝑔𝑒2)
 (4.3) 
• Sex: XOR distance (returns zero for patients of the same gender and one otherwise) 
The authors then used these scores to construct a feature vector for a regression model. 
Although their study considered various similarity metrics, they did not justify their use of 
various metrics. In addition, the advantage of this approach was not investigated in 
comparison to conventional methods. Moreover, regardless of the nature of the variables and 
frequency of measurement for blood test measurements and ECG timeseries, only the 
Euclidean distance between the first measurement of each variable was used for similarity 
calculation. Thus, the unique characteristics of each variable were not the main focus of the 
study. Using a variable-specific similarity metric can overcome the limitations of using only 
one particular similarity metric (utilizing just one similarity metric for all predictors may 
miss information relevant to clinical similarity assessment). The work most relevant to this 
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study is a system called Advanced Analytics for Information Management (AALIM), devised 
by the IBM Almaden Research Center for cardiac diagnosis (Syeda-Mahmood et al. 2007; 
Amir et al. 2010). AALIM computes cardiac PS in each of the following modalities: 
electrocardiogram (ECG or EKG), heart auscultation sounds and cardiac echo videos. In this 
study, the authors employed a weighted linear combination method to fuse all the similarity 
scores into one. However, published evidence on this work covering more details about the 
methodology is very limited.  
4.1.2 Study Objectives 
The study presented here is motivated by the need to use the various types of information in 
EHR data more effectively. The purpose of this study is to devise a multifaceted PS metric in 
which the characteristics of individual clinical variables are considered. Moreover, in the 
context of predictive modeling, this study compares the performance of the multifaceted PS 
metric with that of conventional methods (specifically, cosine and Euclidean distance). 
4.2 Materials and Methods 
4.2.1 Data and Analytical Dataset Preparation 
Data for this study were extracted from the MIMIC-III database since it has a rich variety of 
EHR data. To manage computational time for the pair-wise similarity calculations and at the 
same time preserving the heterogeneity of the ICU patients, only adult patients admitted to 
the medical ICU and surgical ICU were included in this study. To be included, patients must 
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have had at least one measurement for any of the variables in Table 4-1. PMM imputation 
were used to address missing data. While imputing a missing value, an indicator was 
generated to distinguish between an imputed value and an actual measurement (missing 
measurement indicators). In case of multiple ICU admissions, only the first ICU admission 
was considered. Moreover, patients must have stayed in the ICU for at least 24 hours, and 
data for laboratory tests, vital signs, urine output and therapeutic interventions were extracted 
only from the first day of stay in the ICU. Data extraction was performed using Structured 
Query Language (SQL) in PostgreSQL. In the MIMIC III database, the birthdate for patients 
older than 89 years old are shifted to obscure their true age. These patients appear in the 
dataset with ages of over 300 years, therefore, the age value for these patients was treated as 
missing data. Moreover, min-max normalizer was used to linearly rescale each predictor to 
the [0,1] interval.   
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Table 4-1 Data types in a patient profile. 
Category Variables 
Demographics and Admission 
Information 
Age, Gender, Admission type (Emergency, Elective, Urgent), The 
first ICU type in which the patient was cared for (MICU, SICU) 
Laboratory Tests and Urine Output Albumin, Anion Gap, Bicarbonate, Bilirubin, Creatinine, Chloride, 
Glucose, Hematocrit, Hemoglobin, Lactate, Platelet, Potassium, 
PTT, INR, PT, Sodium, Bun, WBC, Urine Output 
Vital Signs Heart Rate Systolic Blood Pressure, Diastolic Blood Pressure, 
Respiratory Rate, Temperature, SpO2, Glasgow Coma Score 
Discharge code ICD-9 
Therapeutic interventions Dialysis (Yes/No), Mechanical Ventilation (Yes/No), Fluid (Colloids 
and Crystalloid) Administration (Yes/No) 
Missing Measurement Indicators Albumin, Anion Gap, Bicarbonate, Bilirubin, Creatinine, Chloride, 
Glucose, Hematocrit, Hemoglobin, Lactate, Platelet, Potassium, 
PTT, INR, PT, Sodium, Bun, WBC, Urine Output 
 
4.2.2 Methodology 
4.2.2.1 Multifaceted PS Metric 
Figure 4-2 shows the overall structure of the methodology of this study. For each new patient 
profile, its similarity to the profiles of other patients is assessed from different perspectives. 
In other words, a similarity score is generated for each variable in the profile. Besides the 
variables’ values, the similarity of the patient to others, in terms of missing measurements, is 
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calculated using the representation introduced in Chapter 2 (Sharafoddini et al. 2019). Then, 
all these similarity scores are aggregated to build a multifaced PS score.  
• Age
• Laboratory Tests
• Vital Signs
• ICD-9 codes
• Medications
•  ...
New patient profile
Hospital Database
Multimodal Patient 
Similarity 
Assessment Module
Fusion 
Module
Vital signs similarity scores
Age similarity score
Laboratory tests similarity score
•  
•  
• K most-similar 
patients
 
Figure 4-2 The overall structure of the proposed method. 
4.2.2.1.1 Individual Similarity Metrics 
4.2.2.1.1.1 Demographics and Admission Information 
For categorical demographic data the well-known Simple Matching Coefficient (SMC) is 
used to measure PS (Sokal 1958). SMC is a statistic for calculating the similarity of two sets.  
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 𝑆𝑀𝐶 =
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑚𝑎𝑡𝑐ℎ𝑖𝑛𝑔 𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑜𝑟𝑠
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑟𝑒𝑑𝑖𝑐𝑡𝑜𝑟𝑠
 (4.4) 
For age, simple absolute difference was used.  
4.2.2.1.1.2 Therapeutic Interventions 
Since therapeutic interventions in ICUs are very broad, this study focused only on the 
presence of the following significant interventions in a patient’s profile: mechanical 
ventilation, fluid administration, and dialysis. These interventions are among the ones that 
require special nursing service—based on the Simplified Therapeutic Intervention Scoring 
System (Reis Miranda et al. 1996)—and also have been used in scoring systems for critically 
ill patients as a marker of their health status (Vincent et al. 2010; Rao et al. 2008). For this 
category of variables, SMC was used to calculate pair-wise PS. 
4.2.2.1.1.3 Laboratory Tests and Urine Output 
While in general wards, phlebotomy (the taking of blood samples) is performed on average 
once a day for each patient, in ICUs this number increases to nearly three to four blood 
samples drawn per day (Smoller et al. 1986; Low et al. 1995). Therefore, the maximum and 
minimum values of all laboratory tests in Table 4-1 were extracted per day—since they can 
represent the worst conditions (Lee et al. 2015a). For urine output, the total amount during 
the first 24 hours was extracted. Then, the Mahalanobis distance was employed to calculate 
the similarity of patients in terms of laboratory results and urine output.  
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4.2.2.1.1.4 ICD-9 Code 
This study employed the hierarchical distance introduced by Gottlieb et al. (2013) for 
calculating the distance between ICD-9 codes. 
 𝑆𝑖𝑚(𝐼𝐶𝐷1, 𝐼𝐶𝐷2) =
𝑁𝑒𝑎𝑟𝑒𝑠𝑡 𝐶𝑜𝑚𝑚𝑜𝑛 𝐴𝑛𝑐𝑒𝑠𝑡𝑜𝑟 (𝐼𝐶𝐷1, 𝐼𝐶𝐷2)
5
 (4.5) 
4.2.2.1.1.5 Vital Signs 
Vital signs are collected more frequently for patients than other data. Thus, the maximum and 
minimum of each vital sign were extracted during non-overlapping 6-hour periods—which 
exceed the longest acceptable gap between charting vital signs (Cahill 2010) and the 
commonly-accepted frequency of charting vital signs (Schulman et al. 2010; Miltner et al. 
2014; Johnson et al. 2014). Then, the Mahalanobis distance was used to calculate the 
similarity of patients in terms of vital signs.  
4.2.2.1.1.6 Absence Indicators 
Absence indicators are binary data, and the literature has introduced many distances for 
comparing the similarity of two sets of binary values of the same or different lengths (Deza et 
al. 2009; Choi et al. 2010). In this study, SMC was used for comparing patients in terms of 
their missing measurements. 
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4.2.2.2 Combining Similarity Scores 
After calculating the individual, variable-specific similarity scores, the next step is to fuse all 
the scores into one. Similarity scores are based on multiple sources of information and can be 
seen as distinct pieces of evidence. In this study, after normalizing each metric, simple 
averaging was used for aggregating all the scores.  
Figure 4-3 demonstrates an example of PS calculation by multifaceted PS metrics in the 
dataset. The similarity of the new patient (ICUStay_Id: 210282) from test set is compared to 
the profile of a patient in the training set (ICUStay_Id: 243452). The similarity is measured 
from different perspectives and then all the scores are aggregated into one similarity score. 
Based on the outcome of the patient on the right and its similarity to the new patient, same 
outcome is expected for the new patient. Data confirm a negative value for the 30-days post-
discharge mortality flag for the new patient. 
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Figure 4-3 A visual representation of multifaceted PS metric calculation.  
Table 4-2 shows a summary of calculations performed in Figure 4-6. All numerical 
variables were normalized and categorical variables were one-hot encoded before 
calculation. 
  
98 
Table 4-2 An overview of individual PS calculation methodologies and example input 
vectors with similarity calculations. 
Category PS calculation methodology Input vectors and similarity calculations 
Demographics and 
Admission 
Information 
 
1- (SMC+ 
Absolute Difference)/2 
1-(SMC([MICU1, ..., Female1],[MICU2, ..., 
Female2])  
+ (|Age1-Age2|))/2 
ICD-9 𝑆𝑖𝑚(𝐼𝐶𝐷1, 𝐼𝐶𝐷2) =
𝑁𝑒𝑎𝑟𝑒𝑠𝑡 𝐶𝑜𝑚𝑚𝑜𝑛 𝐴𝑛𝑐𝑒𝑠𝑡𝑜𝑟 (𝐼𝐶𝐷1,𝐼𝐶𝐷2)
5
  
0/5 
Laboratory Tests 1-Mahalanobis distance 1-Mahalanobis ([min_Glucose1, 
max_Glucose1, ..., max 
Albumin],[ min_Glucose2, max_Glucose2, ..., 
max Albumin2]) 
Vital Signs 1-Mahalanobis distance 1-Mahalanobis ([min_GCS1_6hr, 
max_GCS1_6hr1, ..., 
max_HR1_6hr4],[ min_GCS2_6hr, 
max_GCS2_6hr1, ..., max_HR2_6hr4]) 
Indicators 1-SMC 1-SMC([0,0,...,0,0],[0,0,...,0,0]) 
Intervention 1-SMC 1-SMC([no_Dialysis,no_MV, ...,no_crystalloids ], 
[ no_Dialysis,no_MV, ...,crystalloids]) 
 
4.2.2.3 Experiments 
To benchmark the following experiments, the predictive performance of SAPS-II and SOFA 
scores were investigated in a 10-fold cross-validation set-up.  
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4.2.2.3.1 Evaluating the Validity of the Multifaceted PS Calculation 
Quantifying the accuracy and correctness of a PS metric in an unsupervised problem is 
challenging, since subjective evaluation for such a huge number of pair-wise similarity 
scores seems impossible. This study utilizes the objective evaluation method introduced by 
Keogh et al. (2003). The idea is to use a nearest neighbor classifier on labelled data to 
evaluate the accuracy of a PS metric. It has been repeatedly demonstrated that the 
performance of  k-nearest neighbor (KNN) critically depends on the distance metric (Hu et 
al. 2016b; Wang et al. 2012b; Keogh et al. 2003); therefore, the accuracy of classification is a 
proxy of metric accuracy.  Here, this methodology is performed over various values of K to 
eliminate the effect of number of similar patients. For each new patient, data from a cohort of 
similar patients in the training set were retrieved using the proposed multifaceted PS metric; 
then a prediction was made for a new patient based on a majority vote of the k most similar 
patients. An equivalent approach was used to investigate the performance of the following 
conventional metrics 
• Euclidean distance  
 𝑑𝑖𝑠𝑡(𝑋, 𝑌) = √
∑ (𝑥𝑖 − 𝑦𝑖)2
𝑚
𝑖=1
𝑚
2
 (4.6) 
• Cosine similarity 
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 𝑠𝑖𝑚(𝑋, 𝑌) =
?⃗?. ?⃗⃗?
|?⃗?||?⃗⃗?|
 (4.7) 
In calculating the similarities, all numerical predictors were rescaled to the [0,1] interval 
and one-hot encoder was used for categorical variables. 
4.2.2.3.2 Multifaceted PS metric in predictive modelling 
In this experiment, after retrieving a cohort of similar patients, a logistic regression (LR) and 
decision tree (DT) were trained on the retrieved cohort, and a prediction was made for the 
new patient. The same procedure was followed using a cosine PS metric. AUROC was used 
for analyzing the performance of the prediction models in each scenario. Once overall 
performances are revealed, PS-based scenarios are also compared to a population-based 
approach, in which prediction models are trained on the whole training dataset without using 
PS. In all scenarios, 10-fold cross validation was performed. 
4.3 Results 
4.3.1 Data 
From 38,597 distinct adult patients in MIMIC III database, 33,276 patients have LoS1 for 
their first ICU admission. 15,017 patients were excluded since the first ICU type to which 
they were admitted was not medical ICU or surgical ICU. Finally, after excluding patients 
who did not have at least one measurement for any of the variables in Table 4-1, 17,547 
patients were included in this study. Of these patients, 11,963 were admitted to medical ICU 
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and 5,583 were admitted to surgical ICU. Moreover, 2,927 patients (16.68%) experienced 
death within 30 days of discharge.  
4.3.2 Evaluating the Validity of the Multifaceted PS Calculation 
SAPS-II and SOFA achieved a mean AUROC of 0.764 (sd=0.014) and 0.681 (sd=0.024), 
respectively. 
Figure 4-4 illustrates the AUROC of KNN as a function of K (the number of similar 
patients from the training set). The results confirm our hypothesis that a multifaceted PS 
metric is more accurate in retrieving similar patients than the conventional PS metrics. The 
maximum AUROC of 0.69 (SD=0.016) and 0.699 (SD=0.018) for the Euclidean and cosine 
PS metrics was achieved with 200 and 130 similar patients, respectively. For the multifaceted 
PS metric, the maximum AUROC of 0.789 (SD=0.015) was achieved with 870 patients. 
Although the maximum AUROC for the multifaceted PS metric was achieved with a higher 
value of K, this method outperforms the conventional metrics in all values of K. Appendix D 
reports more detailed AUROC results. The best AUROC was significantly better than the 
AUROC associated with k=5000 (the maximum number of similar patients) for the 
Euclidean (p<10-4), cosine (p<10-4) and multifaceted (p= 0.031) PS metrics. 
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Figure 4-4 Accuracy evaluation of PS Metrics using KNN. The bands demonstrate 
the 95% confidence intervals. 
The predictive performance worsened rapidly as the number of similar patients increased 
for the cosine and Euclidean metrics and more gradually for the multifaceted metric. 
4.3.3 Multifaceted PS Metric in Predictive Modelling 
Figure 4-5 demonstrates the predictive performance of PS-based LR as a function of a similar 
patient-cohort size. Table 4-2 summarizes the detailed results. 
  
103 
 
Figure 4-5 Mortality prediction performance of PS-based LR. The bands 
demonstrate the 95% confidence intervals. 
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Table 4-3 Detailed mortality prediction performance of PS-based LR. 
Number of Similar Patients Multifaceted PS 
AUROC (Mean [95% CI]) 
Cosine PS 
AUROC (Mean [95% CI]) 
2000 0.764 [0.758, 0.758] 0.772 [0.768, 0.777] 
3000 0.776 [0.77, 0.77] 0.78 [0.775, 0.785] 
4000 0.784 [0.778, 0.778] 0.784 [0.779, 0.789] 
5000 0.788 [0.782, 0.782] 0.787 [0.782, 0.792] 
6000 0.788 [0.783, 0.783] 0.789 [0.784, 0.794] 
7000 0.788 [0.782, 0.782] 0.79 [0.785, 0.795] 
8000 0.789 [0.783, 0.783] 0.792 [0.786, 0.797] 
9000 0.79 [0.784, 0.784] 0.792 [0.787, 0.797] 
10000 0.79 [0.785, 0.785] 0.792 [0.787, 0.797] 
11000 0.791 [0.786, 0.786] 0.792 [0.787, 0.797] 
12000 0.79 [0.785, 0.785] 0.792 [0.787, 0.797] 
13000 0.79 [0.785, 0.785] 0.791 [0.786, 0.796] 
14000 0.79 [0.784, 0.784] 0.791 [0.786, 0.796] 
15000 0.788 [0.783, 0.783] 0.789 [0.784, 0.794] 
15792 0.788 [0.783, 0.783] 0.788 [0.783, 0.793] 
 
The maximum AUROC of 0.792 (SD=0.008) and 0.791 (SD=0.009) were achieved when 
using data from 10000 and 11000 similar patients in training based on cosine and 
multifaceted PS metrics. None of the PS metrics outperform the others in this setting, and 
their results were not significantly better than that resulting from a population-based setup 
(AUROC of 0.788 [SD=0.008]). 
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Figure 4-6 shows the predictive performance of PS-based DT as the number of similar 
patients increases for cosine and multifaceted PS metrics. Table 4-4 summarizes the detailed 
results.  
 
Figure 4-6 Mortality prediction performance of PS-based LR. Detailed mortality 
prediction performance of PS-based LR. 
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Table 4-4 Detailed mortality prediction performance of PS-based DT. 
Number of Similar Patients Multifaceted PS 
AUROC (Mean [95% CI]) 
Cosine PS 
AUROC (Mean [95% CI]) 
2000 0.7204 [0.7078, 0.7078] 0.7099 [0.694, 0.7257] 
3000 0.7039 [0.6949, 0.6949] 0.6931 [0.6849, 0.7013] 
4000 0.6827 [0.6762, 0.6762] 0.6804 [0.6721, 0.6887] 
5000 0.6728 [0.6664, 0.6664] 0.6759 [0.6682, 0.6835] 
6000 0.6637 [0.6577, 0.6577] 0.6687 [0.6628, 0.6747] 
7000 0.6604 [0.6555, 0.6555] 0.6663 [0.6602, 0.6724] 
8000 0.6584 [0.653, 0.653] 0.6608 [0.6538, 0.6678] 
9000 0.6551 [0.6501, 0.6501] 0.6553 [0.6492, 0.6615] 
10000 0.6566 [0.6509, 0.6509] 0.6525 [0.6473, 0.6577] 
11000 0.6568 [0.6523, 0.6523] 0.6516 [0.6468, 0.6563] 
12000 0.6528 [0.648, 0.648] 0.6512 [0.6463, 0.6561] 
13000 0.6525 [0.6484, 0.6484] 0.6506 [0.6463, 0.6549] 
14000 0.6506 [0.6477, 0.6477] 0.6499 [0.6469, 0.653] 
15000 0.6533 [0.6499, 0.6499] 0.6501 [0.6467, 0.6535] 
 
Results demonstrate that a smaller number of more-similar patients in the training set can 
result in better performance than when all patients are included. The maximum AUROC of 
0.72 (SD= 0.02) and 0.71 (SD= 0.026) were achieved with 2000 similar patients for the 
multifaceted and cosine PS metrics, respectively. The maximum performances were 
significantly better than those for the model that used 15792 patients (p<10-5). 
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4.4 Discussion 
While precision medicine aims to provide more accurate and personalized treatment for 
patients, a PS metric is a fundamental component for identifying patients who are clinically 
similar. Physicians generally utilize their knowledge, available research, and experience from 
previous patients to make a decision for new patients, and PS analytics can help them in this 
information-retrieval process. Recently, many researchers have introduced various PS 
measurement techniques. However, a challenge in this area is how to define a PS metric that 
can best capture the search intent (Wongsuphasawat et al. 2009). This study introduced a 
multifaceted PS metric in which the similarities of patients are investigated from various 
aspects and then combined to provide one similarity score. The multi-layer nature of the 
multifaceted PS metric provides physicians with the opportunity to customize their similarity 
measure definition. If the similarity in terms of demographics is not of interest or if the 
search intent is to find all similar patients regardless of their gender, the associated part can 
easily be removed from a multifaceted PS metric without changing the system pipeline. In 
other words, the multifaceted PS metric has a modular design, thus, each part can perform 
independently. 
In the current study, comparing a multifaceted PS metric with conventional PS metrics 
(i.e., cosine and Euclidean) showed that the former is more accurate in measuring the 
similarity between patients in KNN setting. Although the proposed method outperformed the 
conventional methods in every value of K, the best performance was achieved by including a 
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higher number of patients in the training set in comparison to conventional metrics. 
Moreover, the advantage of multifaceted PS metric was not observed in the DT and LR 
settings. This can be due to the fact that DT and LR are more invariant to the training set in 
comparison to KNN. Therefore, it may be the case that using different PS metrics resulting in 
different training sets does not significantly change the prediction performance of LR and 
DT. 
The results of this study did not show that the performance of predictive models always 
significantly improves when PS analytics was utilized in defining the training set. Although 
the results from including only similar patients in training a DT demonstrate statistically 
significant improvement in AUROC in comparison to a situation when a DT is trained on the 
whole training dataset, results from the LR model did not strongly support this fact. The best 
AUROC for LR was achieved when 11000 similar patients were included in the training set 
rather than when all the training set was used; however, the AUROC was not significantly 
higher than the population-based setting. This outcome is contrary to that of Lee et al. 
(2015a), who found that PS-based LR significantly outperformed the population-based LR on 
their cohort of patients from MIMIC-II. Although our results are in line with those of Lee et 
al. (2015c), a possible explanation for this lack of strong evidence for the LR model might be 
the difference between the groups of patients included in the studies. The aforementioned 
study used data from patients in the MIMIC-II database who did not have data missing from 
their profile, whereas the present work focused on MICU and SICU units in MIMIC-III and 
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did not limit itself to data from patients with complete profiles.  A recent case study on the 
reproducibility of studies on mortality prediction using the MIMIC database demonstrated 
how subtle differences in the inclusion/exclusion criteria can impact results (Johnson et al. 
2017). 
The current study found that various predictive models can show different behaviours 
when only similar patients are being used for their training. For instance, when fewer but 
more similar patients were included in training a DT, the performance improved. However, 
LR was more invariant to changes in the training set. These results match those observed in 
the earlier study by Lee et al. (2015a) in which improvement in AUROC for DT was three 
times greater than that for LR (the improvements in AUROC for LR and DT were 0.02 and 
0.062, respectively). 
It is important to mention that although the PS analytics often lead to better prediction in 
comparison to population-based techniques, the reduced sample size in this approach leads to 
greater variation in model estimation and prediction accuracy measures. The most clinically 
important finding was the interpretability of the multifaceted PS metric and its suitability for 
visualization analytics. Via a multifaceted PS metric, physicians will have the ability to 
identify the drivers of similarity. 
Our study has limitations. First, the scope was limited to two ICU units, and only from an 
ICU database coming from a single (albeit large) research hospital. Second, since the focus 
was on introducing a new multifaceted PS metric, only averaging was used to fuse the 
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similarity scores. Therefore, further research is needed to investigate the effect of fusion 
methods on the accuracy of the multifaceted PS. Moreover, the pair-wise similarity 
calculation comes at the expense of high computational time, however, future researchers can 
benefit from big data technologies such as Spark and Hadoop or cloud computational 
resources to minimize the computation time. Last but not least, this study investigated the 
performance of PS analytics being used with DT and LR. To investigate the performance of 
PS-based predictive modeling in comparison to population-based methods, a more-
comprehensive list of models, such as random forest and gradient boosting, must be included.   
Several questions still remain to be answered. A natural progression of this work would be 
to analyze the effect of other fusion methods on the accuracy of the multifaceted PS metric. 
A further study could investigate PS variation over time and monitor patient progression over 
time. Last but not least, future researchers can focus on tuning the multifaceted PS metric in 
terms of the metrics used for each variable. 
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Identifying Subpopulations of Septic Patients: A Temporal Data-
Driven Approach 
This chapter utilizes the multifaceted PS metric introduced in previous chapter to identify 
septic patient subpopulations. It also investigates the extra information in the temporal aspect 
of EHR data for phenotyping patient similarity. The identified subpopulations can provide 
insights into customizing care for septic patients. 
5.1 Introduction 
In ICUs, it is very important to monitor patient health status over time. This necessity results 
in multiple measurements of a particular clinical variable across a given patient’s stay. Due 
to the time varying nature of these measurements, they are usually referred to as temporal 
EHR. Since temporal EHR data have valuable information about the evolution of patient 
health status, researchers have been able to detect improvements in predictive modeling (Sha 
et al. 2016; Sun et al. 2010b; Sun et al. 2010a) and patient stratification (Singh et al. 2015) 
through using this information. However, analyzing longitudinal data is accompanied with 
multiple challenges such as irregular sampling rates and varying lengths of available 
measurements, as well as the inherent correlation of repeated measurements of a variable 
over time within the same patient.  
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This chapter focuses on using the information in temporal vital signs data in our 
multifaceted PS metric through functional data analysis (Ramsay 2005). Then, cluster 
analysis will be employed for identifying a subpopulation of septic patients with similar 
clinical needs and trajectories. This information may be used to design customized care 
platforms for patients who share similar needs. 
5.1.1 Literature Review 
Longitudinal data are an important part of EHR data and have initiated interest among 
researchers, many of whom agree that the time-varying aspect of EHR data may contain 
additional information about patient health status (Lehman et al. 2014; Lehman et al. 2015b; 
Lehman et al. 2015a; Singh et al. 2015; Agarwal et al. 2016; Pimentel et al. 2013). ICUs have 
a heterogeneous population with various health status dynamics and similar needs for 
constant care ('Critical Care Statistics'  ; Prin et al. 2012). This heterogeneity adds to the 
importance of finding similar patients and detecting the underlying phenotypic groups. 
Recently, efforts have been made to employ the temporal information of heterogeneous EHR 
data to reveal subpopulations. 
A large and growing body of literature has investigated vital-sign trajectories to discover 
patient subpopulations in order to identify the underlying pathophysiology of diseases and 
suggest customized care pathways. Pimentel et al. (2013) focused on the evolution of vital 
signs in post-operative patients using an unsupervised Gaussian process model. Their study 
revealed four dominant underlying physiological behaviors in their population.  
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Lehman et al. (2014) investigated the discriminative bivariate dynamics of heart rate and 
blood pressure in 450 ICU patients, using a switching vector autoregressive process 
approach. Their study demonstrated that the temporal evolution of the vital signs has 
additional predictive value for sepsis detection beyond the non-temporal approaches. 
Moreover, their study revealed ten prevalent underlying physiological modes for patient 
health status, each of which was correlated with different sepsis risk levels. In addition, their 
exploratory analysis revealed that high-risk modes have less variability in their trajectories. 
Building on this study, they suggested that the observed patterns are due to a patient’s health 
status, undergoing clinical intervention, and possible artifacts. Therefore, similarity can be 
investigated based on the underlying dynamics of vital signs and help healthcare providers 
manage short- and long-term outcomes with appropriate interventions (2015a).  
Lehman et al. (2015b) extended their work and compared the changes in vital signs 
dynamics before and after applying vasopressor treatment. The study demonstrated 
distinguishable differences in the dynamics among survivors and non-survivors. However, 
they did not elaborate on the potentially discriminative nature of vasopressor treatment 
patterns. Agarwal et al. (2016) used a functional clustering model to find sub-populations in a 
cohort of patients with chronic kidney disease, based on creatinine measurement trajectories. 
They found two sub-populations, each with a dominant creatinine trajectory. Exploratory 
analysis of the clusters revealed various discriminative factors between the clusters, including 
the presence of comorbidities and adherence to medication.  
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Along with previous studies, the Latent Class Mixed Models (LCMMs) have been widely 
used for analysis of change over time and for uncovering subpopulations in a heterogeneous 
patient population (Gill et al. 2010; Maggs et al. 2004; Proust-Lima et al. 2009b; Proust-
Lima et al. 2009a; McCulloch et al. 2002; Quantin et al. 1999; Rubin et al. 1997; Muthén et 
al. 1999) for various clinical applications related to hospital reimbursement (Quantin et al. 
1999), schizophrenic behaviour (Rubin et al. 1997), alcohol dependence in youth (Muthén et 
al. 1999) and prostate cancer (Gill et al. 2010; Maggs et al. 2004; Proust-Lima et al. 2009b; 
Proust-Lima et al. 2009a; McCulloch et al. 2002). In these models, two sub-models based on 
the predictors are defined: the probability function of latent class membership and the class-
specific trajectory function. LCMM refers to models that have an unobserved subpopulation 
structure.  
Lin et al. (2000), applying LCMM on data from the Nutritional Prevention of Cancer 
study, focused on the binary outcome of prostate cancer and the prostate-specific antigen 
(PSA) as the predictor. In this study, the longitudinal sub-model was the Linear Mixed Model 
(LMM), and the Expectation Maximization (EM) algorithm was used for coefficient 
estimation. The fitted model uncovered sub-populations, and the PSA trajectories were 
explicitly different between these classes. Building on the previous study, they extended the 
similar model to predict a survival outcome (prostate cancer onset) (Lin et al. 2002). 
McCulloch et al. (2002) reviewed the utility of these models in a health context. Moreover, 
they extended the previous studies and proposed a model for binary (incidence of prostate 
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cancer after 7 years), continuous longitudinal (PSA readings over time), and survival (the 
time until prostate cancer diagnosis) outcome. Considering all this evidence, it seems that 
longitudinal EHR is a valuable resource for finding PS in order to customize care delivery.  
The Third International Consensus Definitions for Sepsis and Sepsis Shock (Sepsis-3) 
defined sepsis as “life threatening organ dysfunction caused by a dysregulated host response 
to infection,” which respectively costs Canada and the United States more than $300 million 
and $20 billion annually, respectively (Singer et al. 2016). Along with this definition, Sepsis-
3 introduced criteria to detect septic cases with the goal of facilitating clinical care. However, 
there are various sepsis guidelines available that may be more helpful for other purposes 
(Rhee et al. 2019). Overall, there are six widely-used criteria for identifying septic patients. 
1. Sepsis-3 criteria: suspected infection with sequential organ failure assessment (SOFA) 
score of greater or equal to two (Singer et al. 2016) 
2. Explicit sepsis: having at least one of the following ICD-9 codes: 
a. 785.52: septic shock 
b. 995.92: severe sepsis 
3. Angus criteria: having at least one of the ICD-9 codes proposed by Angus et al. (2001). 
4. Martin criteria: having at least one of the ICD-9 codes proposed by Martin et al. 
(2003). 
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5. The Centers for Medicare & Medicaid Services (CMS) criteria: uses a combination of 
ICD-9 codes, Systemic Inflammatory Response Syndrome (SIRS) criteria and specific 
thresholds for organ dysfunction (Medicare et al. 2012). 
6. The Centers for Disease Control and Prevention (CDC) complete surveillance criteria:  
suspected infection with organ dysfunction criteria similar to SOFA (Seymour et al. 
2016). 
A number of interventions are used for treating sepsis. The antibiotics treatment usually 
starts immediately after diagnosis. Moreover, patients often receive intravenous fluid. If the 
low blood pressure persists, patients may also receive vasopressor medications, which make 
blood vessels constrict and helps to increase blood pressure. Understanding the various 
interventions for sepsis, and the administration and outcomes, has been a trending topic (Wu 
et al. 2017; Fialho et al. 2013). However, there is still considerable heterogeneity in the 
outcomes of sepsis treatments, a phenomenon known as “treatment effect heterogeneity” 
(Kravitz et al. 2004). Even after many attempts to explain this heterogeneity, there is no 
consensus for much of the variability in outcome of a particular treatment. Many researchers 
have focused on investigating sepsis-related research questions by using EHR data. Johnson 
et al., in their comprehensive study, demonstrated that even in one hospital, there are various 
groups of patients with a diagnosis of “sepsis” who have highly variable outcomes. 
Fialho et al. (2013) suggested the idea of disease-specific models instead of one-size-fits-
all models in ICUs. They focused on fluid resuscitation therapy and attempted to predict the 
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need for vasopressor therapy after failed fluid resuscitation. This study demonstrated that the 
response of fluid resuscitation of each predefined population—pneumonia and pancreatitis 
patients in an ICU—led to a different model. Salgado et al. (2016) used fuzzy ensemble 
models to predict vasopressor dependence. They first found sub-populations in the dataset 
using an unsupervised clustering method and then trained a fuzzy model on each sub-
population. Researchers have also focused on leveraging temporal data in answering sepsis-
related questions. One study utilized the longitudinal measurement of heartrate, mean blood 
pressure and respiratory rate for predicting the onset of septic shock with coupled hidden 
Markov models (Ghosh et al. 2017). They also compared their method to conventional 
approaches such as SVMs. According to their results, methods that account for the temporal 
aspect of data tend to perform better than conventional methods. On the same application, 
Khoshnevisan et al.(2018) demonstrated that using recent temporal patterns with various 
classification methods consistently outperform atemporal approaches. These results support 
the idea of leveraging temporal data when considering septic patients. 
5.1.2 Objectives 
Building on the previous studies, in this research, multifaceted PS is employed to investigate 
the presence of similar subpopulations among septic patients, with a special focus on taking 
the trajectory of their vital signs into consideration. Identifying subpopulations of septic 
patients with similar clinical needs, trajectories, and health status is the main objective of this 
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study. The results may provide a framework for more customized care for each subgroup of 
septic patients. 
5.1.3 Materials and Method 
5.1.3.1 Study Sample 
This study utilized the data from patients admitted to the critical care units of the Beth Israel 
Deaconess Medical Center between 2008 and 2012 (MIMIC III database) provided in 
(Johnson et al. 2018a) and data extraction was done using the code provided by the authors 
(Johnson et al. 2018b). From 23,620 ICU admissions that were initially included, three 
nonadult patients were excluded. 7,536 admission were excluded to only focus on the first 
admission of patients with multiple admissions. Patients who admitted to the cardiothoracic 
surgical service were also excluded since their postoperative physiologic disorders do not 
have the same mortality risk as the other ICU patients (2,298 patients). Moreover, 18 
admissions were removed because they had no charted data. Patients suspected of infection 
more than 24 hours after or before ICU admission were excluded to only focus on patients 
who admitted to ICU with sepsis (824 patients). Moreover, 2270 patients who stayed in the 
ICU for less than 24 hours and 209 patients who had less than two measurements for their 
vital signs in 24 hours were excluded.  Finally, 9321 adult septic patients based on any of the 
following sepsis criteria were included in the study: Sepsis-3 criteria, explicit sepsis, Angus 
criteria, Martin criteria, CMS and CDC criteria. 
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5.1.3.2 Feature Extraction 
For each patient, the following sets of predictors from the first 24 hour of the ICU admission 
were extracted: 
1. Admission and demographic data: ICU service type (MICU, SICU, TSICU, CCU), 
admission type (emergency, elective, urgent), gender (female, male) and age 
2. Minimum and maximum of the following variables: blood urea nitrogen (BUN), 
hematocrit, creatinine, bicarbonate, lactate, potassium, sodium, glucose, platelets, 
white blood cells, and Glasgow Coma Scale 
3. Hourly measurement of vital signs: mean blood pressure (MBP), systolic blood 
pressure (SysBP), heartrate (HR), respiratory rate (RR), SpO2 and body temperature 
(Temp) 
4. Daily total urine output 
5. Interventions: Duration and dosage of each of the following vasopressor 
administration: norepinephrine, epinephrine, phenylephrine, vasopressin, dobutamine 
and dopamine, presence of mechanical ventilation and dialysis. 
To include the temporal aspect of vital signs, in addition to the simple statistical 
characteristics (including maximum, minimum, median, mode, mean, standard deviation and 
number of measurements) that can capture magnitude and variability of variables, functional 
principal components were used to identify the dominant modes of variation in vital signs. In 
the last decade, functional principal component analysis (FPCA) has been widely used in the 
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statistics and machine learning (ML) community for various application, including public 
health and biomedical applications, to reduce the dimensionality of data while preserving the 
information on variability over time (Ullah et al. 2013). The FPCA was applied for sparsely 
or densely observed vital signs via the Principal Analysis by Conditional Estimation (PACE) 
algorithm provided in the R package fdapace (Dai et al. 2017a). In the PACE, functional 
principal components are defined as conditional expectations. The expectation for the 
trajectory 𝑋𝑖(𝑡) for the 𝑖th patient when using only the first 𝑝 eigenfunctions (?̂?𝑘(𝑡)) is 
 ?̂?𝑖
𝑝(𝑡) = ?̂? + ∑ ?̂?𝑖𝑘  ?̂?𝑘(𝑡)
𝑝
𝑘=1
 (4.8) 
where ?̂? is the estimate of the mean function 𝐸(𝑋(𝑡)) = 𝜇(𝑡) , and ?̂?𝑖𝑘 represents the 
functional principal component scores. The first 𝑝 functional principal components were 
extracted for vital signs in such a way that the components cumulatively explain 98% of the 
total variation in the trajectory. 
For laboratory tests, the maximum and minimum measurement during 24 hours was used. 
For vasopressor administration, the duration and total amount of each variable was extracted 
for the first 24 hours. For mechanical ventilation and dialysis only the presence of the 
administration (a binary variable) was utilized. 
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Vital signs in this study were considered as sparse data, therefore, no missing data 
treatment was performed for them. However, for laboratory tests, predictive mean matching 
(PMM) imputation method was employed to address missing data. 
5.1.3.3 Cluster Analysis 
A common practice when clustering datasets with large numbers of variables is to reduce 
dimensionality. This study utilized t-SNE to map patients to a two-dimensional space. The 
conventional t-SNE method utilizes Euclidean distance to map data into a two-dimensional 
space. In this study, the Mahalanobis distance and multifaceted PS were used instead of 
Euclidean distance in mapping data points in the following experiments. Then, DBSCAN 
clustering was used to find subpopulations in the cohort of septic patients. The parameters of 
DBSCAN (epsilon [ɛ] and minimum points [MinPts]) were tuned using the k-distance tuning 
method discussed in Section 3.4. MinPts were set to dimensionality of data pulse one. Then, 
the distance of each point from its k’th (k=MinPts) nearest neighbor was calculated (kdist). 
After calculating and sorting kdists for all data points, the k-distance graph was plotted and 
the value for which the graph showed a strong bend—the knee point—was selected for 
epsilon.  
The silhouette index (Rousseeuw 1987), which evaluates the suitability of assigning a 
patient to a group rather than to another was utilized to evaluate the clustering method. The 
silhouette index is a number between -1 and 1, where a high value means the patient is 
strongly matched to its own cluster and weakly matches other clusters. The silhouette index 
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was calculated for each cluster by averaging the silhouette indices of the patients in that 
cluster.  
For each of the following two scenarios, the same approach was utilized.  
5.1.3.3.1 Investigating the informativeness of temporal data over cross-sectional data 
In the first scenario, statistical characteristics (including maximum, minimum, median, mode, 
mean, standard deviation and number of measurements) and the functional principal 
component scores of vital sign measurements were utilized to calculate the pair-wise 
Mahalanobis distances. The resulting distance matrix was used as the input to our cluster 
analysis pipeline. Then, only the average over 24 hours for the vital sign measurements was 
used, in which the variability over time was lost. The pair-wise Mahalanobis distances were 
then used as the input. The results of both analyses were compared to identify the 
informativeness of temporal data over cross-sectional data. 
5.1.3.3.2 Finding subpopulations in the septic patient cohort 
In the second scenario, the focus was on finding septic patient subpopulations using the 
multifaceted PS metric introduced in Chapter 4. For the vital sign distance calculation, the 
Mahalanobis distance was applied to the Euclidean vector of statistical characteristics and 
functional principal component scores. After evaluating the clusters using the Silhouette 
method, the clusters were compared in terms of the patient and hospitalization characteristics. 
Then, the average severity of illness and prevalence of comorbidities were examined in each 
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cluster using Logistic Organ Dysfunction Score (LODS) (Le Gall et al. 1996), SOFA, SIRS 
and Elixhauser scores (Elixhauser et al. 1998). Moreover, correlation analysis was employed 
to investigate potential association between overall patient outcome (in-hospital and 30-days 
mortality rates, and ICU and hospital length of stays [LOSs]) and average age in clusters. 
The same analysis was performed for investigating the association between average severity 
of illness and patient outcomes in clusters. Moreover, the three most-common diagnoses in 
each cluster were reported. 
5.2 Results 
5.2.1 Data 
This study was not limited to septic patients identified only by Sepsis-3 guidelines, as it was 
of interest to observe how a machine-learning driven approach can identify different groups 
of septic patients. However, the ML-driven clusters were compared with those derived by 
various sepsis definitions. Table 5-1 displays the descriptive characteristic of the included 
patients. 
Table 5-1 Descriptive characteristics of the study cohort. 
Patient Characteristics  
Age (yrs) 63.31  18.42 
Gender 
Female 
 
4211 (45.22%) 
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Male 5101 (54.78%) 
Admission Type 
Elective 
Emergency 
Urgent 
 
657 (7.06%) 
8552 (91.84%) 
103 (1.11%) 
First Care Unit 
MICU 
SICU 
TSICU 
CCU 
 
4247 (45.61%) 
1954 (20.98%) 
1491 (16.01%) 
1293 (13.89%) 
30-day Mortality Count 1211 (13%) 
In-hospital Mortality Count 920 (9.88%) 
Hospital Length of Stay (day) 8.67   8.66 
ICU Length of Stay (day) 3.96  5.09 
 
5.2.2 Functional Principal Component Score Extraction 
The estimate of mean function using local linear smoothing is shown in Figure 5-1, revealing 
the overall decreasing trend for HR, MBP, SysBP and SpO2, and the increasing trend for RR 
and body temperature. 
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Figure 5-1 Smooth estimate of the mean functions for vital signs. 
In Figure 5-2, the first estimated eigenfunction for each vital sign is provided.  
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Figure 5-2 Estimate of the first eigenfunction for various vital signs in the entire 
cohort. 
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Figure 5-3 provides the scree-plots for each vital sign, demonstrating the fraction of total 
variance in data as explained by each functional principal component. The first eigenfunction 
for HR, SysBP and MBP explains more than 80% of the total variation of the data, and for 
SpO2 and Temp accounts for 78.41% and 67.98% of the total variation, respectively. Overall, 
more than 98% of the variation in HR and RR can be explained by the first three 
eigenfunctions. For MBP, SysBP and SpO2 this number increases to four. The first five 
eigenfunctions for Temp explains more than 98% of the variation. The scores for these 
eigenfunctions were extracted for each patient to be used as features for the clustering phase. 
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Figure 5-3 The scree plots show the portion of variance explained by each functional 
principal component. 
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5.2.3 Cluster Analysis 
5.2.3.1 Investigating the informativeness of temporal data over cross-sectional data 
Figure 5-4 demonstrates clustering results when only the average of vital signs is used. As 
can be seen, all patients are considered in one cluster and similar to each other, with a few 
patients labeled as outliers.  
 
Figure 5-4 Clustering septic patients using the average value of vital signs during the 
first 24 hours of admission to ICU. DBSCAN clustering method with MinPts=25 and ɛ 
=2.25 was used. Data were mapped to a two-dimensional space using t-SNE with 
perplexity=25 and 1000 iteration. 
By including the functional principal component scores, small clusters start emerging, 
while excluding them resulted in one cohort. Figure 5-5 demonstrates five clusters identified 
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by DBSCAN after including the information about the trajectories of vital signs. Moreover, 
there is another small cluster emerging at the left end in Figure 5-5, which was not identified 
by DBSCAN clustering method. 
 
Figure 5-5 Clustering septic patients using hourly vital signs during the first 24 
hours of admission to ICU along with the functional principal component scores. 
DBSCAN clustering method with MinPts=25 and ɛ =2.25 was used. Data were mapped 
to a two-dimensional space using t-SNE with perplexity=25 and 1000 iteration. 
For a fair comparison, all the parameters were kept the same and only changed how vital 
signs are represented. These results posit that the temporal aspect of vital signs has additive 
information and can be helpful in clustering septic patients. 
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5.2.3.2 Finding subpopulations in the septic patient cohort 
Cluster analysis was implemented using the multifaceted PS metric on a comprehensive list 
of information from patients provided in Section 5.1.3.1. After tuning the parameters of 
DBSCAN, 9 main clusters and cluster 0 representing outlier samples were identified.  
 
Figure 5-6 Clustering septic patients using multifaceted PS metric on patient 
profiles. DBSCAN clustering method with MinPts=103 and ɛ =1.4 was used. Data were 
mapped to a two-dimensional space using t-SNE with perplexity=100 and 1000 
iteration. 
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The clusters were evaluated using the silhouette statistics. It was observed that except for 
the group of outliers which received a silhouette value of -0.63, the average silhouette value 
for all clusters were positive. Figure 5-7 demonstrates the average silhouette values for all 
clusters in which only one cluster had a weak structure, all other clusters had reasonable and 
strong structures. The silhouette values are color coded based on the ranges proposed in 
(Kaufman et al. 2009). Green ([0.71,1]) indicates that a strong structure has been found for 
that particular cluster. Yellow ([0.51,0.70]) and red (0.50) indicate reasonable and weak 
structures, respectively. 
 
Figure 5-7 The average silhouette values for each cluster. Green, yellow and red 
respectively represent strong, reasonable and weak structures. 
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The distribution of cluster memberships, patient and hospitalization characteristics are 
shown in Table 5-2. The smallest cluster size is 97 and the biggest is 4522. In hospital 
mortality ([3.45%, 24.43%]) and 30-days mortality ([6.9%, 28.24%]) rates varied 
significantly between clusters, implying the various outcomes of septic patients. Clusters # 2, 
8, and 9 had the lowest mortality rates. 
Table 5-2 Patient and hospitalization characteristics in each cluster. 
# Size Age 
(y) 
Male 
(%) 
In-hospital mortality 
(%) 
30-day mortality 
(%) 
Hospital LoS 
(d) 
ICU LoS 
(d) 
0 916 62.94 55.13 19.76 22.05 11.13 5.1 
1 2417 60.41 56.76 13.53 15.72 10.24 5.15 
2 4522 64.01 54.14 3.78 7.41 6.79 2.61 
3 461 68.5 50.54 19.31 24.08 11.56 6.79 
4 131 73.85 52.67 24.43 28.24 7.95 5.73 
5 220 61.48 57.73 12.73 13.18 12.21 5.31 
6 354 65.34 56.78 17.51 19.77 11.56 5.99 
7 136 71.94 50.74 17.65 25.74 8.51 3.12 
8 97 60.87 53.61 4.12 8.25 4.64 2.28 
9 58 47.68 43.10 3.45 6.9 5.57 2.41 
 
It was also observed that the average age was positively correlated with 30-day mortality. 
This association was not as significant for in-hospital mortality. This result may imply that 
death after discharge is more likely among older age groups (Figure 5-8).  
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Figure 5-8 The association between mortality rates and age groups. 
Table 5-3 demonstrates the average Elixhauser comorbidity score in each cluster. The 
average scores of SOFA, LODS and SIRS are also presented for each cluster. The 30-days 
mortality rate was significantly correlated with average SOFA (=0.76, p-value<0.02), 
LODS (=0.87, p-value<0.005) and SIRS (=0.72, p-value<0.02). The same results were 
observed for in-hospital mortality, hospital LoS, and ICU LoS. These results are in line with 
the fact that sicker patients are more vulnerable and, hence, more likely to experience death. 
  
R R= 0.73 , p=0.016 R= 0.8 , p=0.0057 
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Table 5-3 A summary of comorbidities and severity of illness scores in each cluster. 
# Average Elixhauser SOFA LODS SIRS 
0 3.61 6.03 5.53 2.95 
1 2.33 4.11 4.3 2.91 
2 2.14 2.68 2.86 2.53 
3 5.49 8.25 6.23 3.16 
4 3.25 7.07 6.17 2.79 
5 4.18 7.29 5.95 2.73 
6 3 4.61 5.13 3.08 
7 5.85 5.26 5.56 2.76 
8 1.34 2.26 2.37 2.3 
9 1.64 2.36 2.59 2.47 
 
Table 5-4 presents the top three most-common diagnoses assigned by the admitting 
clinicians in each cluster. Clusters number 0 and 3, which have patients with a sepsis 
diagnosis also have very high rates of mortality 
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Table 5-4 Top three most-common diagnoses assigned by the admitting clinicians in 
each cluster (#: number of patients with a particular diagnosis in each cluster). 
Cluster 0 # Cluster 1 # Cluster 2 # 
Sepsis 45 Intracranial hemorrhage 145 Pneumonia 203 
Pneumonia 33 Pneumonia 101 Upper GI bleed 129 
Altered mental status 25 Altered mental status 99 Chest pain 93 
Cluster 3 # Cluster 4 # Cluster 5 # 
Sepsis 77 Congestive heart failure 9 Acute renal failure 9 
Pneumonia 35 Bradycardia 8 Congestive heart failure 8 
Hypotension 23 Chest pain 5 Sepsis 7 
Cluster 6 # Cluster 7 # Cluster 8 # 
Intracranial hemorrhage 13 Stroke, telemetry,  
transient ischemic attack 
15 Stemi 3 
Chest pain 12 Altered mental status 10 Alcohol withdrawal 3 
Chest pain\cardiac cath 9 Pneumonia 10 Bradycardia 3 
Cluster 9 # 
Diabetic ketoacidosis 30 
Hyperglycemia 2 
Upper gi bleed 2 
 
Table 5-5 presents the distribution of sepsis diagnosis based on six sepsis definitions 
(explicit, Angus, Martin, CMS, CDC and Sepsis-3 methodologies) in each cluster. Except for 
cluster numbers 3 and 6, Sepsis-3 criteria identified a higher number of septic patients in 
each cluster. For the two aforementioned clusters, CDC method covered most of the patients. 
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Table 5-5 The distribution of sepsis diagnosis based on six sepsis definitions in each 
cluster. 
# Angus (%) Martin (%) Explicit (%) CDC (%) CMS (%) Sepsis-3 (%) 
0 44.1 29.37 22.82 55.13 25 64.08 
1 37.98 11.17 5.79 37.9 6.41 61.11 
2 20.63 11.26 5.04 20.17 7.7 37.13 
3 78.96 63.77 56.62 94.58 59.65 94.36 
4 44.27 24.43 17.56 64.12 20.61 62.6 
5 45.91 30 18.18 46.82 23.64 70.45 
6 34.18 17.23 12.99 80.23 13.84 71.75 
7 40.44 26.47 13.97 31.62 22.06 56.62 
8 17.53 6.19 3.09 10.31 5.15 20.62 
9 20.69 8.62 6.9 12.07 6.9 25.86 
 
Table 5-6 shows the percentage of patients in each cluster that underwent dialysis or 
mechanical ventilation. It also includes the average administration duration of various 
vasopressor administration. No statistically significant correlation was observed between the 
level of medication that patients received and their outcomes. 
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Table 5-6 Statistical description of medications (average duration in minutes) and 
interventions (percentage of patients who received the intervention) utilized in each cluster. 
# Mechanic
al 
Ventilatio
n (%) 
Dialys
is (%) 
Norepinephri
ne Duration 
(m) 
Epinephri
ne 
Duration 
(m) 
Phenylephri
ne duration 
(m) 
Vasopress
in 
Duration 
(m) 
Dobutami
ne 
Duration 
(m) 
Dopami
ne 
Duration 
(m) 
0 45.52 3.93 4.46 0.64 3.63 4.71 0.5 0.44 
1 100 0 0.21 0 0.3 0.03 0 0.02 
2 0.04 0 0.12 0 0.06 0.01 0 0.02 
3 60.52 0.87 22.4 0.03 1.22 0.35 0.01 0.38 
4 45.8 6.11 3.15 0.15 1.85 1.29 0 21.06 
5 39.55 100 3.06 0.02 0.53 0.08 0 0.15 
6 80.23 1.13 0.42 0 19.61 0.11 0 0.03 
7 2.94 0.74 0.88 0 0.52 0.8 0 0.02 
8 1.03 0 0.43 0.01 0.11 0.15 0.01 0 
9 0 0 0.1 0 0 0 0 0 
 
Table 5-7 represents the average dosage of vasopressors for each cluster. 
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Table 5-7 The average dosage of vasopressors utilized in each cluster. 
# Norepinephrine 
Dosage (mg) 
Epinephrine 
Dosage 
(mg) 
Phenylephrine 
Dosage (mg) 
Vasopressin 
Dosage 
(mg) 
Dobutamine 
Dosage (mg) 
Dopamine 
Dosage 
(mg) 
0 4.77 0.16 41.87 10.86 10.76 18.35 
1 0.1 0 1.2 0.05 0.02 0.72 
2 0.06 0 0.37 0.01 0.06 0.48 
3 13.76 0.01 8.86 0.81 0.26 11.87 
4 3.15 0.06 15.78 2.94 0 683.35 
5 1.82 0.01 2.78 0.17 0 3.63 
6 0.25 0 76.04 0.19 0 0.66 
7 0.69 0 3.21 1.84 0 0.31 
8 0.5 0 1.14 0.36 0.13 0 
9 0.01 0 0 0 0 0 
 
Finally, Figure 5-9 presents the first eigenfunction for each vital sign in each cluster. It can 
be clearly seen that some clusters have completely different trends for their first 
eigenfunctions. This observation highlights the importance of including the variation 
explained by temporal data to capture different evolutions of patient health status. 
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Figure 5-9 First eigen function estimates for HR, SysBP, MBP, SpO2, Temp RR data 
in each cluster. 
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5.3 Discussion 
In this study the focus was on leveraging temporal data in clustering septic patients. 
Summarizing vital sign measurements by their average not only eliminates the information 
on patient health status changes over time, it cannot be helpful in phenotyping septic patients. 
Moreover, incorporating the information on the vital sign trajectories using functional data 
analysis can help in finding distinction among septic patients. 
 The results suggest that although septic patients share similar underlying physiological 
condition, grouping them as one cohort results in a loss of information about their unique 
characteristics. It was demonstrated that clustering analysis enabled identification of nine 
clinically distinguishable subpopulations from a cohort of septic patients. The results also 
showed that the dominant mode of variation for each vital sign differs from one 
subpopulation to another. For instance, the first eigenfunction for SpO2 in cluster #8 shows 
high variation over time while cluster #3 has a near-flat first eigenfunction. It is worth 
mentioning that cluster #8 is among subpopulations with low mortality rates (30-day 
mortality: 8.25%, in-hospital mortality: 4.12%) while cluster #3 has high mortality rates (30-
day mortality: 24.08%, in-hospital mortality: 24.43%). Thus, the variations in vital signs 
trajectories can be informative of patient future outcome.  
 The characteristics of identified clusters were in line with clinical outcomes such as 
increased mortality rates in groups with a higher average age. These results were in line with 
the cluster analysis done by Vranas et al. (2017) that focused on clustering ICU patients and 
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identified clinically distinguishable clusters with sepsis as their most-common admitting 
diagnoses, and thus highlights the potential heterogeneity among septic patients. 
The results also demonstrated that septic patients have different care needs; however, a 
higher level of care was not correlated with poorer outcome. This observation is supported by 
the fact that there are precisely predefined care plans for septic patients at various levels of 
severity of illness, and they are usually effective in controlling the disease. However, 
understanding why therapeutic efficiency differs between subpopulations is critically 
important in caring for septic patients. For instance, cluster #8 has low mortality rates (30-
day mortality: 8.25%, in-hospital mortality: 4.12%) while cluster #7 with similar therapeutic 
patterns has much higher mortality rates (30-day mortality: 25.74%, in-hospital mortality: 
17.65%). A further study with more focus on treatment effectiveness in each subpopulation is 
therefore suggested. 
 In addition, the results showed that the Sepsis-3 criteria are more inclusive than the others, 
except for two clusters for which CDC was more inclusive. Both Sepsis-3 and CDC criteria 
use treatments as proxy of organ failure. This result is supported by that of Johnson et al. 
(2018a) in which Sepsis-3 criteria identified a higher number of patients, followed by CDC. 
However, this finding also suggests more studies are needed on the characteristics of septic 
patients based on Sepsis-3 and its inclusiveness. 
This study has some limitations. First, the data used in this work was from only a single 
medical center (albeit a large one) in the analysis.  Second, the vital signs trajectories were 
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examined in a 24-hour window; however, data from a longer period would better capture 
patient health changes over time. 
In this study we identified groups of septic patients with similar characteristics and needs 
which can facilitate the move toward precision medicine by considering the differences 
between subpopulations to support customized therapy approaches. Therefore, future 
research should focus on investigating the key differences between these subpopulations 
using medical expert opinion and identifying the best practice for each group. Another future 
direction is to use these latent sepsis phenotypes for PS-based predictive modeling by 
training a model for each subpopulation instead of using a one-size-fits-all model.  
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Conclusions and Discussion 
 
The goal of the work presented in this thesis was to introduce new approaches to employing 
PS for more-efficient prediction and clustering of ICU data in order to fulfill the promise of 
precision medicine. To that end, it was demonstrated that missing data in EHR are 
informative and can be used to improve prediction performance. Moreover, this information 
can help in finding similar patients in the ICU. The PS metric itself was one of the focuses of 
this work. A new multifaceted PS metric was introduced that is not only more accurate than 
conventional methods, but is also more interpretable and adaptive to the different use cases. 
Last but not least, it was showed that the temporal information in longitudinal EHR data can 
be used to improve the performance of clustering methods and identify patient 
subpopulations in a focused application of sepsis patients. 
In Chapter 2, it was showed that the hidden information in missing data has implications 
for patient health status and outcomes and that this information can be employed to improve 
the performance of predictive modeling. The performance of different predictive models 
(DT, LR and RF) was investigated when missingness indicators are added to the feature set. 
It was showed that models in which the hidden information of missing data was included 
  
145 
outperformed not only SAPS-II but also similar methods without missing data information in 
predicting in-hospital mortality and 30-day mortality. 
In Chapter 3, an unsupervised study was performed to better understand the 
informativeness of missingness indicators and how they can be used to identify similar 
patients. Missingness indicators were used as representative of lab-test ordering and used 
them for phenotyping patients. Results demonstrated that these indicators capture physicians’ 
opinions about patient needs and symptoms. In the results of clustering, it was observed that 
clusters with higher rates of mortality had higher numbers of performed laboratory tests. 
These results were in line with the fact that ICU physicians tend to order more tests for 
patients who are severely ill, as they need to be monitored closely and comprehensively.  
Chapter 4 focused on introducing a multifaceted PS metric in which the similarity of every 
aspect of the EHR data is considered individually and then various similarity scores are 
combined to make a unified score for two patients. The proposed method significantly 
outperformed the conventional and most-commonly-used metrics, including the cosine PS 
metric, in terms of similarity accuracy, with focus on 30-day mortality. The performance of 
this metric was also investigated when used with other prediction models, including DT and 
LR. Although the multifaceted PS metric outperformed the cosine metric when used with 
DT, similar results were not observed for LR. These results highlight the need for in-depth 
investigation of the performance of various predictive models in a PS-based framework on 
different databases. 
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Finally, in Chapter 5, the results from previous chapters were utilized to identify 
subpopulations among septic patients with special focus on temporal EHR. The results 
demonstrate that temporal data have additive information and can be helpful in clustering 
patients.  
Notwithstanding the contributions that this thesis work has provided, it is important to 
acknowledge the known shortcomings of the research. First, this work has resulted in 
findings that are limited to only one large research healthcare facility, with a special focus on 
its ICU. This focus is largely a consequence of the unavailability of other publicly available 
EHR databases. Moreover, the findings from the study in Chapter 4 were limited to a simple 
averaging combining method. Investigations into the impacts of other fusion methods on the 
accuracy and predictive power of the multifaceted PS metric would be of interest, though 
were beyond the aim of the current study.  
Overall, each of the five studies in this thesis contributes to current knowledge about 
missing data in EHR, PS analytics in patient stratification, PS metric in predictive modeling 
and informativeness of temporal EHR. Chapter 2 provided a new insight into missing data in 
EHR and was novel in that it is the first study comprehensively examining the 
informativeness of missing data in ICU EHRs. Chapter 3 built on the previous study by 
exploring ICU patient subpopulations using the information in missing data. The findings 
supported the informativeness of missing data and promoted the new insight into missing 
data. Chapter 4 introduced the idea of multifaceted PS and investigated its validity. Finally, 
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Chapter 5 provided evidence on additive information of temporal EHR and how this 
information can help in identifying subpopulations of septic people.  
The methods provided in this dissertation can easily be implemented in the back-end of the 
various interactive data visualization products at care facilities to help clinicians better 
understand the data. Moreover, these techniques can easily be implemented on the cloud as 
an application programming interface (API) and be employed by a simple call to the API at 
any time for various applications.” 
Despite these promising contributions, questions remain. Although much knowledge exists 
on imputation methods, as evidenced in Chapter 2, more research is needed to explore the 
additive information of missing data in various care units and particularly general wards 
where missing data is more substantial than ICUs. The findings from the exploratory work in 
Chapter 3 provided only insights into phenotyping ICU patients using missing data. Future 
research should be undertaken to examine the test-ordering behavior among clinicians using 
missing data information. Moreover, to develop a full picture of the multifaceted PS 
introduced in Chapter 4, additional studies will be needed to investigate its capabilities on 
various datasets in predicting other clinical outcomes than mortality. Last but not least, while 
Chapter 5 demonstrated the informativeness of temporal EHR data in phenotyping septic 
patients, there is abundant room for further analysis of these subpopulations and identifying 
more efficient care plan for patients who demonstrate similar trajectories. Moreover, in this 
work, we used AUROC discrimination measure to evaluate the performance of the predictive 
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models. Besides other discrimination measure such as area under the precision recall curve, 
future researchers can also perform evaluation from calibration perspective (Steyerberg 
2009). 
 
 
  
149 
Bibliography 
Abraham, W. T., and D. W. Russell. 2004. 'Missing data: a review of current methods and 
applications in epidemiological research', Current Opinion in Psychiatry, 17: 315-21. 
Agarwal, Vibhu, and Nigam H Shah. 2016. 'Learning Attributes of Disease Progression from 
Trajectories of Sparse Lab Values.' in, Biocomputing 2017 (World Scientific). 
Aggarwal, Charu C. 2014. Data Classification: Algorithms and Applications (Chapman and 
Hall/CRC ). 
Agniel, Denis, Isaac S. Kohane, and Griffin M. Weber. 2018. 'Biases in electronic health record data 
due to processes within the healthcare system: retrospective observational study', BMJ, 361. 
Ahn, S. Y., J. Ryu, S. H. Baek, J. W. Han, J. H. Lee, S. Ahn, K. I. Kim, H. J. Chin, K. Y. Na, D. W. 
Chae, K. W. Kim, and S. Kim. 2014. 'Serum anion gap is predictive of mortality in an elderly 
population', Exp Gerontol, 50: 122-7. 
Amir, A., D. Beymer, J. Grace, H. Greenspan, D. Gruhl, A. Hobbs, K. Pohl, T. Syeda-Mahmood, J. 
Terdiman, and F. Wang. 2010. 'AALIM: a cardiac clinical decision support system powered 
by advanced multi-modal analytics', Studies in health technology and informatics, 160: 846-
50. 
Ammenwerth, E., P. Schnell-Inderst, C. Machan, and U. Siebert. 2008. 'The effect of electronic 
prescribing on medication errors and adverse drug events: a systematic review', J Am Med 
Inform Assoc, 15: 585-600. 
Andridge, R. R., and R. J. Little. 2010. 'A Review of Hot Deck Imputation for Survey Non-response', 
Int Stat Rev, 78: 40-64. 
Angus, D. C., W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky. 2001. 
'Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and 
associated costs of care', Crit Care Med, 29: 1303-10. 
Asiimwe, S. B., S. Okello, and C. C. Moore. 2014. 'Frequency of vital signs monitoring and its 
association with mortality among adults with severe sepsis admitted to a general medical 
ward in Uganda', PLoS One, 9: e89879. 
Baraldi, A. N., and C. K. Enders. 2010. 'An introduction to modern missing data analyses', J Sch 
Psychol, 48: 5-37. 
Basole, R. C., M. L. Braunstein, V. Kumar, H. Park, M. Kahng, D. H. Chau, A. Tamersoy, D. A. 
Hirsh, N. Serban, J. Bost, B. Lesnick, B. L. Schissel, and M. Thompson. 2015. 
'Understanding variations in pediatric asthma care processes in the emergency department 
using visual analytics', J Am Med Inform Assoc, 22: 318-23. 
Bazick, H. S., D. Chang, K. Mahadevappa, F. K. Gibbons, and K. B. Christopher. 2011. 'Red cell 
distribution width and all-cause mortality in critically ill patients', Crit Care Med, 39: 1913-
21. 
Beier, K., S. Eppanapally, H. S. Bazick, D. Chang, K. Mahadevappa, F. K. Gibbons, and K. B. 
Christopher. 2011. 'Elevation of blood urea nitrogen is predictive of long-term mortality in 
critically ill patients independent of "normal" creatinine', Crit Care Med, 39: 305-13. 
Bellazzi, Riccardo, Fulvia Ferrazzi, and Lucia Sacchi. 2011. 'Predictive data mining in clinical 
medicine: a focus on selected methods and applications', Wiley Interdisciplinary Reviews: 
Data Mining and Knowledge Discovery, 1: 416-30. 
Blumenthal, D. 2010. 'Launching HITECH', N Engl J Med, 362: 382-5. 
Bobrowski, L. 2006. 'Induction of similarity measures and medical diagnosis support rules through 
separable, linear data transformations', Methods of Information in Medicine, 45: 200-03. 
 150 
Bose, E. L., G. Clermont, L. Chen, A. W. Dubrawski, D. Ren, L. A. Hoffman, M. R. Pinsky, and M. 
Hravnak. 2018. 'Cardiorespiratory instability in monitored step-down unit patients: using 
cluster analysis to identify patterns of change', J Clin Monit Comput, 32: 117-26. 
Botsis, T., G. Hartvigsen, F. Chen, and C. Weng. 2010. 'Secondary Use of EHR: Data Quality Issues 
and Informatics Opportunities', Summit Transl Bioinform, 2010: 1-5. 
Brown, S. A. 2016. 'Patient Similarity: Emerging Concepts in Systems and Precision Medicine', 
Front Physiol, 7: 561. 
Buuren, Stef van. 2012. Flexible Imputation of Missing Data (CRC press). 
Cadogan, S. L., J. P. Browne, C. P. Bradley, and M. R. Cahill. 2015. 'The effectiveness of 
interventions to improve laboratory requesting patterns among primary care physicians: a 
systematic review', Implement Sci, 10: 167. 
Cahill, Ken. 2010. 'Royal Prince Alfred Hospital Patient Observation (Vital Signs) Policy - Adult'. 
Campanella, P., E. Lovato, C. Marone, L. Fallacara, A. Mancuso, W. Ricciardi, and M. L. Specchia. 
2016. 'The impact of electronic health records on healthcare quality: a systematic review and 
meta-analysis', Eur J Public Health, 26: 60-4. 
Campbell-Scherer, Denise. 2010. 'Multimorbidity: a challenge for evidence-based medicine', 
Evidence Based Medicine, 15: 165-66. 
Campillo-Gimenez, B., W. Jouini, S. Bayat, and M. Cuggia. 2013. 'Improving Case-Based Reasoning 
Systems by Combining K-Nearest Neighbour Algorithm with Logistic Regression in the 
Prediction of Patients' Registration on the Renal Transplant Waiting List', PLoS One, 8. 
Cardona-Morrell, M., M. Nicholson, and K. Hillman. 2015. 'Vital Signs: From Monitoring to 
Prevention of Deterioration in General Wards.' in Jean-Louis Vincent (ed.), Annual Update in 
Intensive Care and Emergency Medicine 2015 (Springer International Publishing: Cham). 
Cauthen, C. A., M. J. Lipinski, A. Abbate, D. Appleton, A. Nusca, A. Varma, E. Goudreau, M. J. 
Cowley, and G. W. Vetrovec. 2008. 'Relation of blood urea nitrogen to long-term mortality in 
patients with heart failure', Am J Cardiol, 101: 1643-7. 
Cebul, R. D., T. E. Love, A. K. Jain, and C. J. Hebert. 2011. 'Electronic health records and quality of 
diabetes care', N Engl J Med, 365: 825-33. 
Celi, L. A., R. G. Mark, D. J. Stone, and R. A. Montgomery. 2013. '"Big data" in the intensive care 
unit. Closing the data loop', Am J Respir Crit Care Med, 187: 1157-60. 
Chan, K. S., J. B. Fowles, and J. P. Weiner. 2010. 'Review: electronic health records and the 
reliability and validity of quality measures: a review of the literature', Med Care Res Rev, 67: 
503-27. 
Charlson, M. E., P. Pompei, K. L. Ales, and C. R. MacKenzie. 1987. 'A new method of classifying 
prognostic comorbidity in longitudinal studies: development and validation', J Chronic Dis, 
40: 373-83. 
Chattopadhyay, S., P. Ray, H. S. Chen, M. B. Lee, and H. C. Chiang. 2008. 'Suicidal risk evaluation 
using a similarity-based classifier', Lecture Notes in Computer Science (including subseries 
Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics), 5139 LNAI: 51-
61. 
Choi, Seung-Seok, Sung-Hyuk Cha, and Charles C Tappert. 2010. 'A survey of binary similarity and 
distance measures', Journal of Systemics, Cybernetics and Informatics, 8: 43-48. 
Cismondi, F., L. A. Celi, A. S. Fialho, S. M. Vieira, S. R. Reti, J. M. Sousa, and S. N. Finkelstein. 
2013. 'Reducing unnecessary lab testing in the ICU with artificial intelligence', Int J Med 
Inform, 82: 345-58. 
 151 
Coiera, E. 2009. 'Building a National Health IT System from the middle out', J Am Med Inform Assoc, 
16: 271-3. 
Collins, F. S., and H. Varmus. 2015. 'A new initiative on precision medicine', N Engl J Med, 372: 
793-5. 
Collins, Francis S. 2015. "NIH Precision Medicine Initiative." In NIH Medline Plus, 19-21. North 
Carolina: StayWell. 
Conti, Rena, David L. Veenstra, Katrina Armstrong, Lawrence J. Lesko, and Scott D. Grosse. 2010. 
'Personalized Medicine and Genomics: Challenges and Opportunities in Assessing 
Effectiveness, Cost-Effectiveness, and Future Research Priorities', Medical Decision Making, 
30: 328-40. 
Cook, Nancy R. 2007. 'Response to Letters Regarding Article, “Use and Misuse of the Receiver 
Operating Characteristic Curve in Risk Prediction”', Circulation, 116: E134-E34. 
'Critical Care Statistics'. Society of Critical Care Medicine, Accessed 2019-05-03. 
https://www.sccm.org/Communications/Critical-Care-Statistics. 
Currie, G. P., D. K. Lee, and B. J. Lipworth. 2006. 'Long-acting beta2-agonists in asthma: not so 
SMART?', Drug Saf, 29: 647-56. 
Dai, X, PZ Hadjipantelis, H Ji, HG Mueller, and JL Wang. 2017a. "fdapace: Functional data analysis 
and empirical dynamics. R package version 0.4. 0." In. 
Dai, Y., S. Lokhandwala, W. Long, R. Mark, and L. W. H. Lehman. 2017b. "Phenotyping 
hypotensive patients in critical care using hospital discharge summaries." In 4th IEEE EMBS 
International Conference on Biomedical and Health Informatics, BHI 2017, 401-04. Institute 
of Electrical and Electronics Engineers Inc. 
Daniels, Marcia, and Steven A. Schroeder. 1977. 'Variation among Physicians in Use of Laboratory 
Tests II. Relation to Clinical Productivity and Outcomes of Care', Med Care, 15: 482-87. 
David, G., L. Bernstein, and R. R. Coifman. 2011. 'Generating evidence based interpretation of 
hematology screens via anomaly characterization', Open Clinical Chemistry Journal, 4: 10-
16. 
Delegates, ASA House of. 2014. 'ASA Physical Status Classification System', American Society of 
Anesthesiologists (ASA). https://www.asahq.org/resources/clinical-information/asa-physical-
status-classification-system. 
Delen, D., G. Walker, and A. Kadam. 2005. 'Predicting breast cancer survivability: a comparison of 
three data mining methods', Artif Intell Med, 34: 113-27. 
Devine, E. B., R. N. Hansen, J. L. Wilson-Norton, N. M. Lawless, A. W. Fisk, D. K. Blough, D. P. 
Martin, and S. D. Sullivan. 2010. 'The impact of computerized provider order entry on 
medication errors in a multispecialty group practice', J Am Med Inform Assoc, 17: 78-84. 
Deza, Michel Marie, and Elena Deza. 2009. 'Encyclopedia of distances.' in, Encyclopedia of 
Distances (Springer). 
Elixhauser, A., C. Steiner, D. R. Harris, and R. M. Coffey. 1998. 'Comorbidity measures for use with 
administrative data', Med Care, 36: 8-27. 
Ester, Martin, Hans-Peter Kriegel, Jörg Sander, and Xiaowei Xu. 1996. "A density-based algorithm 
for discovering clusters in large spatial databases with noise." In Kdd, 226-31. 
Farley, J. F., C. R. Harley, and J. W. Devine. 2006. 'A comparison of comorbidity measurements to 
predict healthcare expenditures', Am J Manag Care, 12: 110-9. 
Fialho, A. S., L. A. Celi, F. Cismondi, S. M. Vieira, S. R. Reti, J. M. Sousa, and S. N. Finkelstein. 
2013. 'Disease-based modeling to predict fluid response in intensive care units', Methods Inf 
Med, 52: 494-502. 
 152 
Fitzmaurice, Garrett M., Nan M. Laird, and James H. Ware. 2011. Applied longitudinal analysis 
(Wiley: Hoboken, N.J.). 
Forster, M., C. Bailey, M. W. Brinkhof, C. Graber, A. Boulle, M. Spohr, E. Balestre, M. May, O. 
Keiser, A. Jahn, M. Egger, and Art-Linc collaboration of International Epidemiological 
Databases to Evaluate AIDS. 2008. 'Electronic medical record systems, data quality and loss 
to follow-up: survey of antiretroviral therapy programmes in resource-limited settings', Bull 
World Health Organ, 86: 939-47. 
Frassica, J. J. 2003. 'Frequency of laboratory test utilization in the intensive care unit and its 
implications for large scale data collection efforts', AMIA Annu Symp Proc, 12: 844. 
Ghassemi, M., L. A. Celi, and D. J. Stone. 2015. 'State of the art review: the data revolution in critical 
care', Crit Care, 19: 118. 
Ghosh, S., J. Li, L. Cao, and K. Ramamohanarao. 2017. 'Septic shock prediction for ICU patients via 
coupled HMM walking on sequential contrast patterns', J Biomed Inform, 66: 19-31. 
Gill, T. M., E. A. Gahbauer, L. Han, and H. G. Allore. 2010. 'Trajectories of disability in the last year 
of life', N Engl J Med, 362: 1173-80. 
Ginsburg, G. S., and H. F. Willard. 2009. 'Genomic and personalized medicine: foundations and 
applications', Transl Res, 154: 277-87. 
Girardi, D., S. Wartner, G. Halmerbauer, M. Ehrenmuller, H. Kosorus, and S. Dreiseitl. 2016. 'Using 
concept hierarchies to improve calculation of patient similarity', J Biomed Inform, 63: 66-73. 
Gorelick, M. H. 2006. 'Bias arising from missing data in predictive models', J Clin Epidemiol, 59: 
1115-23. 
Gottlieb, A., G. Y. Stein, E. Ruppin, R. B. Altman, and R. Sharan. 2013. 'A method for inferring 
medical diagnoses from patient similarities', BMC Med, 11: 194. 
Gottlieb, A., G. Y. Stein, E. Ruppin, and R. Sharan. 2011. 'PREDICT: a method for inferring novel 
drug indications with application to personalized medicine', Mol Syst Biol, 7: 496. 
Gotz, D., and K. Wongsuphasawat. 2012a. 'Interactive intervention analysis', AMIA Annu Symp Proc, 
2012: 274-80. 
Gotz, David, Harry Stavropoulos, Jimeng Sun, and Fei Wang. 2012b. "ICDA: a platform for 
Intelligent Care Delivery Analytics." In AMIA. 
Gowda, S., P. B. Desai, V. V. Hull, A. A. Math, S. N. Vernekar, and S. S. Kulkarni. 2009. 'A review 
on laboratory liver function tests', Pan Afr Med J, 3: 17. 
Griffin, S. J., P. S. Little, C. N. Hales, A. L. Kinmonth, and N. J. Wareham. 2000. 'Diabetes risk 
score: towards earlier detection of Type 2 diabetes in general practice', Diabetes/Metabolism 
Research and Reviews, 16: 164-71. 
Groenwold, R. H., I. R. White, A. R. Donders, J. R. Carpenter, D. G. Altman, and K. G. Moons. 
2012. 'Missing covariate data in clinical research: when and when not to use the missing-
indicator method for analysis', CMAJ, 184: 1265-9. 
Gupta, S., T. Tran, W. Luo, D. Phung, R. L. Kennedy, A. Broad, D. Campbell, D. Kipp, M. Singh, M. 
Khasraw, L. Matheson, D. M. Ashley, and S. Venkatesh. 2014. 'Machine-learning prediction 
of cancer survival: a retrospective study using electronic administrative records and a cancer 
registry', BMJ Open, 4: e004007. 
Haase, Peter, Ronny Siebes, and Frank van Harmelen. 2004. 'Peer Selection in Peer-to-Peer Networks 
with Semantic Topologies.' in Mokrane Bouzeghoub, Carole Goble, Vipul Kashyap and 
Stefano Spaccapietra (eds.), Semantics of a Networked World. Semantics for Grid Databases 
(Springer Berlin Heidelberg: Berlin, Heidelberg). 
 153 
Han, Y., Y. Yang, Y. Yan, Z. Ma, N. Sebe, and X. Zhou. 2015. 'Semisupervised feature selection via 
spline regression for video semantic recognition', IEEE Trans Neural Netw Learn Syst, 26: 
252-64. 
Harrell, M., D. Fabbri, and M. Levy. 2016. "Evaluating EHR Data Availability for Cohort Selection 
in Retrospective Studies." In 2016 IEEE International Conference on Healthcare Informatics 
(ICHI), 380-87. 
Haukoos, J. S., and C. D. Newgard. 2007. 'Advanced statistics: missing data in clinical research--part 
1: an introduction and conceptual framework', Acad Emerg Med, 14: 662-8. 
Hayrinen, K., K. Saranto, and P. Nykanen. 2008. 'Definition, structure, content, use and impacts of 
electronic health records: a review of the research literature', Int J Med Inform, 77: 291-304. 
Henriques, J., P. Carvalho, S. Paredes, T. Rocha, J. Habetha, M. Antunes, and J. Morais. 2015a. 
'Prediction of Heart Failure Decompensation Events by Trend Analysis of Telemonitoring 
Data', IEEE Journal of Biomedical and Health Informatics, 19: 1757-69. 
Hielscher, T., M. Spiliopoulou, H. Volzke, and J. P. Kuhn. 2014. "Using Participant Similarity for the 
Classification of Epidemiological Data on Hepatic Steatosis." In Computer-Based Medical 
Systems (CBMS), 2014 IEEE 27th International Symposium on, 1-7. 
Hood, Leroy, and David J Galas. 2009. 'Systems biology and emerging technologies will catalyze the 
transition from reactive medicine to predictive, personalized, preventive and participatory 
(P4) medicine', Interdisciplinary Bio Central, 1: 6. 
Houeland, T. G. 2011a. "An efficient random decision tree algorithm for case-based reasoning 
systems." In Proceedings of the 24th International Florida Artificial Intelligence Research 
Society, FLAIRS - 24, 401-06. 
Houeland, Tor Gunnar. 2011b. "An Efficient Random Decision Tree Algorithm for Case-Based 
Reasoning Systems." In FLAIRS Conference. 
Hu, Jianying, Adam Perer, and Fei Wang. 2016a. 'Data Driven Analytics for Personalized 
Healthcare.' in, Healthcare Information Management Systems. 
Hu, L. Y., M. W. Huang, S. W. Ke, and C. F. Tsai. 2016b. 'The distance function effect on k-nearest 
neighbor classification for medical datasets', SpringerPlus, 5: 1304. 
Huai, M., C. Miao, Q. Suo, Y. Li, J. Gao, and A. Zhang. 2018. "Uncorrelated patient similarity 
learning." In SIAM International Conference on Data Mining, SDM 2018, 270-78. 
Hunziker, S., L. A. Celi, J. Lee, and M. D. Howell. 2012. 'Red cell distribution width improves the 
simplified acute physiology score for risk prediction in unselected critically ill patients', Crit 
Care, 16: R89. 
Ishwaran, Hemant, Udaya B. Kogalur, Eugene H. Blackstone, and Michael S. Lauer. 2008. 'Random 
survival forests', The Annals of Applied Statistics, 2: 841-60. 
Jensen, P. B., L. J. Jensen, and S. Brunak. 2012. 'Mining electronic health records: towards better 
research applications and clinical care', Nat Rev Genet, 13: 395-405. 
Jensen, R. E., K. S. Chan, J. P. Weiner, J. B. Fowles, and S. M. Neale. 2009. 'Implementing electronic 
health record-based quality measures for developmental screening', Pediatrics, 124: e648-54. 
Johnson, A. E., M. M. Ghassemi, S. Nemati, K. E. Niehaus, D. A. Clifton, and G. D. Clifford. 2016a. 
'Machine Learning and Decision Support in Critical Care', Proc IEEE Inst Electr Electron 
Eng, 104: 444-66. 
Johnson, A. E., T. J. Pollard, L. Shen, L. W. Lehman, M. Feng, M. Ghassemi, B. Moody, P. 
Szolovits, L. A. Celi, and R. G. Mark. 2016b. 'MIMIC-III, a freely accessible critical care 
database', Sci Data, 3: 160035. 
 154 
Johnson, A. E. W., J. Aboab, J. D. Raffa, T. J. Pollard, R. O. Deliberato, L. A. Celi, and D. J. Stone. 
2018a. 'A Comparative Analysis of Sepsis Identification Methods in an Electronic Database', 
Crit Care Med, 46: 494-99. 
Johnson, Alistair E. W., Tom J. Pollard, and Roger G. Mark. 2017. "Reproducibility in critical care: a 
mortality prediction case study." In Proceedings of the 2nd Machine Learning for Healthcare 
Conference, edited by Doshi-Velez Finale, Fackler Jim, Kale David, Ranganath Rajesh, 
Wallace Byron and Wiens Jenna, 361--76. Proceedings of Machine Learning Research: 
PMLR. 
Johnson, Alistair, and Tom Pollard. 2018b. "sepsis3-mimic." In.: Zenodo. 
Johnson, K. D., C. Winkelman, C. J. Burant, M. Dolansky, and V. Totten. 2014. 'The factors that 
affect the frequency of vital sign monitoring in the emergency department', J Emerg Nurs, 40: 
27-35. 
Jones, R. B., and A. J. Hedley. 1986. 'A computer in the diabetic clinic.Completeness of data in a 
clinical information system for diabetes', Practical Diabetes International, 3: 295-96. 
Jurisica, Igor, John Mylopoulos, Janice Glasgow, Heather Shapiro, and Robert F. Casper. 1998. 
'Case-based reasoning in IVF: prediction and knowledge mining', Artif Intell Med, 12: 1-24. 
Kajimoto, K., N. Sato, T. Takano, and registry investigators of the Acute Decompensated Heart 
Failure Syndromes. 2015. 'Relation between elevated blood urea nitrogen, clinical features or 
comorbidities, and clinical outcome in patients hospitalized for acute heart failure 
syndromes', Int J Cardiol, 201: 311-4. 
Kaufman, Leonard, and Peter J Rousseeuw. 2009. Finding groups in data: an introduction to cluster 
analysis (John Wiley & Sons). 
Keogh, Eamonn, and Shruti Kasetty. 2003. 'On the Need for Time Series Data Mining Benchmarks: 
A Survey and Empirical Demonstration', Data Mining and Knowledge Discovery, 7: 349-71. 
Kern, L. M., Y. Barron, R. V. Dhopeshwarkar, A. Edwards, R. Kaushal, and Hitec Investigators. 
2013. 'Electronic health records and ambulatory quality of care', J Gen Intern Med, 28: 496-
503. 
Khoshnevisan, F., J. Ivy, M. Capan, R. Arnold, J. Huddleston, and M. Chi. 2018. "Recent Temporal 
Pattern Mining for Septic Shock Early Prediction." In 2018 IEEE International Conference 
on Healthcare Informatics (ICHI), 229-40. 
Khoury, Muin J. 2016. "The Shift From Personalized Medicine to Precision Medicine and Precision 
Public Health: Words Matter!" In. Genomics and Health Impact Blog. 
Kim, M. J., Y. H. Kim, I. S. Sol, S. Y. Kim, J. D. Kim, H. Y. Kim, K. W. Kim, M. H. Sohn, and K. E. 
Kim. 2017. 'Serum anion gap at admission as a predictor of mortality in the pediatric 
intensive care unit', Sci Rep, 7: 1456. 
Knaus, W. A., E. A. Draper, D. P. Wagner, and J. E. Zimmerman. 1985. 'APACHE II: a severity of 
disease classification system', Crit Care Med, 13: 818-29. 
Knol, M. J., K. J. Janssen, A. R. Donders, A. C. Egberts, E. R. Heerdink, D. E. Grobbee, K. G. 
Moons, and M. I. Geerlings. 2010. 'Unpredictable bias when using the missing indicator 
method or complete case analysis for missing confounder values: an empirical example', J 
Clin Epidemiol, 63: 728-36. 
Koppel, Ross. 2009. 'EMR entry error: not so benign', U.S. Department of Health and Human 
Services, Accessed 2019-05-03. https://psnet.ahrq.gov/webmm/case/199/emr-entry-error-not-
so-benign. 
Kravitz, R. L., N. Duan, and J. Braslow. 2004. 'Evidence-based medicine, heterogeneity of treatment 
effects, and the trouble with averages', Milbank Q, 82: 661-87. 
 155 
Kuhn, Max, and Kjell Johnson. 2013. Applied predictive modeling (Springer). 
Lasko, Thomas A., Joshua C. Denny, and Mia A. Levy. 2013. 'Computational Phenotype Discovery 
Using Unsupervised Feature Learning over Noisy, Sparse, and Irregular Clinical Data', PLoS 
One, 8: e66341. 
Le Gall, J. R., J. Klar, S. Lemeshow, F. Saulnier, C. Alberti, A. Artigas, and D. Teres. 1996. 'The 
Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive 
care unit. ICU Scoring Group', JAMA, 276: 802-10. 
Le Gall, J. R., S. Lemeshow, and F. Saulnier. 1993. 'A new Simplified Acute Physiology Score 
(SAPS II) based on a European/North American multicenter study', JAMA, 270: 2957-63. 
Lee, J, D M Maslove, and J A Dubin. 2015a. 'Personalized mortality prediction driven by electronic 
medical data and a patient similarity metric', PLoS One, 10: e0127428. 
Lee, J., and D. M. Maslove. 2015b. 'Using information theory to identify redundancy in common 
laboratory tests in the intensive care unit', BMC Med Inform Decis Mak, 15: 59. 
Lee, S. W., S. Kim, K. Y. Na, R. H. Cha, S. W. Kang, C. W. Park, D. R. Cha, S. G. Kim, S. A. Yoon, 
S. Y. Han, J. H. Park, J. H. Chang, C. S. Lim, and Y. S. Kim. 2016. 'Serum Anion Gap 
Predicts All-Cause Mortality in Patients with Advanced Chronic Kidney Disease: A 
Retrospective Analysis of a Randomized Controlled Study', PLoS One, 11: e0156381. 
Lehman, L. W., R. P. Adams, L. Mayaud, G. B. Moody, A. Malhotra, R. G. Mark, and S. Nemati. 
2015a. 'A physiological time series dynamics-based approach to patient monitoring and 
outcome prediction', IEEE J Biomed Health Inform, 19: 1068-76. 
Lehman, L. w. H., S. Nemati, and R. G. Mark. 2015b. "Hemodynamic monitoring using switching 
autoregressive dynamics of multivariate vital sign time series." In 2015 Computing in 
Cardiology Conference (CinC), 1065-68. 
Lehman, L. w. H., S. Nemati, G. B. Moody, T. Heldt, and R. G. Mark. 2014. "Uncovering clinical 
significance of vital sign dynamics in critical care." In Computing in Cardiology 2014, 1141-
44. 
Levinson, Andrew T, Brian P Casserly, and Mitchell M Levy. 2011. "Reducing mortality in severe 
sepsis and septic shock." In Seminars in respiratory and critical care medicine, 195-205. 
Thieme Medical Publishers. 
Li, J., L. Guo, and N. Handly. 2009. "Hospital Admission Prediction Using Pre-hospital Variables." 
In 2009 IEEE International Conference on Bioinformatics and Biomedicine, 283-86. 
Li, J., and Z. Lu. 2012. "A new method for computational drug repositioning using drug pairwise 
similarity." In 2012 IEEE International Conference on Bioinformatics and Biomedicine, 1-4. 
Li, P., Y. Nie, and J. Yu. 2016. 'Fusing literature and full network data improves disease similarity 
computation', BMC Bioinformatics, 17: 326. 
Lin, H., C. E. McCulloch, B. W. Turnbull, E. H. Slate, and L. C. Clark. 2000. 'A latent class mixed 
model for analysing biomarker trajectories with irregularly scheduled observations', Stat Med, 
19: 1303-18. 
Lin, Haiqun, Bruce W. Turnbull, Charles E. McCulloch, and Elizabeth H. Slate. 2002. 'Latent Class 
Models for Joint Analysis of Longitudinal Biomarker and Event Process Data', Journal of the 
American Statistical Association, 97: 53-65. 
Litchfleld, I. J., R. J. Lilford, L. M. Bentham, and S. M. Greenfield. 2014. 'A qualitative exploration 
of the motives behind the decision to order a liver function test in primary care', Quality in 
Primary Care, 22: 201-10. 
Little, R. J., R. D'Agostino, M. L. Cohen, K. Dickersin, S. S. Emerson, J. T. Farrar, C. Frangakis, J. 
W. Hogan, G. Molenberghs, S. A. Murphy, J. D. Neaton, A. Rotnitzky, D. Scharfstein, W. J. 
 156 
Shih, J. P. Siegel, and H. Stern. 2012. 'The prevention and treatment of missing data in 
clinical trials', N Engl J Med, 367: 1355-60. 
Little, Roderick J. A. 1988. 'Missing-Data Adjustments in Large Surveys', Journal of Business & 
Economic Statistics, 6: 287-96. 
Low, L. L., G. R. Harrington, and D. P. Stoltzfus. 1995. 'The effect of arterial lines on blood-drawing 
practices and costs in intensive care units', Chest, 108: 216-9. 
Lowsky, D. J., Y. Ding, D. K. K. Lee, C. E. McCulloch, L. F. Ross, J. R. Thistlethwaite, and S. A. 
Zenios. 2013. 'A K-nearest neighbors survival probability prediction method', Statistics in 
Medicine, 32: 2062-69. 
Maaten, Laurens van der, and Geoffrey Hinton. 2008. 'Visualizing data using t-SNE', Journal of 
Machine Learning Research, 9: 2579-605. 
Maggs, J. L., and J. E. Schulenberg. 2004. 'Trajectories of alcohol use during the transition to 
adulthood', Alcohol Research & Health, 28: 195-201. 
Martens, F. K., E. C. Tonk, J. G. Kers, and A. C. Janssens. 2016. 'Small improvement in the area 
under the receiver operating characteristic curve indicated small changes in predicted risks', J 
Clin Epidemiol, 79: 159-64. 
Martin, G. S., D. M. Mannino, S. Eaton, and M. Moss. 2003. 'The epidemiology of sepsis in the 
United States from 1979 through 2000', N Engl J Med, 348: 1546-54. 
McCulloch, C. E., H. Lin, E. H. Slate, and B. W. Turnbull. 2002. 'Discovering subpopulation 
structure with latent class mixed models', Stat Med, 21: 417-29. 
McKee, P. A., W. P. Castelli, P. M. McNamara, and W. B. Kannel. 1971. 'The natural history of 
congestive heart failure: the Framingham study', N Engl J Med, 285: 1441-6. 
Medicare, Centers for, and Medicaid Services. 2012. "Implementation of severe sepsis and septic 
shock: management bundle measure (NQF# 0500)." In National Quality Forum. 
Menendez, M. E., V. Neuhaus, C. N. van Dijk, and D. Ring. 2014. 'The Elixhauser comorbidity 
method outperforms the Charlson index in predicting inpatient death after orthopaedic 
surgery', Clin Orthop Relat Res, 472: 2878-86. 
Meystre, S. M., G. K. Savova, K. C. Kipper-Schuler, and J. F. Hurdle. 2008. 'Extracting information 
from textual documents in the electronic health record: a review of recent research', Yearb 
Med Inform: 128-44. 
Miltner, R. S., K. D. Johnson, and R. Deierhoi. 2014. 'Exploring the frequency of blood pressure 
documentation in emergency departments', J Nurs Scholarsh, 46: 98-105. 
Miner, Linda, Pat Bolding, Joseph Hilbe, Mitchell Goldstein, Thomas Hill, Robert Nisbet, Nephi 
Walton, and Gary Miner. 2014. Practical Predictive Analytics and Decisioning Systems for 
Medicine: Informatics Accuracy and Cost-Effectiveness for Healthcare Administration and 
Delivery Including Medical Research (Academic Press). 
Mitchell, Tom M. 1997. Machine Learning (McGraw-Hill: New York). 
Moghadam, H., M. Rahgozar, and S. Gharaghani. 2016. 'Scoring multiple features to predict drug 
disease associations using information fusion and aggregation', SAR QSAR Environ Res, 27: 
609-28. 
Morrison, Zoe, Ann Robertson, Kathrin Cresswell, Sarah Crowe, and Aziz Sheikh. 2011. 
'Understanding Contrasting Approaches to Nationwide Implementations of Electronic Health 
Record Systems: England, the USA and Australia', Journal of Healthcare Engineering, 2: 25-
42. 
Mukherjee, D., and E. J. Topol. 2002. 'Pharmacogenomics in cardiovascular diseases', Prog 
Cardiovasc Dis, 44: 479-98. 
 157 
Muthén, Bengt, and Kerby Shedden. 1999. 'Finite Mixture Modeling with Mixture Outcomes Using 
the EM Algorithm', Biometrics, 55: 463-69. 
Myers, Teresa A. 2011. 'Goodbye, Listwise Deletion: Presenting Hot Deck Imputation as an Easy and 
Effective Tool for Handling Missing Data', Communication Methods and Measures, 5: 297-
310. 
Newgard, C. D., and J. S. Haukoos. 2007. 'Advanced statistics: missing data in clinical research--part 
2: multiple imputation', Acad Emerg Med, 14: 669-78. 
Oliveira, Anderson Magalhães, Marcio Vasconcelos Oliveira, and Claudio Lima Souza. 2014. 
'Prevalence of unnecessary laboratory tests and related avoidable costs in intensive care unit', 
Jornal Brasileiro de Patologia e Medicina Laboratorial, 50: 410-16. 
Oztekin, A., D. Delen, and Z. J. Kong. 2009. 'Predicting the graft survival for heart-lung 
transplantation patients: an integrated data mining methodology', Int J Med Inform, 78: e84-
96. 
Panahiazar, M., V. Taslimitehrani, N. L. Pereira, and J. Pathak. 2015. "Using EHRs for Heart Failure 
Therapy Recommendation Using Multidimensional Patient Similarity Analytics." In 26th 
Medical Informatics in Europe Conference, MIE 2015, edited by R. Cornet, L. Stoicu-
Tivadar, R. Cornet, C. L. Parra Calderon, S. K. Andersen, A. Horbst and M. Hercigonja-
Szekeres, 369-73. IOS Press. 
Parimbelli, E., S. Marini, L. Sacchi, and R. Bellazzi. 2018. 'Patient similarity for precision medicine: 
A systematic review', J Biomed Inform, 83: 87-96. 
Park, Yoon-Joo, Byung-Chun Kim, and Se-Hak Chun. 2006. 'New knowledge extraction technique 
using probability for case-based reasoning: application to medical diagnosis', Expert Systems, 
23: 2-20. 
Patel, K. V., R. D. Semba, L. Ferrucci, A. B. Newman, L. P. Fried, R. B. Wallace, S. Bandinelli, C. S. 
Phillips, B. Yu, S. Connelly, M. G. Shlipak, P. H. Chaves, L. J. Launer, W. B. Ershler, T. B. 
Harris, D. L. Longo, and J. M. Guralnik. 2010. 'Red cell distribution width and mortality in 
older adults: a meta-analysis', J Gerontol A Biol Sci Med Sci, 65: 258-65. 
PCAST. 2008 "Priorities for Personalized Medicine." In.: President’s Council of Advisors on Science 
and Technology. 
Peck, J. S., S. A. Gaehde, D. J. Nightingale, D. Y. Gelman, D. S. Huckins, M. F. Lemons, E. W. 
Dickson, and J. C. Benneyan. 2013. 'Generalizability of a simple approach for predicting 
hospital admission from an emergency department', Acad Emerg Med, 20: 1156-63. 
Pencina, M. J., R. B. D'Agostino, K. M. Pencina, A. C. Janssens, and P. Greenland. 2012. 
'Interpreting incremental value of markers added to risk prediction models', American Journal 
of Epidemiology, 176: 473-81. 
Peng, H., F. Long, and C. Ding. 2005. 'Feature selection based on mutual information: criteria of 
max-dependency, max-relevance, and min-redundancy', IEEE Trans Pattern Anal Mach 
Intell, 27: 1226-38. 
Perer, Adam, and David Gotz. 2013. "Data-driven exploration of care plans for patients." In CHI '13 
Extended Abstracts on Human Factors in Computing Systems on - CHI EA '13, 439-44. Paris, 
France: ACM. 
Perlman, L., A. Gottlieb, N. Atias, E. Ruppin, and R. Sharan. 2011. 'Combining drug and gene 
similarity measures for drug-target elucidation', Journal of Computational Biology, 18: 133-
45. 
Perotte, A., R. Pivovarov, K. Natarajan, N. Weiskopf, F. Wood, and N. Elhadad. 2014. 'Diagnosis 
code assignment: models and evaluation metrics', J Am Med Inform Assoc, 21: 231-7. 
 158 
Pigott, Therese D. 2010. 'A Review of Methods for Missing Data', Educational Research and 
Evaluation, 7: 353-83. 
Pimentel, M, D Clifton, Lei Clifton, and Lionel Tarassenko. 2013. "Modelling patient time-series data 
from electronic health records using Gaussian processes." In Advances in Neural Information 
Processing Systems: Workshop on Machine Learning for Clinical Data Analysis, 1-4. 
Harrahs and Harveys, Lake Tahoe. 
Pollard, T. J., A. E. W. Johnson, J. D. Raffa, L. A. Celi, R. G. Mark, and O. Badawi. 2018. 'The eICU 
Collaborative Research Database, a freely available multi-center database for critical care 
research', Sci Data, 5: 180178. 
Porcheret, M., R. Hughes, D. Evans, K. Jordan, T. Whitehurst, H. Ogden, P. Croft, and Network 
North Staffordshire General Practice Research. 2004. 'Data quality of general practice 
electronic health records: the impact of a program of assessments, feedback, and training', J 
Am Med Inform Assoc, 11: 78-86. 
Prin, M., and H. Wunsch. 2012. 'International comparisons of intensive care: informing outcomes and 
improving standards', Curr Opin Crit Care, 18: 700-6. 
Pringle, M., P. Ward, and C. Chilvers. 1995. 'Assessment of the completeness and accuracy of 
computer medical records in four practices committed to recording data on computer', Br J 
Gen Pract, 45: 537-41. 
Proust-Lima, C., and J. M. Taylor. 2009a. 'Development and validation of a dynamic prognostic tool 
for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint 
modeling approach', Biostatistics, 10: 535-49. 
Proust-Lima, Cécile, Pierre Joly, Jean-François Dartigues, and Hélène Jacqmin-Gadda. 2009b. 'Joint 
modelling of multivariate longitudinal outcomes and a time-to-event: A nonlinear latent class 
approach', Computational Statistics & Data Analysis, 53: 1142-54. 
Purtle, S. W., T. Moromizato, C. K. McKane, F. K. Gibbons, and K. B. Christopher. 2014. 'The 
association of red cell distribution width at hospital discharge and out-of-hospital mortality 
following critical illness*', Crit Care Med, 42: 918-29. 
Quantin, C., E. Sauleau, P. Bolard, C. Mousson, M. Kerkri, P. Brunet Lecomte, T. Moreau, and L. 
Dusserre. 1999. 'Modeling of High-cost Patient Distribution within Renal Failure Diagnosis 
Related Group', Journal of Clinical Epidemiology, 52: 251-58. 
Ramsay, James. 2005. 'Functional data analysis', Encyclopedia of Statistics in Behavioral Science. 
Rao, M H, Prashanti Marella, and Bipphy Kath. 2008. 'Assessment of Severity and Outcome of 
Critical Illness', Indian Journal Of Anaesthesia, 2008: 652-62. 
Reis Miranda, Dinis, Angelique de Rijk, and Wilmar Schaufeli. 1996. 'Simplified Therapeutic 
Intervention Scoring System', Crit Care Med, 24: 64-73. 
Reisner-Senelar, L. 2011. 'The birth of intensive care medicine: Bjorn Ibsen's records', Intensive Care 
Med, 37: 1084-6. 
Rhee, C., Z. Zhang, S. S. Kadri, D. J. Murphy, G. S. Martin, E. Overton, C. W. Seymour, D. C. 
Angus, R. Dantes, L. Epstein, D. Fram, R. Schaaf, R. Wang, M. Klompas, and C. D. C. 
Prevention Epicenters Program. 2019. 'Sepsis Surveillance Using Adult Sepsis Events 
Simplified eSOFA Criteria Versus Sepsis-3 Sequential Organ Failure Assessment Criteria', 
Crit Care Med, 47: 307-14. 
Robinson, P. N. 2012. 'Deep phenotyping for precision medicine', Hum Mutat, 33: 777-80. 
Robnik-Šikonja, Marko, and Igor Kononenko. 2003. 'Theoretical and empirical analysis of ReliefF 
and RReliefF', Machine Learning, 53: 23-69. 
 159 
Rodriguez, R. 2001a. 'Demystifying critical care: a new series provides a succinct, modern approach 
aimed at primary care physicians', West J Med, 175: 366-7. 
Rodriguez, Robert. 2001b. 'Demystifying critical care: A new series provides a succinct, modern 
approach aimed at primary care physicians', Western Journal of Medicine, 175: 366-67. 
Roth, Philip L. 1994. 'Missing Data: A Conceptual Review for Applied Psychologists', Personnel 
Psychology, 47: 537-60. 
Rothwell, P. M. 2005. 'External validity of randomised controlled trials: "to whom do the results of 
this trial apply?"', Lancet, 365: 82-93. 
Rousseeuw, Peter J. 1987. 'Silhouettes: A graphical aid to the interpretation and validation of cluster 
analysis', Journal of Computational and Applied Mathematics, 20: 53-65. 
Rubin, Donald B., and Ying Nian Wu. 1997. 'Modeling Schizophrenic Behavior Using General 
Mixture Components', Biometrics, 53: 243-61. 
Rusanov, A., N. G. Weiskopf, S. Wang, and C. Weng. 2014. 'Hidden in plain sight: bias towards sick 
patients when sampling patients with sufficient electronic health record data for research', 
BMC Med Inform Decis Mak, 14: 51. 
Saeed, M., M. Villarroel, A. T. Reisner, G. Clifford, L. W. Lehman, G. Moody, T. Heldt, T. H. Kyaw, 
B. Moody, and R. G. Mark. 2011. 'Multiparameter Intelligent Monitoring in Intensive Care 
II: a public-access intensive care unit database', Crit Care Med, 39: 952-60. 
Saeed, Mohammed, and Roger Mark. 2006a. 'A Novel Method for the Efficient Retrieval of Similar 
Multiparameter Physiologic Time Series Using Wavelet-Based Symbolic Representations', 
AMIA Annual Symposium Proceedings, 2006: 679-83. 
Saeed, Mohammed, and Roger G Mark. 2006b. "A novel method for the efficient retrieval of similar 
multiparameter physiologic time series using wavelet-based symbolic representations." In 
AMIA. 
Saeys, Y., I. Inza, and P. Larranaga. 2007. 'A review of feature selection techniques in 
bioinformatics', Bioinformatics, 23: 2507-17. 
Safran, C., M. Bloomrosen, W. E. Hammond, S. Labkoff, S. Markel-Fox, P. C. Tang, D. E. Detmer, 
and Panel Expert. 2007. 'Toward a national framework for the secondary use of health data: 
an American Medical Informatics Association White Paper', J Am Med Inform Assoc, 14: 1-9. 
Sahu, A., H. A. Cooper, and J. A. Panza. 2006. 'The initial anion gap is a predictor of mortality in 
acute myocardial infarction', Coron Artery Dis, 17: 409-12. 
Salgado, Cátia M., Susana M. Vieira, Luís F. Mendonça, Stan Finkelstein, and João M. C. Sousa. 
2016. 'Ensemble fuzzy models in personalized medicine: Application to vasopressors 
administration', Engineering Applications of Artificial Intelligence, 49: 141-48. 
Schork, N. J. 2015. 'Personalized medicine: Time for one-person trials', Nature, 520: 609-11. 
Schulman, C. S., and L. Staul. 2010. 'Standards for frequency of measurement and documentation of 
vital signs and physical assessments', Crit Care Nurse, 30: 74-6. 
Senol, K., B. Saylam, F. Kocaay, and M. Tez. 2013. 'Red cell distribution width as a predictor of 
mortality in acute pancreatitis', Am J Emerg Med, 31: 687-9. 
Serden, L., R. Lindqvist, and M. Rosen. 2003. 'Have DRG-based prospective payment systems 
influenced the number of secondary diagnoses in health care administrative data?', Health 
Policy, 65: 101-7. 
Seymour, C. W., C. M. Coopersmith, C. S. Deutschman, F. Gesten, M. Klompas, M. Levy, G. S. 
Martin, T. M. Osborn, C. Rhee, D. K. Warren, R. S. Watson, and D. C. Angus. 2016. 
'Application of a Framework to Assess the Usefulness of Alternative Sepsis Criteria', Crit 
Care Med, 44: e122-30. 
 160 
Sha, Ying, Janani Venugopalan, and May D. Wang. 2016. "A Novel Temporal Similarity Measure for 
Patients Based on Irregularly Measured Data in Electronic Health Records." In Proceedings 
of the 7th ACM International Conference on Bioinformatics, Computational Biology, and 
Health Informatics - BCB '16, 337-44. Seattle, WA, USA: ACM. 
Sharabiani, M. T., P. Aylin, and A. Bottle. 2012. 'Systematic review of comorbidity indices for 
administrative data', Med Care, 50: 1109-18. 
Sharafoddini, A., J. A. Dubin, and J. Lee. 2017. 'Patient Similarity in Prediction Models Based on 
Health Data: A Scoping Review', JMIR Med Inform, 5: e7. 
Sharafoddini, A., J. A. Dubin, D. M. Maslove, and J. Lee. 2019. 'A New Insight Into Missing Data in 
Intensive Care Unit Patient Profiles: Observational Study', JMIR Med Inform, 7: e11605. 
Sharafoddini, Anis, Joel A. Dubin, and Joon Lee. 2018. 'Finding Similar Patient Subpopulations in 
the ICU Using Laboratory Test Ordering Patterns', Proceedings of the 7th International 
Conference on Bioinformatics and Biomedical Science. 
Shivade, C., P. Raghavan, E. Fosler-Lussier, P. J. Embi, N. Elhadad, S. B. Johnson, and A. M. Lai. 
2014. 'A review of approaches to identifying patient phenotype cohorts using electronic 
health records', J Am Med Inform Assoc, 21: 221-30. 
Singer, M., C. S. Deutschman, C. W. Seymour, M. Shankar-Hari, D. Annane, M. Bauer, R. Bellomo, 
G. R. Bernard, J. D. Chiche, C. M. Coopersmith, R. S. Hotchkiss, M. M. Levy, J. C. 
Marshall, G. S. Martin, S. M. Opal, G. D. Rubenfeld, T. van der Poll, J. L. Vincent, and D. C. 
Angus. 2016. 'The Third International Consensus Definitions for Sepsis and Septic Shock 
(Sepsis-3)', JAMA, 315: 801-10. 
Singh, A., G. Nadkarni, O. Gottesman, S. B. Ellis, E. P. Bottinger, and J. V. Guttag. 2015. 
'Incorporating temporal EHR data in predictive models for risk stratification of renal function 
deterioration', J Biomed Inform, 53: 220-8. 
Singh, Anima. 2015. 'Exploiting hierarchical and temporal information in building predictive models 
from EHR data', Massachusetts Institute of Technology. 
Singh, Anima, Girish Nadkarni, John Guttag, and Erwin Bottinger. 2014. 'Leveraging hierarchy in 
medical codes for predictive modeling': 96-103. 
Smoller, B. R., and M. S. Kruskall. 1986. 'Phlebotomy for diagnostic laboratory tests in adults. 
Pattern of use and effect on transfusion requirements', N Engl J Med, 314: 1233-5. 
Snyderman, R. 2012. 'Personalized health care: from theory to practice', Biotechnol J, 7: 973-9. 
Sokal, Robert R. 1958. 'A statistical method for evaluating systematic relationship', University of 
Kansas science bulletin, 28: 1409-38. 
Solomon, Daniel H., Hideki Hashimoto, Lawren Daltroy, and Matthew H. Liang. 1998. 'Techniques 
to Improve Physicians' Use of Diagnostic Tests', JAMA, 280: 2020-27. 
Soto, C. M., K. P. Kleinman, and S. R. Simon. 2002. 'Quality and correlates of medical record 
documentation in the ambulatory care setting', BMC Health Serv Res, 2: 22. 
Southern, D. A., H. Quan, and W. A. Ghali. 2004. 'Comparison of the Elixhauser and Charlson/Deyo 
methods of comorbidity measurement in administrative data', Med Care, 42: 355-60. 
Standards, International Organization for. 2005. "ISO/TR 20514:2005 Health informatics -- 
Electronic health record -- Definition, scope and context." In, 27. International Organization 
for Standards. 
Sterne, J. A., I. R. White, J. B. Carlin, M. Spratt, P. Royston, M. G. Kenward, A. M. Wood, and J. R. 
Carpenter. 2009. 'Multiple imputation for missing data in epidemiological and clinical 
research: potential and pitfalls', BMJ, 338: b2393. 
 161 
sSteyerberg, Ewout W. 2009. Clinical prediction models : a practical approach to development, 
validation, and updating (Springer: New York, NY). 
Stockdale, Myrah, and Kenneth Royal. 2016. 'Missing data as a validity threat for medical and 
healthcare education research: problems and solutions', International Journal of Healthcare, 
2: 67. 
Su, Xiaoyuan, and Taghi M. Khoshgoftaar. 2009. 'A Survey of Collaborative Filtering Techniques', 
Advances in Artificial Intelligence, 2009: 1-19. 
Sun, J., D. Sow, J. Hu, and S. Ebadollahi. 2010a. "A system for mining temporal physiological data 
streams for advanced prognostic decision support." In Proceedings - IEEE International 
Conference on Data Mining, ICDM, 1061-66. 
Sun, Jimeng, Daby Sow, Jianying Hu, and S. Ebadollahi. 2010b. "Localized Supervised Metric 
Learning on Temporal Physiological Data." In Pattern Recognition (ICPR), 2010 20th 
International Conference on, 4149-52. 
Suo, Q., F. Ma, Y. Yuan, M. Huai, W. Zhong, A. Zhang, and J. Gao. 2017. "Personalized disease 
prediction using a CNN-based similarity learning method." In 2017 IEEE International 
Conference on Bioinformatics and Biomedicine (BIBM), 811-16. 
Syeda-Mahmood, T., F. Wang, D. Beymer, A. Amir, M. Richmond, and S. N. Hashmi. 2007. 
"AALIM: Multimodal mining for cardiac decision support." In 2007 Computers in 
Cardiology, 209-12. 
Tang, P. C., M. P. LaRosa, and S. M. Gorden. 1999. 'Use of Computer-based Records, Completeness 
of Documentation, and Appropriateness of Documented Clinical Decisions', Journal of the 
American Medical Informatics Association, 6: 245-51. 
Tashkandi, Araek, Ingmar Wiese, and Lena Wiese. 2018. 'Efficient In-Database Patient Similarity 
Analysis for Personalized Medical Decision Support Systems', Big Data Research, 13: 52-64. 
Thiru, K., S. de Lusignan, and N. Hague. 2016. 'Have the completeness and accuracy of computer 
medical records in general practice improved in the last five years? The report of a two-
practice pilot study', Health informatics journal, 5: 224-32. 
Ullah, S., and C. F. Finch. 2013. 'Applications of functional data analysis: A systematic review', Bmc 
Medical Research Methodology, 13: 43. 
Vesin, A., E. Azoulay, S. Ruckly, L. Vignoud, K. Rusinova, D. Benoit, M. Soares, P. Azeivedo-Maia, 
F. Abroug, J. Benbenishty, and J. F. Timsit. 2013. 'Reporting and handling missing values in 
clinical studies in intensive care units', Intensive Care Med, 39: 1396-404. 
Vincent, J. L., and R. Moreno. 2010. 'Clinical review: scoring systems in the critically ill', Crit Care, 
14: 207. 
Vranas, K. C., J. K. Jopling, T. E. Sweeney, M. C. Ramsey, A. S. Milstein, C. G. Slatore, G. J. 
Escobar, and V. X. Liu. 2017. 'Identifying Distinct Subgroups of ICU Patients: A Machine 
Learning Approach', Crit Care Med, 45: 1607-15. 
Wang, F., J. Hu, and J. Sun. 2012a. "Medical prognosis based on patient similarity and expert 
feedback." In Proceedings - International Conference on Pattern Recognition, 1799-802. 
Wang, F., J. Sun, and S. Ebadollahi. 2011a. "Integrating distance metrics learned from multiple 
experts and its application in patient similarity assessment." In 11th SIAM International 
Conference on Data Mining, SDM 2011, 59-70. Mesa, AZ. 
Wang, Fei. 2015. 'Adaptive semi-supervised recursive tree partitioning: The ART towards large scale 
patient indexing in personalized healthcare', Journal of Biomedical Informatics, 55: 41-54. 
Wang, Fei, and Jimeng Sun. 2015. 'PSF: A Unified Patient Similarity Evaluation Framework through 
Metric Learning with Weak Supervision', IEEE J Biomed Health Inform, 19: 1-1. 
 162 
Wang, Xiaoyue, Abdullah Mueen, Hui Ding, Goce Trajcevski, Peter Scheuermann, and Eamonn 
Keogh. 2012b. 'Experimental comparison of representation methods and distance measures 
for time series data', Data Mining and Knowledge Discovery, 26: 275-309. 
Wattenberg, Martin, Fernanda Viégas, and Ian Johnson. 2016. 'How to use t-sne effectively', Distill, 
1: e2. 
Weiskopf, N. G., G. Hripcsak, S. Swaminathan, and C. Weng. 2013a. 'Defining and measuring 
completeness of electronic health records for secondary use', J Biomed Inform, 46: 830-6. 
Weiskopf, N. G., A. Rusanov, and C. Weng. 2013b. 'Sick patients have more data: the non-random 
completeness of electronic health records', AMIA Annu Symp Proc, 2013: 1472-7. 
Weiskopf, N. G., and C. Weng. 2013c. 'Methods and dimensions of electronic health record data 
quality assessment: enabling reuse for clinical research', J Am Med Inform Assoc, 20: 144-51. 
Wells, B. J., K. M. Chagin, A. S. Nowacki, and M. W. Kattan. 2013. 'Strategies for handling missing 
data in electronic health record derived data', EGEMS (Wash DC), 1: 1035. 
Wennberg, J. E. 1984. 'Dealing with medical practice variations: a proposal for action', Health Aff 
(Millwood), 3: 6-32. 
Wiese, Ingmar, Nicole Sarna, Lena Wiese, Araek Tashkandi, and Ulrich Sax. 2018. 'Concept 
acquisition and improved in-database similarity analysis for medical data', Distributed and 
Parallel Databases. 
Wongsuphasawat, K., and B. Shneiderman. 2009. "Finding comparable temporal categorical records: 
A similarity measure with an interactive visualization." In 2009 IEEE Symposium on Visual 
Analytics Science and Technology, 27-34. 
Wu, M., M. Ghassemi, M. Feng, L. A. Celi, P. Szolovits, and F. Doshi-Velez. 2017. 'Understanding 
vasopressor intervention and weaning: risk prediction in a public heterogeneous clinical time 
series database', J Am Med Inform Assoc, 24: 488-95. 
Yan, Y., X. Shao, and Z. Jiang. 2014. 'Inferring novel indications of approved drugs via a learning 
method with local and global consistency', PLoS One, 9: e107100. 
Yuhua, Li, Z. A. Bandar, and D. McLean. 2003. 'An approach for measuring semantic similarity 
between words using multiple information sources', Ieee Transactions on Knowledge and 
Data Engineering, 15: 871-82. 
Zhang, H., F. Zhu, H. H. Dodge, G. A. Higgins, G. S. Omenn, Y. Guan, and Initiative Alzheimer's 
Disease Neuroimaging. 2018. 'A similarity-based approach to leverage multi-cohort medical 
data on the diagnosis and prognosis of Alzheimer's disease', GigaScience, 7: giy085-giy85. 
Zhang, P., F. Wang, and J. Hu. 2014a. 'Towards drug repositioning: a unified computational 
framework for integrating multiple aspects of drug similarity and disease similarity', AMIA 
Annu Symp Proc, 2014: 1258-67. 
Zhang, Ping, Fei Wang, Jianying Hu, and Robert Sorrentino. 2014b. 'Towards Personalized Medicine: 
Leveraging Patient Similarity and Drug Similarity Analytics', AMIA Summits on 
Translational Science Proceedings, 2014: 132-36. 
Zhang, Z., and X. Xu. 2014c. 'Lactate clearance is a useful biomarker for the prediction of all-cause 
mortality in critically ill patients: a systematic review and meta-analysis*', Crit Care Med, 
42: 2118-25. 
Zhou, X. H., G. J. Eckert, and W. M. Tierney. 2001. 'Multiple imputation in public health research', 
Stat Med, 20: 1541-9. 
Zhu, Z., C. Yin, B. Qian, Y. Cheng, J. Wei, and F. Wang. 2017. "Measuring patient similarities via a 
deep architecture with medical concept embedding." In Proceedings - IEEE International 
Conference on Data Mining, ICDM, 749-58. 
 163 
Zimmerman, J. E., M. G. Seneff, X. Sun, D. P. Wagner, and W. A. Knaus. 1997. 'Evaluating 
laboratory usage in the intensive care unit: patient and institutional characteristics that 
influence frequency of blood sampling', Crit Care Med, 25: 737-48. 
Zolbanin, Hamed Majidi, Dursun Delen, and Amir Hassan Zadeh. 2015. 'Predicting overall 
survivability in comorbidity of cancers: A data mining approach', Decision Support Systems, 
74: 150-61. 
 
  
 164 
Appendix A 
An Overview of Prediction Models 
Generally, prediction models can be broadly grouped into two categories: classification and 
regression. Although both groups aim to discover the underlying relationship between 
predictors and outcomes, they differ in types of outcomes. Discussed below is the set of 
commonly used machine learning algorithms that were named in this dissertation. 
• Logistic Regression (LR): LR is a type of regression analysis that seeks the relation 
between predictors and a binary outcome. In other words, this model predicts the 
probability of an outcome occurring. 
• Decision Tree (DT): DT model is a non-parametric method used for classification and 
regression. A DT algorithm recursively splits data set into smaller homogenous 
subdivisions based on a set of criteria. In DT, each node represents a test on a 
predictor, and the derived branches relate to the possible values for the predictor. 
Then, instances are classified by starting from the root node and following the 
branches based on their predictor values. 
• Linear Discriminant Analysis (LDA): This algorithm searches for a linear 
combination of predictors that separates instances in different classes. LDA assumes 
Gaussian distribution density within each class. 
• Support Vector Machine (SVM): An SVM algorithm finds a separating hyperplane or 
set of hyperplanes in predictors’ space that has the maximum distance from instances 
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on each side. In other words, SVM tries to maximize the margins between the 
instances in each class. 
• Naive Bayes (NB): This classification method is based on Bayes’ rule and assumes 
that predictors are independent of one another. The basic model has been modified, 
and various versions have been introduced to improve performance. 
• k-Nearest Neighbors (KNN): This method is based on the assumption that similar 
instances have similar characteristics. For each instance, KNN finds a cohort of k 
nearest instances based on a distance metric and classifies the new instance based on 
the majority vote of the cohort. 
• Random Forest (RF): This algorithm constructs a set of DT models on different sub-
samples of the data, and the output class will be the aggregation of the classes of all 
trees. In other words, RF is an ensemble of DTs. 
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Appendix B 
An Overview of Clustering Algorithms 
Below, a brief description of the clustering algorithms discussed in this dissertation is 
provided. 
• Partition-based clustering algorithms: the core idea of this type of method is to 
consider the center of data points in each cluster as the representative (center) of the 
cluster. K-means is one of the most famous clustering methods. K-means iteratively 
updates the representatives of the clusters until some criteria of convergence are 
satisfied. This method is timely and computationally efficient. However, it is sensitive 
to the number of clusters and outliers. 
• Hierarchical clustering algorithms: hierarchical algorithms successively construct 
clusters by merging or splitting previously built clusters. These algorithms are further 
categorized into agglomerative (bottom-up) or divisive (top-down) algorithms, and 
are suitable for datasets that have clusters with arbitrary shapes.  
• Fuzzy clustering algorithms: in fuzzy clustering, an instance can be a member of 
more than one clusters. A set of membership degrees is assigned to each data point 
and used to determine to which degree it belongs to each cluster. This group of 
methods is suitable for datasets with overlapping clusters. 
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• Density-based clustering algorithms: the idea of these algorithms is that the clusters 
are located where data has a high density and are separated by regions with a lower 
density of data.  
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Appendix C 
Detailed Results of Chapter 2 
Table C1 The association between indicators (missing=1 and not missing =0) and 
mortality flag (deceased=1, alive=0) using Phi coefficient. 
 In-hospital Mortality 30-days Mortality 
Indicator Day1 Day2 Day3 Day1 Day2 Day3 
ALT -0.14 -0.12 -0.12 -0.14 -0.12 -0.11 
ALK -0.14 -0.12 -0.11 -0.14 -0.12 -0.1 
pH -0.11 -0.13 -0.15 -0.08 -0.1 -0.11 
PCO -0.11 -0.16 -0.18 -0.08 -0.13 -0.15 
PO -0.11 -0.16 -0.18 -0.08 -0.13 -0.15 
BE -0.11 -0.16 -0.18 -0.08 -0.13 -0.15 
AST -0.14 -0.12 -0.12 -0.14 -0.12 -0.11 
Na 0.01 0.03 0.04 0.01 0.02 0.05 
K 0 0.01 0.01 -0.01 0 0.03 
Cl 0.03 0.03 0.04 0.02 0.03 0.06 
HCO 0.03 0.03 0.04 0.02 0.03 0.05 
AG -0.01 0 0.01 -0.02 0 0.01 
BG -0.02 0 0.01 -0.02 -0.01 0.02 
BUN 0.04 0.04 0.06 0.04 0.04 0.07 
Cr 0.04 0.05 0.06 0.04 0.04 0.07 
Ca -0.1 -0.04 -0.04 -0.12 -0.05 -0.04 
WBC 0.03 0.04 0.06 0.02 0.04 0.06 
RBC 0.02 0.03 0.04 0.02 0.03 0.05 
HGB 0.03 0.03 0.05 0.02 0.03 0.05 
HCT 0.04 0.05 0.05 0.03 0.05 0.06 
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MCV 0.02 0.03 0.04 0.02 0.03 0.05 
MCH 0.02 0.03 0.04 0.02 0.03 0.05 
MCHC 0.02 0.03 0.05 0.02 0.03 0.05 
RDW 0.02 0.03 0.05 0.02 0.03 0.05 
PLT 0.03 0.04 0.05 0.03 0.04 0.05 
NE -0.1 -0.07 -0.08 -0.11 -0.08 -0.07 
LY -0.1 -0.07 -0.08 -0.11 -0.08 -0.07 
MO -0.1 -0.07 -0.08 -0.11 -0.08 -0.07 
EO -0.1 -0.07 -0.08 -0.11 -0.08 -0.07 
BA -0.1 -0.07 -0.08 -0.11 -0.08 -0.07 
LAC -0.12 -0.15 -0.15 -0.1 -0.13 -0.12 
Mg -0.03 0.01 0.02 -0.05 0.01 0.03 
PTT -0.04 -0.09 -0.09 -0.04 -0.09 -0.09 
Phos -0.1 -0.05 -0.04 -0.12 -0.06 -0.04 
PT -0.04 -0.09 -0.08 -0.04 -0.09 -0.09 
TBil -0.14 -0.12 -0.12 -0.14 -0.12 -0.11 
Table C2 Detailed results for predictor importance evaluation with regard to 30-day 
mortality. Numbers represent the ranking after aggregating the ranking results from the 
three different feature-selection methods. 
Day One Day Two Day Three 
Hot Deck PMM Hot Deck PMM Hot Deck PMM 
BUN 0.7429
36 
BUN 0.7623
97 
BUN 0.9007 AG 0.7954
19 
RDW 0.6933
05 
RDW 0.7489
97 
RDW 0.6825
17 
RDW 0.6800
87 
RDW 0.8518
29 
HCO3 0.7833
37 
BUN 0.6666
67 
BUN 0.6666
67 
MCH
C 
0.6770
31 
MCH
C 
0.6689
65 
HCO3 0.6551
54 
BUN 0.7767
7 
HCO3 0.5438
71 
HCO3 0.5449
64 
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AG 0.5247
67 
AG 0.5404
84 
AG 0.5808
52 
BE 0.6095
32 
BE 0.4940
6 
BE 0.5405
42 
I-Ca 0.4755
64 
I-Ca 0.4364
29 
MCH
C 
0.4480
53 
RDW 0.6087
11 
AG 0.4492
86 
pH 0.4884
33 
I-
Phos 
0.4645
9 
Cr 0.4360
71 
Cr 0.4050
85 
I-PO2 0.5871
51 
Cr 0.3985
43 
AG 0.4504
26 
PO2 0.4474
35 
HCO3 0.4167
41 
Cl 0.3828
46 
I-
PCO2 
0.5859
47 
I-
PCO2 
0.3752
11 
I-LAC 0.4187
16 
HCO3 0.4447
44 
PO2 0.4042
89 
MCV 0.3758
21 
I-BE 0.5855
92 
I-PO2 0.3749
31 
I-pH 0.4046
3 
Cr 0.4287
55 
MCV 0.3869
64 
I-LAC 0.3598
97 
Cl 0.5315
8 
I-BE 0.3741
27 
Cr 0.4000
08 
I-LAC 0.3871
9 
I-
Phos 
0.3744
31 
Na 0.3580
51 
PT 0.4620
85 
PCO2 0.3597
71 
Phos 0.3876
61 
HGB 0.3737
06 
PTT 0.3539
13 
PTT 0.3569
26 
LAC 0.4618
69 
NE 0.3576
08 
I-
PCO2 
0.3870
19 
MCV 0.3691
12 
HGB 0.3427
86 
Phos 0.3376
63 
Cr 0.4519
99 
MCH
C 
0.3318
02 
I-PO2 0.3867
39 
LY 0.3678
66 
pH 0.3276
7 
PT 0.3337
79 
PTT 0.4249
56 
PT 0.3284
78 
I-BE 0.3859
35 
PTT 0.3342
4 
LAC 0.3203
39 
I-PO2 0.3335 Na 0.4224
74 
LAC 0.2899
64 
PCO2 0.3672
57 
RBC 0.3334
82 
BE 0.3202
99 
I-
PCO2 
0.3328
14 
Phos 0.4191
71 
LY 0.2876
81 
NE 0.3607
91 
I-TBil 0.3207
28 
I-LAC 0.3182
16 
I-BE 0.3325
17 
I-LAC 0.4154
75 
pH 0.2836
43 
MCV 0.3512
66 
BG 0.3190
01 
PCO2 0.3166
68 
BE 0.2903
59 
MCV 0.3683
43 
MCV 0.2816
27 
I-PTT 0.3383
52 
I-ALT 0.3158
39 
I-TBil 0.3127
7 
I-
Phos 
0.2846
44 
MCH
C 
0.3631
46 
I-LAC 0.2703
27 
LAC 0.3312
05 
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I-AST 0.3148
76 
I-ALK 0.3055
29 
I-TBil 0.2836
94 
I-pH 0.3524
43 
Phos 0.2627
58 
MCH
C 
0.3298
17 
PT 0.3034
47 
I-ALT 0.3030
33 
I-pH 0.2735
27 
I-PT 0.3381
44 
I-pH 0.2394
26 
PT 0.3295
86 
I-ALK 0.3020
31 
I-AST 0.3020
74 
I-PTT 0.2615
53 
I-TBil 0.3254
66 
BG 0.2212
39 
I-PT 0.2999
4 
LAC 0.2776
14 
PT 0.2963
26 
I-PT 0.2582
42 
I-PTT 0.3253
62 
I-PTT 0.2212
11 
RBC 0.2386
42 
Cl 0.2760
99 
RBC 0.2937
54 
PLT 0.2529
63 
pH 0.3124
81 
WBC 0.2174
81 
I-
Phos 
0.2379
35 
pH 0.2738
49 
Phos 0.2888
46 
I-Ca 0.2480
52 
PCO2 0.3079
02 
I-PT 0.2149
63 
I-TBil 0.2378
11 
PLT 0.2733
01 
LY 0.2854
21 
NE 0.2474
63 
BG 0.3019
89 
I-TBil 0.2133
62 
BG 0.2228
07 
I-PT 0.2561
03 
ALK 0.2845
28 
I-ALK 0.2363
76 
I-ALK 0.3014
9 
I-ALT 0.2052
11 
WBC 0.2193
08 
PCO2 0.2552
03 
BG 0.2826
68 
LAC 0.2322
78 
PO2 0.2975
96 
PTT 0.2044
95 
I-ALT 0.2143
5 
I-PTT 0.2495
78 
PLT 0.2798
92 
I-ALT 0.2290
95 
PLT 0.2911
6 
I-AST 0.2020
47 
LY 0.2127
83 
MCH 0.2327
07 
NE 0.2666
46 
I-AST 0.2231
72 
I-ALT 0.2858
26 
I-ALK 0.1984
13 
I-AST 0.2096
72 
Phos 0.2186
56 
Cl 0.2233
53 
BG 0.2181
29 
TBil 0.2831
23 
PLT 0.1983
22 
PO2 0.2082
79 
BE 0.2084
77 
TBil 0.2161
97 
HGB 0.2089
15 
I-AST 0.2816
95 
Cl 0.1884
06 
PTT 0.2061
23 
Na 0.2074
31 
MCH 0.2127
88 
PCO2 0.2019
61 
LY 0.2716
01 
PO2 0.1806
45 
PLT 0.2006
99 
I-NE 0.2006
87 
I-NE 0.1962
31 
WBC 0.2019
17 
MCH 0.2615
53 
I-
Phos 
0.1673
56 
Cl 0.1955
87 
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I-MO 0.2006
87 
I-MO 0.1962
31 
Ca 0.1936
41 
I-
Phos 
0.2614 I-Ca 0.1652
53 
I-ALK 0.1922
4 
I-EO 0.2006
87 
I-EO 0.1962
31 
BA 0.1869
36 
Ca 0.2427
39 
Mg 0.1547
38 
Ca 0.1850
77 
I-BA 0.2006
87 
I-BA 0.1962
31 
RBC 0.1819
05 
WBC 0.2426
47 
Na 0.1468
87 
Mg 0.1563
56 
I-LY 0.2006
08 
I-LY 0.1961
52 
pH 0.1680
43 
I-Ca 0.2008
65 
Ca 0.1440
49 
Na 0.1495
34 
I-
PCO2 
0.1876
62 
WBC 0.1716
99 
HCT 0.1661
9 
HGB 0.1933
31 
TBil 0.1403
46 
MCH 0.1466
59 
I-PO2 0.1876
62 
Ca 0.1673
12 
LY 0.1598
86 
RBC 0.1880
82 
RBC 0.1070
89 
I-Ca 0.1443
85 
I-BE 0.1875
34 
AST 0.1625
32 
Mg 0.1313
04 
ALK 0.1841
85 
I-NE 0.0974
67 
TBil 0.1422
64 
NE 0.1731
5 
I-
PCO2 
0.1569
81 
TBil 0.1269
85 
BA 0.1698
45 
I-LY 0.0974
67 
EO 0.1421
07 
WBC 0.1669
62 
I-PO2 0.1569
81 
MCH 0.1200
35 
AST 0.1668
8 
I-MO 0.0974
67 
BA 0.1420
31 
Ca 0.1638
23 
I-BE 0.1568
53 
I-NE 0.1036
39 
Mg 0.1591
73 
I-EO 0.0974
67 
I-NE 0.0999
61 
I-pH 0.1598
75 
BA 0.1497
17 
I-LY 0.1036
39 
NE 0.1501
39 
I-BA 0.0974
67 
I-LY 0.0999
61 
I-Mg 0.1400
9 
Na 0.1460
76 
I-MO 0.1036
39 
HCT 0.1179
54 
K 0.0897
82 
I-MO 0.0999
61 
ALK 0.1310
4 
I-pH 0.1449
73 
I-EO 0.1036
39 
EO 0.1149
59 
AST 0.0841
85 
I-EO 0.0999
61 
TBil 0.1117
02 
I-Mg 0.1110
8 
I-BA 0.1036
39 
I-NE 0.1133
55 
ALK 0.0820
93 
I-BA 0.0999
61 
EO 0.1093
63 
I-BG 0.1066
93 
ALK 0.0948
55 
I-LY 0.1133
55 
I-Mg 0.0707
01 
I-
RDW 
0.0941
93 
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BA 0.1087
85 
EO 0.1060
64 
MO 0.0922
4 
I-MO 0.1133
55 
BA 0.0699
68 
K 0.0922
06 
I-BG 0.1032
06 
I-AG 0.1026
7 
K 0.0750
67 
I-EO 0.1133
55 
I-Cl 0.0698
21 
I-RBC 0.0858
6 
I-AG 0.0984
21 
I-PT 0.0922
05 
EO 0.0638
87 
I-BA 0.1133
55 
I-Cr 0.0690
27 
I-
MCV 
0.0858
6 
AST 0.0852
18 
I-PTT 0.0808
4 
I-Mg 0.0636
62 
MO 0.1080
44 
I-BUN 0.0678
5 
I-
MCH 
0.0858
6 
I-K 0.0851
22 
MO 0.0629
42 
PO2 0.0554
18 
K 0.1038
65 
I-BG 0.0651
49 
ALK 0.0843
26 
ALT 0.0610
17 
ALT 0.0559
05 
I-HCT 0.0552
02 
ALT 0.0780
95 
MO 0.0566
12 
AST 0.0814
58 
Mg 0.0520
26 
Mg 0.0441
78 
I-
MCH
C 
0.0457
23 
I-
RDW 
0.0774
68 
I-HCT 0.0545
67 
I-
MCH
C 
0.0807
82 
I-BUN 0.0488
02 
HCT 0.0441
35 
I-RBC 0.0455
97 
I-
MCH
C 
0.0767
33 
I-PLT 0.0526
54 
I-Mg 0.0651
96 
HCT 0.0473
72 
I-PLT 0.0352
78 
I-
MCV 
0.0455
97 
I-RBC 0.0766
01 
I-
HCO3 
0.0505
89 
I-Cr 0.0596
82 
I-Cr 0.0453
43 
K 0.0344
45 
I-
MCH 
0.0455
97 
I-
MCV 
0.0766
01 
I-K 0.0491
23 
I-BUN 0.0585
04 
MO 0.0375
29 
I-K 0.0340
74 
I-
RDW 
0.0452
42 
I-
MCH 
0.0766
01 
EO 0.0484
83 
I-
WBC 
0.0555
85 
K 0.0359 I-HGB 0.0332
98 
AST 0.0451
6 
I-HGB 0.0690
39 
MCH 0.0482
14 
I-HGB 0.0552
67 
I-Na 0.0284
94 
I-
MCV 
0.0330
14 
I-BUN 0.0319
37 
I-HCT 0.0632
31 
I-
WBC 
0.0470
5 
MO 0.0550
48 
I-Cl 0.0263
07 
I-
MCH 
0.0330
14 
I-PLT 0.0305
4 
I-PLT 0.0572
16 
I-Na 0.0466
79 
I-HCT 0.0549
35 
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I-PLT 0.0235
85 
I-
MCH
C 
0.0328
4 
ALT 0.0304
51 
I-
WBC 
0.0556
54 
ALT 0.0454
15 
I-PLT 0.0488
78 
I-
HCO3 
0.0232
89 
I-
RDW 
0.0328
36 
I-
WBC 
0.0288
15 
I-Cr 0.0438
87 
I-HGB 0.0396
08 
I-Cl 0.0440
26 
I-
WBC 
0.0157
26 
I-RBC 0.0327
37 
I-Cr 0.0283
58 
I-BUN 0.0418
46 
I-
RDW 
0.0351
26 
I-K 0.0432
33 
I-HCT 0.0124
93 
I-
WBC 
0.0281
94 
I-HGB 0.0275
24 
I-Cl 0.0342
06 
I-
MCH
C 
0.0329
41 
I-Na 0.0429
2 
I-HGB 0.0116
58 
I-HCT 0.0236
48 
I-K 0.0275
06 
I-
HCO3 
0.0337
03 
I-RBC 0.0324
01 
I-
HCO3 
0.0412
08 
I-
MCV 
0.0113
73 
I-Cr 0.0167
8 
I-AG 0.0213
07 
I-Na 0.0313
93 
I-
MCV 
0.0324
01 
I-BG 0.0387
48 
I-
MCH 
0.0113
73 
I-BUN 0.0166
79 
I-BG 0.0203
66 
I-Mg 0.0229
61 
I-
MCH 
0.0324
01 
I-AG 0.0306
97 
I-
MCH
C 
0.0111
98 
I-Na 0.0140
31 
I-Cl 0.0192
71 
I-BG 0.0170
67 
HGB 0.0278 HGB 0.0305
18 
I-
RDW 
0.0111
94 
I-Cl 0.0077
22 
I-
HCO3 
0.0192
6 
I-AG 0.0156
87 
I-AG 0.0257
59 
HCT 0.0231
2 
I-RBC 0.0110
95 
I-
HCO3 
0.0054
57 
I-Na 0.0136
49 
I-K 0.0135
39 
HCT 0.0203
15 
ALT 0 
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Table C3 Detailed results for predictor importance evaluation with regard to in-hospital mortality. Numbers represent the 
ranking after aggregating the ranking results from the three different feature-selection methods. 
Day One Day Two Day Three 
Hot Deck PMM Hot Deck PMM Hot Deck PMM 
BUN 0.792686 BUN 0.825715 BUN 0.871227 BUN 1 BE 0.66376 RDW 0.75246 
AG 0.66198 AG 0.668918 AG 0.856826 RDW 0.711852 BUN 0.640534 BUN 0.635729 
RDW 0.599006 RDW 0.573188 RDW 0.810929 HCO3 0.684191 HCO3 0.626034 BE 0.633926 
HCO3 0.590773 HCO3 0.531746 HCO3 0.802246 AG 0.664339 RDW 0.61847 HCO3 0.62367 
MCHC 0.584486 MCHC 0.507343 I-PO2 0.594496 BE 0.528778 I-BE 0.587481 I-BE 0.595553 
BG 0.53102 PCO2 0.489483 I-PCO2 0.593258 MCHC 0.503805 I-PCO2 0.587166 I-PCO2 0.595238 
PO2 0.521196 Cr 0.480181 I-BE 0.592893 PT 0.453111 I-PO2 0.586851 I-PO2 0.594924 
Cr 0.487362 BE 0.452599 I-LAC 0.548438 Cl 0.429405 pH 0.515275 pH 0.556242 
MCV 0.417346 I-LAC 0.436382 Cl 0.529452 I-LAC 0.425279 AG 0.494856 Phos 0.494694 
I-LAC 0.411539 LAC 0.415773 PTT 0.511771 Cr 0.395266 I-LAC 0.489909 AG 0.492864 
I-ALT 0.387559 HGB 0.414263 Phos 0.497639 I-PO2 0.382404 PCO2 0.438274 I-pH 0.470007 
I-AST 0.387498 pH 0.402466 MCHC 0.485717 I-PCO2 0.381737 I-pH 0.437812 I-LAC 0.469215 
I-ALK 0.385754 I-TBil 0.399363 Na 0.473093 I-BE 0.381448 Cr 0.416895 Cr 0.415249 
I-TBil 0.384603 I-Ca 0.395278 Cr 0.461062 PTT 0.357339 Phos 0.355405 LAC 0.396136 
I-Phos 0.381937 I-ALT 0.376004 I-pH 0.460122 Phos 0.352738 PT 0.328079 NE 0.338372 
I-Ca 0.380717 I-AST 0.375944 Ca 0.422747 Na 0.345109 I-PTT 0.311758 PT 0.326491 
LY 0.373098 LY 0.375163 PT 0.386761 I-PT 0.333936 NE 0.304336 LY 0.319146 
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PTT 0.36056 I-ALK 0.366346 PLT 0.371176 BG 0.320947 LAC 0.290642 MCV 0.314868 
PLT 0.359362 RBC 0.36628 BE 0.365499 I-pH 0.317841 MCV 0.286645 PCO2 0.304013 
Phos 0.358443 Phos 0.360009 I-PT 0.362492 LAC 0.307212 I-PT 0.280568 MCHC 0.297485 
HGB 0.353079 BG 0.359947 BG 0.356136 PO2 0.295944 I-TBil 0.276302 RBC 0.280764 
LAC 0.345373 PO2 0.333154 LAC 0.343797 MCV 0.293408 I-ALT 0.273609 I-AST 0.274608 
I-PCO2 0.340782 PLT 0.332843 I-PTT 0.342374 HGB 0.289974 I-AST 0.269524 I-TBil 0.274146 
I-PO2 0.340782 MCV 0.330676 MCV 0.341198 PCO2 0.287056 MCHC 0.257425 I-ALT 0.270957 
I-BE 0.340621 PT 0.324238 RBC 0.30348 I-PTT 0.286421 BG 0.256086 I-ALK 0.262906 
PCO2 0.336776 I-Phos 0.324092 I-TBil 0.300585 NE 0.283794 PLT 0.254084 I-PTT 0.260668 
PT 0.328778 I-PCO2 0.31347 PCO2 0.300358 I-TBil 0.282065 I-ALK 0.25055 I-PT 0.25894 
RBC 0.313951 I-PO2 0.31347 I-ALK 0.295056 LY 0.264846 WBC 0.240404 BG 0.254835 
pH 0.312077 I-BE 0.313312 I-ALT 0.293048 TBil 0.25852 RBC 0.229375 PLT 0.253083 
BE 0.301225 PTT 0.313247 I-AST 0.288134 RBC 0.257641 Cl 0.224759 WBC 0.239337 
I-pH 0.293267 I-pH 0.312705 HGB 0.287403 MCH 0.256053 I-Ca 0.220419 Cl 0.230215 
NE 0.291994 ALK 0.258992 I-Phos 0.278502 pH 0.254797 I-Phos 0.211873 PTT 0.201343 
Cl 0.282029 Na 0.228743 PO2 0.247892 I-ALK 0.245638 PTT 0.202375 Mg 0.188997 
MCH 0.259909 TBil 0.227722 WBC 0.245929 I-ALT 0.23875 Mg 0.190069 PO2 0.173802 
WBC 0.225897 AST 0.226631 LY 0.230429 I-AST 0.237073 Ca 0.182171 BA 0.164709 
I-NE 0.218566 WBC 0.221189 pH 0.21219 BA 0.229466 LY 0.163745 Ca 0.163818 
I-MO 0.218566 I-NE 0.214159 MCH 0.204618 PLT 0.227216 PO2 0.160079 MO 0.161944 
I-EO 0.218566 I-MO 0.214159 I-Ca 0.202655 WBC 0.193095 Na 0.150253 MCH 0.155433 
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I-BA 0.218566 I-EO 0.214159 HCT 0.195806 ALK 0.187838 TBil 0.139763 Na 0.149719 
I-LY 0.218487 I-BA 0.214159 NE 0.194221 HCT 0.180302 MCH 0.131544 TBil 0.139005 
Ca 0.209441 I-LY 0.214082 BA 0.189756 Ca 0.171374 K 0.117619 EO 0.136577 
Na 0.195981 Ca 0.211277 Mg 0.159471 I-Phos 0.14342 I-NE 0.114392 K 0.117024 
I-PT 0.185589 NE 0.204053 TBil 0.136629 MO 0.142681 I-LY 0.114392 I-Phos 0.115488 
I-PTT 0.183623 BA 0.18897 I-NE 0.125957 Mg 0.134089 I-MO 0.114392 I-NE 0.113881 
TBil 0.138903 EO 0.17213 I-LY 0.125957 AST 0.119857 I-EO 0.114392 I-LY 0.113881 
AST 0.134067 MCH 0.170869 I-MO 0.125957 I-NE 0.112565 I-BA 0.114392 I-MO 0.113881 
EO 0.127119 I-PT 0.170498 I-EO 0.125957 I-LY 0.112565 BA 0.110613 I-EO 0.113881 
ALK 0.110338 I-PTT 0.160825 I-BA 0.125957 I-MO 0.112565 AST 0.108952 I-BA 0.113881 
BA 0.108381 Cl 0.154443 K 0.096208 I-EO 0.112565 MO 0.083459 AST 0.112826 
MO 0.099866 ALT 0.098121 AST 0.079471 I-BA 0.112565 EO 0.074052 I-Ca 0.088959 
I-Mg 0.09522 I-BG 0.095042 MO 0.073539 I-Ca 0.097019 I-Mg 0.072413 ALK 0.066881 
ALT 0.086944 I-AG 0.081084 EO 0.059083 EO 0.090394 ALK 0.067309 I-RDW 0.059171 
Mg 0.05808 I-Mg 0.06207 ALK 0.050719 I-BG 0.077374 ALT 0.06125 I-MCHC 0.057317 
K 0.055639 I-K 0.054604 I-MCHC 0.049679 I-AG 0.070263 I-WBC 0.047277 I-RBC 0.056806 
I-HCT 0.038074 K 0.054598 I-RBC 0.049543 K 0.068477 I-Cr 0.046987 I-MCV 0.056806 
I-AG 0.03646 Mg 0.041903 I-MCV 0.049543 I-K 0.064423 I-BUN 0.043822 I-MCH 0.056806 
I-BG 0.034724 I-RBC 0.039129 I-MCH 0.049543 ALT 0.043276 I-PLT 0.040581 I-Cr 0.050183 
I-BUN 0.028065 I-MCV 0.039069 I-HCT 0.047944 I-HCT 0.036985 I-HCT 0.03936 I-PLT 0.047133 
I-K 0.027928 I-MCH 0.039069 I-HGB 0.047702 I-RDW 0.03124 I-RDW 0.039224 I-WBC 0.047106 
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I-Cr 0.027837 I-MCHC 0.038744 I-RDW 0.046801 I-PLT 0.029356 I-MCHC 0.037362 I-BUN 0.047027 
HCT 0.024159 I-HCT 0.036842 ALT 0.0414 I-WBC 0.027678 I-RBC 0.036849 I-HCT 0.045927 
I-PLT 0.022738 I-RDW 0.036652 I-BUN 0.040751 I-Cr 0.027393 I-MCV 0.036849 I-HGB 0.038626 
I-WBC 0.019027 I-Cr 0.0327 I-PLT 0.03946 I-BUN 0.026789 I-MCH 0.036849 I-Cl 0.034929 
I-RDW 0.018714 I-PLT 0.03036 I-Cr 0.039221 I-MCHC 0.023899 I-HGB 0.035416 I-HCO3 0.034152 
I-HGB 0.016144 I-BUN 0.030341 I-WBC 0.034229 I-RBC 0.023775 I-Cl 0.031698 I-AG 0.030166 
I-RBC 0.015815 I-HCO3 0.021465 I-Cl 0.02632 I-MCV 0.023775 I-HCO3 0.03092 I-K 0.027199 
I-MCV 0.015754 I-Cl 0.021105 I-HCO3 0.025802 I-MCH 0.023775 HGB 0.027294 HGB 0.027109 
I-MCH 0.015754 I-WBC 0.018852 I-Na 0.020485 I-HGB 0.022524 I-Na 0.023554 I-Na 0.026809 
I-MCHC 0.015422 HCT 0.018361 I-Mg 0.019784 I-HCO3 0.022448 HCT 0.020428 I-Mg 0.024299 
I-HCO3 0.01364 I-Na 0.016962 I-K 0.005176 I-Mg 0.020097 I-BG 0.007874 HCT 0.020301 
I-Cl 0.013272 I-HGB 0.016188 I-AG 0.00514 I-Cl 0.018554 I-AG 0.003873 ALT 0.017294 
I-Na 0.009183 MO 0.008405 I-BG 0.003625 I-Na 0.016975 I-K 0.003757 I-BG 0.010681 
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Table C4 Detailed AUROC values for all three days models for 30-days mortality. 
 Day1 Day2 Day3 
AUROC AUROC-SD AUROC AUROC-SD AUROC AUROC-SD 
Logistic 
Regression 
Indicator 
Only 
0.683639 0.012024 0.662923 0.010076 0.658562 0.016731 
HD 0.764109 0.007059 0.742167 0.015646 0.734406 0.009016 
HD + 
Indicator 
0.785046 0.008317 0.76738 0.013904 0.761211 0.01254 
PMM 0.765781 0.00824 0.749135 0.013908 0.733725 0.012114 
PMM + 
Indicator 
0.786277 0.010084 0.772205 0.012432 0.760894 0.013726 
SAPS II 0.781272 0.010389 0.734669 0.016996 0.704888 0.014114 
SAPS II 
+Indicator 
0.804469 0.010902 0.758655 0.014826 0.738983 0.013721 
Decision 
Tree 
Indicator 
Only 
0.650103 0.030717 0.626416 0.013378 0.629829 0.029985 
HD 0.710146 0.008507 0.686409 0.018551 0.664421 0.023127 
HD + 
Indicator 
0.721343 0.009624 0.699798 0.017404 0.673743 0.010208 
PMM 0.707519 0.010437 0.683301 0.024034 0.660748 0.024769 
PMM + 
Indicator 
0.714665 0.016703 0.695593 0.022077 0.676769 0.023449 
SAPS II 0.781272 0.010389 0.64003 0.020941 0.631917 0.014237 
SAPS II 
+Indicator 
0.804469 0.010902 0.733759 0.019449 0.716765 0.015101 
Random 
Forest 
Indicator 
Only 
0.505464 0.006078 0.514214 0.011948 0.530299 0.009883 
HD 0.773757 0.008081 0.7451 0.011768 0.72928 0.007846 
HD + 
Indicator 
0.792436 0.008205 0.766697 0.011666 0.754279 0.010198 
PMM 0.778668 0.009603 0.757371 0.00969 0.741238 0.014159 
 180 
PMM + 
Indicator 
0.790357 0.01027 0.77025 0.010431 0.751982 0.011704 
SAPS II 0.598363 0.007601 0.582176 0.013028 0.581908 0.010418 
SAPS II 
+Indicator 
0.702174 0.009598 0.669676 0.016399 0.662755 0.014661 
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Table C5 Detailed AUROC values for all three days models for in-hospital mortality. 
 Day1 Day2 Day3 
AUROC AUROC-
SD 
AUROC AUROC-
SD 
AUROC AUROC-
SD 
Logistic 
Regression 
Indicator Only 0.714672 0.017386 0.691756 0.012501 0.692288 0.015078 
HD 0.764219 0.018237 0.741566 0.01794 0.732094 0.0221 
HD + Indicator 0.798866 0.01876 0.779967 0.01663 0.774248 0.013158 
PMM 0.764211 0.019857 0.747549 0.016608 0.73011 0.018976 
PMM + 
Indicator 
0.798734 0.018334 0.783444 0.015014 0.772708 0.012686 
SAPS II 0.787666 0.014567 0.733107 0.011018 0.697324 0.017352 
SAPS II 
+Indicator 
0.817011 0.014251 0.768525 0.013978 0.751957 0.013731 
Decision Tree Indicator Only 0.617608 0.084701 0.645272 0.010946 0.518569 0.010091 
HD 0.712456 0.016019 0.685595 0.025948 0.732607 0.018908 
HD + Indicator 0.733814 0.021929 0.718591 0.014642 0.768959 0.015584 
PMM 0.712825 0.014675 0.692577 0.013314 0.740328 0.019537 
PMM + 
Indicator 
0.731189 0.017454 0.72262 0.023738 0.765453 0.014443 
SAPS II 0.661025 0.021642 0.64404 0.016882 0.545543 0.009066 
SAPS II 
+Indicator 
0.785751 0.016167 0.740022 0.012199 0.662513 0.015397 
Random Forest Indicator Only 0.506492 0.002377 0.511513 0.004844 0.518569 0.010091 
HD 0.774549 0.01358 0.748636 0.021041 0.732607 0.018908 
HD + Indicator 0.802737 0.013752 0.778569 0.018496 0.768959 0.015584 
PMM 0.787579 0.015326 0.759913 0.019799 0.740328 0.019537 
PMM + 
Indicator 
0.802973 0.01194 0.780929 0.016078 0.765453 0.014443 
SAPS II 0.579601 0.010443 0.556754 0.013962 0.545543 0.009066 
 182 
SAPS II 
+Indicator 
0.689969 0.015505 0.658816 0.017864 0.662513 0.015397 
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Appendix D 
Detailed Results of Chapter 4 
Table D1 Detailed mortality prediction performance of PS-based KNN. 
Number 
of 
Similar 
Patients 
Multifaceted PS 
AUROC (Mean [95% CI]) 
Cosine PS 
AUROC (Mean [95% CI]) 
Euclidean PS 
AUROC (Mean [95% CI]) 
1 0.5522 [0.5442, 0.5442] 0.5499 [0.544, 0.5559] 0.5452 [0.5354, 0.5549] 
10 0.6729 [0.6631, 0.6631] 0.6477 [0.6369, 0.6586] 0.6497 [0.6368, 0.6626] 
20 0.7096 [0.6979, 0.6979] 0.6717 [0.6583, 0.685] 0.6706 [0.6569, 0.6844] 
30 0.7269 [0.7138, 0.7138] 0.6815 [0.6691, 0.6938] 0.6796 [0.6667, 0.6924] 
40 0.7355 [0.7221, 0.7221] 0.6884 [0.6758, 0.701] 0.6854 [0.674, 0.6969] 
50 0.743 [0.7318, 0.7318] 0.6904 [0.6777, 0.7031] 0.6885 [0.6779, 0.699] 
60 0.7488 [0.7374, 0.7374] 0.6925 [0.6796, 0.7055] 0.6881 [0.6784, 0.6978] 
70 0.7545 [0.7446, 0.7446] 0.6934 [0.6814, 0.7054] 0.6879 [0.678, 0.6979] 
80 0.7571 [0.7469, 0.7469] 0.6957 [0.6834, 0.7081] 0.6874 [0.6769, 0.6979] 
90 0.7608 [0.7494, 0.7494] 0.6966 [0.6855, 0.7076] 0.6885 [0.6782, 0.6989] 
100 0.7628 [0.7519, 0.7519] 0.6972 [0.6856, 0.7088] 0.6883 [0.6783, 0.6983] 
110 0.7648 [0.7541, 0.7541] 0.6983 [0.687, 0.7096] 0.6874 [0.6769, 0.6979] 
120 0.7651 [0.7542, 0.7542] 0.6983 [0.6864, 0.7101] 0.6881 [0.6775, 0.6987] 
130 0.7675 [0.7567, 0.7567] 0.6989 [0.6874, 0.7103] 0.6885 [0.6773, 0.6997] 
140 0.7691 [0.7587, 0.7587] 0.6982 [0.6868, 0.7097] 0.6884 [0.6774, 0.6993] 
150 0.7714 [0.7608, 0.7608] 0.6986 [0.687, 0.7101] 0.6884 [0.6773, 0.6995] 
160 0.7726 [0.7619, 0.7619] 0.6979 [0.6868, 0.7091] 0.6888 [0.6781, 0.6996] 
170 0.7729 [0.7622, 0.7622] 0.6984 [0.6872, 0.7096] 0.689 [0.6789, 0.6991] 
180 0.7745 [0.7643, 0.7643] 0.6977 [0.6867, 0.7088] 0.6893 [0.6788, 0.6997] 
190 0.7758 [0.7656, 0.7656] 0.698 [0.6867, 0.7093] 0.6897 [0.6794, 0.6999] 
 184 
200 0.7768 [0.7667, 0.7667] 0.6988 [0.6875, 0.7102] 0.6897 [0.6797, 0.6996] 
210 0.7773 [0.7675, 0.7675] 0.698 [0.6866, 0.7093] 0.6891 [0.6794, 0.6988] 
220 0.7788 [0.7689, 0.7689] 0.6983 [0.6867, 0.7098] 0.6893 [0.6794, 0.6991] 
230 0.7799 [0.7704, 0.7704] 0.6976 [0.6859, 0.7094] 0.6893 [0.6796, 0.699] 
240 0.78 [0.7705, 0.7705] 0.698 [0.6863, 0.7097] 0.6892 [0.6798, 0.6986] 
250 0.7805 [0.7709, 0.7709] 0.6978 [0.686, 0.7096] 0.6886 [0.6792, 0.6981] 
260 0.7812 [0.7717, 0.7717] 0.698 [0.6861, 0.7099] 0.688 [0.6785, 0.6974] 
270 0.7821 [0.7727, 0.7727] 0.6978 [0.6859, 0.7098] 0.6883 [0.6786, 0.698] 
280 0.7823 [0.7733, 0.7733] 0.6978 [0.6859, 0.7097] 0.6879 [0.6782, 0.6976] 
290 0.7834 [0.7743, 0.7743] 0.6972 [0.6859, 0.7086] 0.6874 [0.6777, 0.6972] 
300 0.7839 [0.7751, 0.7751] 0.6973 [0.6861, 0.7085] 0.687 [0.6771, 0.6969] 
310 0.785 [0.7762, 0.7762] 0.697 [0.686, 0.7081] 0.6868 [0.6771, 0.6966] 
320 0.7855 [0.7764, 0.7764] 0.6968 [0.6858, 0.7078] 0.6865 [0.6769, 0.6961] 
330 0.7858 [0.7772, 0.7772] 0.6966 [0.6854, 0.7078] 0.686 [0.6763, 0.6957] 
340 0.786 [0.7773, 0.7773] 0.6967 [0.6855, 0.7078] 0.6854 [0.6756, 0.6951] 
350 0.7862 [0.7777, 0.7777] 0.6964 [0.6852, 0.7075] 0.6852 [0.6753, 0.6952] 
360 0.7864 [0.7778, 0.7778] 0.6958 [0.6848, 0.7069] 0.6853 [0.6756, 0.6951] 
370 0.7861 [0.7772, 0.7772] 0.6957 [0.6847, 0.7066] 0.6854 [0.676, 0.6948] 
380 0.7861 [0.7772, 0.7772] 0.695 [0.6839, 0.7062] 0.6846 [0.6751, 0.6941] 
390 0.7862 [0.7773, 0.7773] 0.695 [0.6836, 0.7064] 0.6845 [0.675, 0.694] 
400 0.7865 [0.7774, 0.7774] 0.6945 [0.6833, 0.7058] 0.6841 [0.6747, 0.6935] 
410 0.7869 [0.7779, 0.7779] 0.6947 [0.6837, 0.7057] 0.6835 [0.6739, 0.6931] 
420 0.7865 [0.7778, 0.7778] 0.6947 [0.6838, 0.7057] 0.6832 [0.6737, 0.6927] 
430 0.7868 [0.7785, 0.7785] 0.6946 [0.6835, 0.7057] 0.6828 [0.6732, 0.6925] 
440 0.7873 [0.7795, 0.7795] 0.6946 [0.6835, 0.7057] 0.6824 [0.6728, 0.6921] 
450 0.7871 [0.7792, 0.7792] 0.6943 [0.6832, 0.7055] 0.6822 [0.6726, 0.6918] 
460 0.787 [0.7794, 0.7794] 0.6943 [0.6831, 0.7054] 0.6817 [0.6722, 0.6913] 
470 0.7869 [0.7793, 0.7793] 0.6941 [0.683, 0.7051] 0.6816 [0.6722, 0.691] 
480 0.7874 [0.7796, 0.7796] 0.6943 [0.6836, 0.7051] 0.6812 [0.6717, 0.6908] 
490 0.787 [0.7796, 0.7796] 0.6938 [0.6831, 0.7046] 0.6811 [0.6717, 0.6904] 
 185 
500 0.7868 [0.7795, 0.7795] 0.6935 [0.6829, 0.7041] 0.6808 [0.6715, 0.6901] 
510 0.7866 [0.7795, 0.7795] 0.6934 [0.6829, 0.7039] 0.6806 [0.6713, 0.6899] 
520 0.7865 [0.7794, 0.7794] 0.6932 [0.6827, 0.7038] 0.6805 [0.6711, 0.6899] 
530 0.7866 [0.7796, 0.7796] 0.6931 [0.6827, 0.7035] 0.6803 [0.671, 0.6897] 
540 0.7867 [0.7795, 0.7795] 0.693 [0.6823, 0.7036] 0.6801 [0.6707, 0.6895] 
550 0.7869 [0.7796, 0.7796] 0.6931 [0.6823, 0.7039] 0.6799 [0.6705, 0.6894] 
560 0.787 [0.7796, 0.7796] 0.6929 [0.682, 0.7038] 0.6797 [0.6702, 0.6892] 
570 0.7868 [0.7795, 0.7795] 0.6926 [0.6819, 0.7034] 0.6792 [0.6697, 0.6886] 
580 0.787 [0.7797, 0.7797] 0.6921 [0.6812, 0.703] 0.6789 [0.6695, 0.6884] 
590 0.7869 [0.7796, 0.7796] 0.6919 [0.6808, 0.7029] 0.6786 [0.669, 0.6882] 
600 0.7872 [0.7797, 0.7797] 0.6915 [0.6805, 0.7026] 0.6783 [0.6686, 0.6879] 
610 0.7873 [0.7796, 0.7796] 0.6913 [0.6802, 0.7023] 0.6778 [0.6682, 0.6874] 
620 0.7876 [0.7798, 0.7798] 0.6912 [0.68, 0.7023] 0.6776 [0.6681, 0.6871] 
630 0.7877 [0.7798, 0.7798] 0.6909 [0.6798, 0.7019] 0.6771 [0.6679, 0.6864] 
640 0.7879 [0.7802, 0.7802] 0.6906 [0.6796, 0.7017] 0.6766 [0.6674, 0.6858] 
650 0.7884 [0.7806, 0.7806] 0.6906 [0.6796, 0.7016] 0.6764 [0.6672, 0.6856] 
660 0.7882 [0.7804, 0.7804] 0.6904 [0.6793, 0.7016] 0.6762 [0.6669, 0.6855] 
670 0.7877 [0.7799, 0.7799] 0.6901 [0.6789, 0.7012] 0.6761 [0.6668, 0.6853] 
680 0.7878 [0.7801, 0.7801] 0.6899 [0.6788, 0.701] 0.6759 [0.6665, 0.6852] 
690 0.7876 [0.7798, 0.7798] 0.6897 [0.6786, 0.7007] 0.6754 [0.666, 0.6848] 
700 0.7878 [0.7798, 0.7798] 0.6894 [0.6783, 0.7004] 0.6752 [0.6656, 0.6847] 
710 0.7881 [0.7797, 0.7797] 0.6893 [0.6783, 0.7003] 0.6753 [0.6657, 0.6848] 
720 0.7882 [0.7797, 0.7797] 0.689 [0.678, 0.7] 0.6753 [0.6656, 0.685] 
730 0.7879 [0.7795, 0.7795] 0.6888 [0.6777, 0.6999] 0.6752 [0.6655, 0.6849] 
740 0.7881 [0.78, 0.78] 0.6886 [0.6776, 0.6995] 0.6751 [0.6653, 0.6849] 
750 0.7883 [0.7802, 0.7802] 0.6884 [0.6774, 0.6993] 0.6749 [0.6651, 0.6846] 
760 0.7883 [0.78, 0.78] 0.6881 [0.6774, 0.6988] 0.6749 [0.6652, 0.6846] 
770 0.7885 [0.7803, 0.7803] 0.688 [0.6772, 0.6988] 0.6747 [0.665, 0.6845] 
780 0.7887 [0.7805, 0.7805] 0.6878 [0.6772, 0.6984] 0.6745 [0.6647, 0.6843] 
790 0.7887 [0.7804, 0.7804] 0.6875 [0.6769, 0.698] 0.6743 [0.6646, 0.6839] 
 186 
800 0.7889 [0.7803, 0.7803] 0.6872 [0.6767, 0.6978] 0.6741 [0.6643, 0.6839] 
810 0.789 [0.7803, 0.7803] 0.687 [0.6765, 0.6975] 0.6738 [0.664, 0.6836] 
820 0.7891 [0.7804, 0.7804] 0.6869 [0.6763, 0.6974] 0.6739 [0.6641, 0.6837] 
830 0.7889 [0.7801, 0.7801] 0.687 [0.6765, 0.6976] 0.6739 [0.664, 0.6838] 
840 0.7891 [0.7801, 0.7801] 0.6867 [0.6762, 0.6973] 0.6735 [0.6636, 0.6835] 
850 0.7891 [0.78, 0.78] 0.6865 [0.6759, 0.697] 0.6735 [0.6636, 0.6835] 
860 0.7891 [0.7797, 0.7797] 0.6866 [0.6761, 0.6971] 0.6734 [0.6635, 0.6833] 
870 0.7893 [0.7798, 0.7798] 0.6864 [0.676, 0.6969] 0.6733 [0.6632, 0.6834] 
880 0.7893 [0.7797, 0.7797] 0.6865 [0.676, 0.6971] 0.6733 [0.6632, 0.6835] 
890 0.7892 [0.7794, 0.7794] 0.6864 [0.6759, 0.697] 0.6734 [0.6634, 0.6833] 
900 0.7893 [0.7794, 0.7794] 0.6861 [0.6756, 0.6967] 0.6731 [0.663, 0.6832] 
910 0.7891 [0.7792, 0.7792] 0.6861 [0.6756, 0.6967] 0.6728 [0.6627, 0.6829] 
920 0.7892 [0.7795, 0.7795] 0.6859 [0.6754, 0.6964] 0.6725 [0.6624, 0.6825] 
930 0.7891 [0.7792, 0.7792] 0.6857 [0.6753, 0.6961] 0.6723 [0.6621, 0.6825] 
940 0.789 [0.7791, 0.7791] 0.6855 [0.6752, 0.6959] 0.6724 [0.6622, 0.6825] 
950 0.7891 [0.7794, 0.7794] 0.6854 [0.675, 0.6958] 0.6722 [0.6621, 0.6823] 
960 0.7885 [0.7786, 0.7786] 0.6853 [0.6748, 0.6958] 0.672 [0.662, 0.682] 
970 0.7886 [0.7787, 0.7787] 0.6852 [0.6747, 0.6957] 0.6718 [0.6618, 0.6818] 
980 0.7884 [0.7784, 0.7784] 0.685 [0.6746, 0.6954] 0.6717 [0.6616, 0.6818] 
990 0.7885 [0.7787, 0.7787] 0.6849 [0.6745, 0.6953] 0.6716 [0.6613, 0.6818] 
1000 0.7885 [0.7789, 0.7789] 0.6847 [0.6744, 0.6951] 0.6714 [0.6611, 0.6818] 
1010 0.7884 [0.7788, 0.7788] 0.6844 [0.674, 0.6947] 0.671 [0.6609, 0.6812] 
1020 0.7885 [0.7789, 0.7789] 0.6843 [0.674, 0.6947] 0.6709 [0.6608, 0.681] 
1030 0.7886 [0.779, 0.779] 0.6841 [0.6739, 0.6943] 0.6709 [0.6608, 0.681] 
1040 0.7888 [0.7791, 0.7791] 0.6841 [0.674, 0.6943] 0.6709 [0.6608, 0.681] 
1050 0.7886 [0.7789, 0.7789] 0.684 [0.6739, 0.6941] 0.6706 [0.6605, 0.6806] 
1060 0.7887 [0.779, 0.779] 0.6839 [0.6738, 0.6939] 0.6702 [0.6602, 0.6803] 
1070 0.7883 [0.7787, 0.7787] 0.6837 [0.6736, 0.6938] 0.67 [0.6599, 0.6801] 
1080 0.7883 [0.7786, 0.7786] 0.6834 [0.6733, 0.6934] 0.6698 [0.6597, 0.6799] 
1090 0.7884 [0.7787, 0.7787] 0.6831 [0.673, 0.6931] 0.6696 [0.6595, 0.6797] 
 187 
1100 0.788 [0.7784, 0.7784] 0.6829 [0.6728, 0.693] 0.6698 [0.6597, 0.6799] 
1110 0.7882 [0.7787, 0.7787] 0.6828 [0.6726, 0.693] 0.6695 [0.6595, 0.6795] 
1120 0.7881 [0.7786, 0.7786] 0.6827 [0.6725, 0.693] 0.6692 [0.6592, 0.6793] 
1130 0.7881 [0.7788, 0.7788] 0.6826 [0.6723, 0.6929] 0.6691 [0.659, 0.6791] 
1140 0.7882 [0.7788, 0.7788] 0.6826 [0.6723, 0.693] 0.6687 [0.6585, 0.6789] 
1150 0.788 [0.7786, 0.7786] 0.6825 [0.6721, 0.6929] 0.6685 [0.6583, 0.6788] 
1160 0.7882 [0.7788, 0.7788] 0.6823 [0.6719, 0.6928] 0.6683 [0.6582, 0.6785] 
1170 0.788 [0.7785, 0.7785] 0.6823 [0.6718, 0.6928] 0.6682 [0.6581, 0.6782] 
1180 0.7878 [0.7783, 0.7783] 0.6822 [0.6717, 0.6927] 0.6682 [0.6582, 0.6783] 
1190 0.7878 [0.7782, 0.7782] 0.682 [0.6715, 0.6926] 0.6682 [0.6582, 0.6783] 
1200 0.7878 [0.7783, 0.7783] 0.6818 [0.6714, 0.6923] 0.6683 [0.6584, 0.6782] 
1210 0.788 [0.7786, 0.7786] 0.6817 [0.6714, 0.6921] 0.6683 [0.6585, 0.678] 
1220 0.7881 [0.7786, 0.7786] 0.6818 [0.6714, 0.6921] 0.6682 [0.6585, 0.6779] 
1230 0.7881 [0.7786, 0.7786] 0.6818 [0.6715, 0.6921] 0.6679 [0.6582, 0.6776] 
1240 0.7882 [0.7787, 0.7787] 0.6817 [0.6714, 0.6919] 0.6681 [0.6583, 0.6778] 
1250 0.788 [0.7786, 0.7786] 0.6818 [0.6715, 0.692] 0.6678 [0.658, 0.6776] 
1260 0.788 [0.7786, 0.7786] 0.6817 [0.6714, 0.6919] 0.6677 [0.658, 0.6774] 
1270 0.788 [0.7785, 0.7785] 0.6814 [0.6712, 0.6916] 0.6677 [0.658, 0.6774] 
1280 0.7879 [0.7785, 0.7785] 0.6812 [0.671, 0.6914] 0.6678 [0.658, 0.6776] 
1290 0.7875 [0.7781, 0.7781] 0.6812 [0.671, 0.6914] 0.6677 [0.6579, 0.6774] 
1300 0.7875 [0.7781, 0.7781] 0.681 [0.6708, 0.6912] 0.6675 [0.6577, 0.6772] 
1310 0.7876 [0.7782, 0.7782] 0.681 [0.6708, 0.6912] 0.6674 [0.6575, 0.6773] 
1320 0.7874 [0.7781, 0.7781] 0.6809 [0.6708, 0.6911] 0.6674 [0.6575, 0.6774] 
1330 0.7871 [0.7777, 0.7777] 0.6808 [0.6707, 0.6909] 0.6671 [0.6572, 0.6771] 
1340 0.7871 [0.7777, 0.7777] 0.6807 [0.6705, 0.6909] 0.6671 [0.6572, 0.677] 
1350 0.7873 [0.778, 0.778] 0.6806 [0.6703, 0.6909] 0.6671 [0.6573, 0.6768] 
1360 0.7871 [0.7777, 0.7777] 0.6805 [0.6702, 0.6909] 0.6672 [0.6576, 0.6768] 
1370 0.787 [0.7775, 0.7775] 0.6804 [0.6702, 0.6906] 0.667 [0.6575, 0.6766] 
1380 0.7867 [0.7771, 0.7771] 0.6803 [0.67, 0.6905] 0.667 [0.6574, 0.6767] 
1390 0.7864 [0.7769, 0.7769] 0.6802 [0.6699, 0.6904] 0.667 [0.6574, 0.6767] 
 188 
1400 0.7864 [0.7769, 0.7769] 0.6802 [0.67, 0.6904] 0.6671 [0.6575, 0.6768] 
1410 0.7867 [0.7773, 0.7773] 0.6802 [0.67, 0.6904] 0.6668 [0.6571, 0.6765] 
1420 0.7865 [0.7768, 0.7768] 0.6801 [0.67, 0.6903] 0.6669 [0.6572, 0.6765] 
1430 0.7863 [0.7768, 0.7768] 0.6799 [0.6697, 0.6902] 0.6669 [0.6573, 0.6766] 
1440 0.7862 [0.7766, 0.7766] 0.6799 [0.6696, 0.6901] 0.6669 [0.6573, 0.6766] 
1450 0.7863 [0.7766, 0.7766] 0.6797 [0.6695, 0.6899] 0.6669 [0.6572, 0.6765] 
1460 0.7862 [0.7767, 0.7767] 0.6797 [0.6695, 0.6898] 0.6666 [0.6569, 0.6763] 
1470 0.7863 [0.7766, 0.7766] 0.6794 [0.6694, 0.6895] 0.6666 [0.6569, 0.6763] 
1480 0.7862 [0.7765, 0.7765] 0.6794 [0.6694, 0.6895] 0.6666 [0.657, 0.6762] 
1490 0.7861 [0.7764, 0.7764] 0.6792 [0.6692, 0.6892] 0.6664 [0.6568, 0.6761] 
1500 0.7862 [0.7765, 0.7765] 0.6791 [0.6691, 0.6892] 0.6664 [0.6568, 0.6761] 
1510 0.7861 [0.7766, 0.7766] 0.6791 [0.6691, 0.6891] 0.6662 [0.6566, 0.6758] 
1520 0.786 [0.7763, 0.7763] 0.6789 [0.6689, 0.6889] 0.6663 [0.6566, 0.6759] 
1530 0.7859 [0.7763, 0.7763] 0.6788 [0.6688, 0.6888] 0.6661 [0.6566, 0.6757] 
1540 0.786 [0.7763, 0.7763] 0.6788 [0.6688, 0.6888] 0.6659 [0.6563, 0.6755] 
1550 0.786 [0.7761, 0.7761] 0.6787 [0.6687, 0.6887] 0.6658 [0.6563, 0.6753] 
1560 0.786 [0.7762, 0.7762] 0.6786 [0.6687, 0.6885] 0.6655 [0.6559, 0.6752] 
1570 0.7861 [0.7762, 0.7762] 0.6786 [0.6686, 0.6885] 0.6655 [0.6557, 0.6753] 
1580 0.7858 [0.7758, 0.7758] 0.6784 [0.6684, 0.6884] 0.6653 [0.6555, 0.6752] 
1590 0.786 [0.776, 0.776] 0.6783 [0.6683, 0.6883] 0.6654 [0.6554, 0.6753] 
1600 0.7859 [0.7758, 0.7758] 0.6782 [0.6683, 0.6882] 0.6655 [0.6556, 0.6754] 
1610 0.786 [0.7759, 0.7759] 0.6782 [0.6682, 0.6881] 0.6654 [0.6555, 0.6752] 
1620 0.7859 [0.7758, 0.7758] 0.6781 [0.6682, 0.6881] 0.6652 [0.6555, 0.675] 
1630 0.7861 [0.776, 0.776] 0.6781 [0.6681, 0.688] 0.6651 [0.6553, 0.6749] 
1640 0.786 [0.7761, 0.7761] 0.678 [0.6681, 0.6879] 0.6652 [0.6555, 0.6749] 
1650 0.7863 [0.7763, 0.7763] 0.6779 [0.668, 0.6878] 0.665 [0.6551, 0.6748] 
1660 0.7862 [0.7763, 0.7763] 0.6779 [0.6679, 0.6878] 0.6649 [0.655, 0.6748] 
1670 0.786 [0.776, 0.776] 0.6777 [0.6678, 0.6876] 0.6649 [0.6549, 0.6749] 
1680 0.7862 [0.7762, 0.7762] 0.6777 [0.6678, 0.6875] 0.665 [0.655, 0.6749] 
1690 0.7861 [0.7762, 0.7762] 0.6776 [0.6678, 0.6875] 0.665 [0.6551, 0.675] 
 189 
1700 0.7863 [0.7764, 0.7764] 0.6776 [0.6679, 0.6874] 0.6651 [0.6551, 0.675] 
1710 0.7863 [0.7766, 0.7766] 0.6776 [0.6678, 0.6874] 0.6649 [0.655, 0.6749] 
1720 0.7863 [0.7768, 0.7768] 0.6777 [0.6679, 0.6874] 0.665 [0.655, 0.675] 
1730 0.7864 [0.7768, 0.7768] 0.6776 [0.6679, 0.6874] 0.6651 [0.6551, 0.675] 
1740 0.7863 [0.7768, 0.7768] 0.6776 [0.6678, 0.6874] 0.6652 [0.6552, 0.6752] 
1750 0.786 [0.7765, 0.7765] 0.6776 [0.6678, 0.6873] 0.6652 [0.6552, 0.6752] 
1760 0.786 [0.7765, 0.7765] 0.6773 [0.6675, 0.6871] 0.6651 [0.6551, 0.6752] 
1770 0.7859 [0.7765, 0.7765] 0.6772 [0.6673, 0.6871] 0.6652 [0.6552, 0.6753] 
1780 0.7861 [0.7768, 0.7768] 0.6772 [0.6674, 0.6871] 0.6653 [0.6553, 0.6753] 
1790 0.7862 [0.7768, 0.7768] 0.6772 [0.6674, 0.687] 0.6651 [0.6551, 0.6752] 
1800 0.7861 [0.7768, 0.7768] 0.677 [0.6672, 0.6869] 0.665 [0.655, 0.675] 
1810 0.7862 [0.777, 0.777] 0.6769 [0.6671, 0.6867] 0.6649 [0.6549, 0.6749] 
1820 0.7861 [0.7767, 0.7767] 0.6768 [0.6669, 0.6866] 0.6648 [0.6548, 0.6747] 
1830 0.7862 [0.7768, 0.7768] 0.6766 [0.6668, 0.6864] 0.6645 [0.6546, 0.6745] 
1840 0.786 [0.7766, 0.7766] 0.6766 [0.6667, 0.6864] 0.6645 [0.6546, 0.6745] 
1850 0.786 [0.7765, 0.7765] 0.6766 [0.6668, 0.6865] 0.6647 [0.6547, 0.6746] 
1860 0.7859 [0.7764, 0.7764] 0.6766 [0.6668, 0.6864] 0.6645 [0.6546, 0.6745] 
1870 0.7859 [0.7763, 0.7763] 0.6765 [0.6667, 0.6864] 0.6643 [0.6543, 0.6743] 
1880 0.7858 [0.776, 0.776] 0.6763 [0.6664, 0.6862] 0.6642 [0.6542, 0.6742] 
1890 0.7858 [0.7759, 0.7759] 0.6763 [0.6665, 0.6862] 0.6643 [0.6542, 0.6743] 
1900 0.7858 [0.776, 0.776] 0.6761 [0.6662, 0.6861] 0.6642 [0.6542, 0.6741] 
1910 0.7859 [0.776, 0.776] 0.676 [0.666, 0.686] 0.664 [0.654, 0.674] 
1920 0.7859 [0.776, 0.776] 0.6759 [0.6658, 0.6859] 0.6639 [0.6538, 0.674] 
1930 0.786 [0.7761, 0.7761] 0.6758 [0.6658, 0.6859] 0.6637 [0.6534, 0.6739] 
1940 0.7858 [0.7762, 0.7762] 0.6758 [0.6658, 0.6859] 0.6636 [0.6534, 0.6738] 
1950 0.7858 [0.7761, 0.7761] 0.6758 [0.6658, 0.6859] 0.6636 [0.6533, 0.6739] 
1960 0.7859 [0.7761, 0.7761] 0.6758 [0.6659, 0.6857] 0.6637 [0.6535, 0.6738] 
1970 0.7855 [0.7756, 0.7756] 0.6757 [0.6658, 0.6856] 0.6635 [0.6535, 0.6736] 
1980 0.7858 [0.7759, 0.7759] 0.6756 [0.6657, 0.6855] 0.6635 [0.6534, 0.6736] 
1990 0.7857 [0.7758, 0.7758] 0.6756 [0.6657, 0.6855] 0.6634 [0.6532, 0.6736] 
 190 
2000 0.7858 [0.776, 0.776] 0.6755 [0.6656, 0.6855] 0.6633 [0.6532, 0.6734] 
2010 0.7857 [0.7758, 0.7758] 0.6755 [0.6656, 0.6854] 0.6634 [0.6534, 0.6733] 
2020 0.7856 [0.7759, 0.7759] 0.6754 [0.6654, 0.6854] 0.6633 [0.6534, 0.6732] 
2030 0.7856 [0.7758, 0.7758] 0.6753 [0.6653, 0.6854] 0.6632 [0.6532, 0.6731] 
2040 0.7858 [0.7762, 0.7762] 0.6752 [0.6652, 0.6853] 0.6629 [0.6529, 0.6729] 
2050 0.7859 [0.7762, 0.7762] 0.6752 [0.6651, 0.6852] 0.663 [0.6531, 0.6729] 
2060 0.7859 [0.7762, 0.7762] 0.6751 [0.665, 0.6851] 0.6629 [0.653, 0.6729] 
2070 0.7859 [0.7762, 0.7762] 0.675 [0.665, 0.685] 0.6629 [0.653, 0.6729] 
2080 0.7858 [0.776, 0.776] 0.675 [0.6649, 0.685] 0.6629 [0.653, 0.6728] 
2090 0.7855 [0.7757, 0.7757] 0.6749 [0.6649, 0.685] 0.6629 [0.653, 0.6729] 
2100 0.7856 [0.7758, 0.7758] 0.6748 [0.6648, 0.6848] 0.6629 [0.653, 0.6728] 
2110 0.7857 [0.776, 0.776] 0.6747 [0.6647, 0.6848] 0.6628 [0.6528, 0.6728] 
2120 0.7856 [0.7759, 0.7759] 0.6747 [0.6646, 0.6848] 0.6628 [0.6528, 0.6727] 
2130 0.7854 [0.7758, 0.7758] 0.6746 [0.6645, 0.6847] 0.6627 [0.6527, 0.6727] 
2140 0.7853 [0.7758, 0.7758] 0.6745 [0.6644, 0.6846] 0.6627 [0.6528, 0.6726] 
2150 0.7852 [0.7757, 0.7757] 0.6744 [0.6644, 0.6845] 0.6626 [0.6526, 0.6725] 
2160 0.7852 [0.7756, 0.7756] 0.6743 [0.6642, 0.6844] 0.6625 [0.6526, 0.6723] 
2170 0.7852 [0.7757, 0.7757] 0.6743 [0.6642, 0.6843] 0.6623 [0.6524, 0.6722] 
2180 0.7857 [0.7763, 0.7763] 0.6741 [0.6641, 0.6842] 0.6624 [0.6524, 0.6724] 
2190 0.7856 [0.7761, 0.7761] 0.674 [0.664, 0.6839] 0.6621 [0.6522, 0.6721] 
2200 0.7856 [0.7763, 0.7763] 0.674 [0.664, 0.684] 0.662 [0.652, 0.672] 
2210 0.7855 [0.7762, 0.7762] 0.6738 [0.6638, 0.6838] 0.6621 [0.6521, 0.6722] 
2220 0.7855 [0.7762, 0.7762] 0.6737 [0.6636, 0.6837] 0.6621 [0.6521, 0.6721] 
2230 0.7855 [0.7762, 0.7762] 0.6737 [0.6636, 0.6837] 0.6622 [0.6522, 0.6722] 
2240 0.7854 [0.7761, 0.7761] 0.6737 [0.6637, 0.6837] 0.6621 [0.6521, 0.672] 
2250 0.7853 [0.7761, 0.7761] 0.6735 [0.6634, 0.6836] 0.6621 [0.6522, 0.6721] 
2260 0.7851 [0.7759, 0.7759] 0.6735 [0.6635, 0.6836] 0.6621 [0.6522, 0.672] 
2270 0.7852 [0.7762, 0.7762] 0.6736 [0.6635, 0.6836] 0.6621 [0.6522, 0.6721] 
2280 0.7853 [0.7761, 0.7761] 0.6735 [0.6635, 0.6835] 0.6621 [0.6522, 0.672] 
2290 0.7853 [0.7763, 0.7763] 0.6734 [0.6633, 0.6835] 0.662 [0.652, 0.6719] 
 191 
2300 0.7853 [0.7762, 0.7762] 0.6733 [0.6631, 0.6835] 0.662 [0.652, 0.6719] 
2310 0.7854 [0.7763, 0.7763] 0.6734 [0.6632, 0.6836] 0.6619 [0.652, 0.6718] 
2320 0.7853 [0.7763, 0.7763] 0.6733 [0.6631, 0.6835] 0.6619 [0.652, 0.6718] 
2330 0.7854 [0.7764, 0.7764] 0.6733 [0.6631, 0.6834] 0.662 [0.6522, 0.6718] 
2340 0.7854 [0.7764, 0.7764] 0.6732 [0.663, 0.6833] 0.6619 [0.652, 0.6718] 
2350 0.7855 [0.7765, 0.7765] 0.6731 [0.6629, 0.6833] 0.6618 [0.652, 0.6716] 
2360 0.7854 [0.7764, 0.7764] 0.673 [0.6628, 0.6832] 0.6618 [0.652, 0.6716] 
2370 0.785 [0.7759, 0.7759] 0.673 [0.6628, 0.6832] 0.6617 [0.6518, 0.6716] 
2380 0.7853 [0.7762, 0.7762] 0.6728 [0.6626, 0.6829] 0.6616 [0.6517, 0.6715] 
2390 0.7852 [0.7761, 0.7761] 0.6727 [0.6626, 0.6828] 0.6615 [0.6517, 0.6714] 
2400 0.7851 [0.7759, 0.7759] 0.6727 [0.6626, 0.6829] 0.6614 [0.6515, 0.6713] 
2410 0.7849 [0.7758, 0.7758] 0.6727 [0.6626, 0.6828] 0.6614 [0.6516, 0.6713] 
2420 0.7851 [0.776, 0.776] 0.6726 [0.6625, 0.6827] 0.6614 [0.6516, 0.6712] 
2430 0.7853 [0.7761, 0.7761] 0.6726 [0.6624, 0.6828] 0.6614 [0.6517, 0.6711] 
2440 0.7851 [0.7759, 0.7759] 0.6726 [0.6625, 0.6827] 0.6613 [0.6517, 0.671] 
2450 0.7851 [0.7759, 0.7759] 0.6726 [0.6626, 0.6826] 0.6615 [0.6517, 0.6712] 
2460 0.7852 [0.7759, 0.7759] 0.6726 [0.6627, 0.6825] 0.6614 [0.6517, 0.6712] 
2470 0.7851 [0.7758, 0.7758] 0.6726 [0.6627, 0.6825] 0.6612 [0.6514, 0.671] 
2480 0.7851 [0.7758, 0.7758] 0.6725 [0.6626, 0.6824] 0.6611 [0.6512, 0.6709] 
2490 0.7855 [0.7761, 0.7761] 0.6724 [0.6625, 0.6823] 0.661 [0.6512, 0.6708] 
2500 0.7853 [0.7761, 0.7761] 0.6723 [0.6624, 0.6822] 0.6611 [0.6513, 0.6709] 
2510 0.7853 [0.776, 0.776] 0.6721 [0.6623, 0.682] 0.6609 [0.6511, 0.6708] 
2520 0.7854 [0.7761, 0.7761] 0.6721 [0.6622, 0.6819] 0.661 [0.6512, 0.6708] 
2530 0.7854 [0.7762, 0.7762] 0.6722 [0.6624, 0.682] 0.6608 [0.6511, 0.6706] 
2540 0.7852 [0.776, 0.776] 0.6722 [0.6624, 0.6821] 0.6607 [0.651, 0.6705] 
2550 0.7852 [0.7761, 0.7761] 0.6721 [0.6622, 0.682] 0.6607 [0.6509, 0.6705] 
2560 0.7852 [0.776, 0.776] 0.672 [0.6622, 0.6819] 0.6605 [0.6507, 0.6702] 
2570 0.785 [0.7759, 0.7759] 0.672 [0.6623, 0.6817] 0.6604 [0.6506, 0.6702] 
2580 0.785 [0.776, 0.776] 0.672 [0.6623, 0.6817] 0.6604 [0.6507, 0.6701] 
2590 0.7848 [0.7759, 0.7759] 0.6719 [0.6621, 0.6816] 0.6603 [0.6505, 0.6701] 
 192 
2600 0.7846 [0.7757, 0.7757] 0.6718 [0.6621, 0.6815] 0.6601 [0.6503, 0.6698] 
2610 0.7846 [0.7758, 0.7758] 0.6718 [0.6621, 0.6815] 0.66 [0.6502, 0.6698] 
2620 0.7847 [0.776, 0.776] 0.6719 [0.6622, 0.6815] 0.6599 [0.65, 0.6698] 
2630 0.7847 [0.7758, 0.7758] 0.6718 [0.6622, 0.6813] 0.66 [0.6501, 0.6699] 
2640 0.7846 [0.7758, 0.7758] 0.6717 [0.6621, 0.6812] 0.6599 [0.6501, 0.6697] 
2650 0.7845 [0.7757, 0.7757] 0.6716 [0.6621, 0.6811] 0.6599 [0.6501, 0.6697] 
2660 0.7845 [0.7756, 0.7756] 0.6715 [0.662, 0.681] 0.6598 [0.65, 0.6696] 
2670 0.7844 [0.7755, 0.7755] 0.6713 [0.6618, 0.6807] 0.6598 [0.6501, 0.6696] 
2680 0.7845 [0.7757, 0.7757] 0.6712 [0.6617, 0.6806] 0.6598 [0.6499, 0.6696] 
2690 0.7843 [0.7754, 0.7754] 0.6711 [0.6617, 0.6805] 0.6598 [0.65, 0.6696] 
2700 0.7844 [0.7755, 0.7755] 0.6712 [0.6619, 0.6806] 0.6598 [0.6499, 0.6696] 
2710 0.7844 [0.7755, 0.7755] 0.6711 [0.6617, 0.6805] 0.6597 [0.6499, 0.6695] 
2720 0.7844 [0.7756, 0.7756] 0.671 [0.6616, 0.6804] 0.6596 [0.6498, 0.6694] 
2730 0.7842 [0.7752, 0.7752] 0.6709 [0.6615, 0.6803] 0.6594 [0.6497, 0.6692] 
2740 0.7842 [0.7753, 0.7753] 0.6708 [0.6614, 0.6802] 0.6594 [0.6496, 0.6692] 
2750 0.7841 [0.7752, 0.7752] 0.6708 [0.6615, 0.6802] 0.6594 [0.6496, 0.6693] 
2760 0.7841 [0.7752, 0.7752] 0.6708 [0.6615, 0.6802] 0.6594 [0.6497, 0.6692] 
2770 0.784 [0.7751, 0.7751] 0.6708 [0.6614, 0.6802] 0.6593 [0.6496, 0.6691] 
2780 0.7839 [0.775, 0.775] 0.6707 [0.6613, 0.6802] 0.6592 [0.6495, 0.669] 
2790 0.7839 [0.7751, 0.7751] 0.6707 [0.6612, 0.6802] 0.6592 [0.6495, 0.669] 
2800 0.7837 [0.775, 0.775] 0.6707 [0.6611, 0.6803] 0.6593 [0.6495, 0.6691] 
2810 0.7839 [0.7752, 0.7752] 0.6708 [0.6612, 0.6803] 0.6594 [0.6496, 0.6692] 
2820 0.7838 [0.7751, 0.7751] 0.6706 [0.661, 0.6803] 0.6594 [0.6497, 0.6692] 
2830 0.7841 [0.7753, 0.7753] 0.6705 [0.6609, 0.6802] 0.6594 [0.6497, 0.6691] 
2840 0.784 [0.7752, 0.7752] 0.6705 [0.6609, 0.6801] 0.6594 [0.6496, 0.6691] 
2850 0.7841 [0.7752, 0.7752] 0.6704 [0.6608, 0.68] 0.6594 [0.6496, 0.6692] 
2860 0.7841 [0.7752, 0.7752] 0.6702 [0.6606, 0.6798] 0.6593 [0.6496, 0.6691] 
2870 0.7842 [0.7752, 0.7752] 0.6702 [0.6607, 0.6797] 0.6593 [0.6494, 0.6691] 
2880 0.7841 [0.7752, 0.7752] 0.6701 [0.6605, 0.6797] 0.6592 [0.6495, 0.669] 
2890 0.7841 [0.7752, 0.7752] 0.67 [0.6604, 0.6796] 0.6592 [0.6494, 0.669] 
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2900 0.7841 [0.7751, 0.7751] 0.67 [0.6605, 0.6796] 0.6592 [0.6493, 0.669] 
2910 0.784 [0.7751, 0.7751] 0.67 [0.6603, 0.6796] 0.6592 [0.6494, 0.6691] 
2920 0.7838 [0.7749, 0.7749] 0.6699 [0.6602, 0.6796] 0.6591 [0.6492, 0.669] 
2930 0.7837 [0.775, 0.775] 0.6697 [0.66, 0.6794] 0.6591 [0.6492, 0.669] 
2940 0.7837 [0.7749, 0.7749] 0.6696 [0.6599, 0.6792] 0.659 [0.6492, 0.6689] 
2950 0.7837 [0.7751, 0.7751] 0.6695 [0.6598, 0.6791] 0.659 [0.6493, 0.6688] 
2960 0.784 [0.7755, 0.7755] 0.6695 [0.6598, 0.6792] 0.659 [0.6493, 0.6688] 
2970 0.7838 [0.7752, 0.7752] 0.6695 [0.6598, 0.6792] 0.6591 [0.6493, 0.6688] 
2980 0.7839 [0.7752, 0.7752] 0.6695 [0.6598, 0.6792] 0.6591 [0.6494, 0.6688] 
2990 0.7837 [0.775, 0.775] 0.6694 [0.6598, 0.6791] 0.6589 [0.6492, 0.6685] 
3000 0.7837 [0.7749, 0.7749] 0.6694 [0.6597, 0.6791] 0.659 [0.6493, 0.6687] 
3010 0.7837 [0.7748, 0.7748] 0.6693 [0.6596, 0.679] 0.659 [0.6493, 0.6688] 
3020 0.7836 [0.7749, 0.7749] 0.6692 [0.6594, 0.679] 0.6591 [0.6493, 0.6688] 
3030 0.7836 [0.7749, 0.7749] 0.6692 [0.6594, 0.679] 0.659 [0.6493, 0.6687] 
3040 0.7835 [0.7749, 0.7749] 0.6692 [0.6594, 0.679] 0.659 [0.6493, 0.6687] 
3050 0.7833 [0.7748, 0.7748] 0.6691 [0.6594, 0.6789] 0.6589 [0.6491, 0.6687] 
3060 0.7833 [0.7747, 0.7747] 0.669 [0.6592, 0.6789] 0.6589 [0.6491, 0.6686] 
3070 0.7833 [0.7747, 0.7747] 0.669 [0.6593, 0.6788] 0.6589 [0.6492, 0.6686] 
3080 0.7833 [0.7747, 0.7747] 0.669 [0.6592, 0.6788] 0.6588 [0.6491, 0.6686] 
3090 0.7832 [0.7747, 0.7747] 0.6689 [0.6591, 0.6787] 0.6588 [0.6492, 0.6685] 
3100 0.7832 [0.7745, 0.7745] 0.6688 [0.659, 0.6786] 0.6588 [0.6491, 0.6685] 
3110 0.7832 [0.7745, 0.7745] 0.6687 [0.6588, 0.6786] 0.6588 [0.649, 0.6686] 
3120 0.7831 [0.7745, 0.7745] 0.6688 [0.6588, 0.6787] 0.6589 [0.6493, 0.6686] 
3130 0.7831 [0.7745, 0.7745] 0.6687 [0.6589, 0.6786] 0.6588 [0.6492, 0.6684] 
3140 0.7829 [0.7744, 0.7744] 0.6686 [0.6587, 0.6785] 0.6587 [0.6491, 0.6683] 
3150 0.7831 [0.7746, 0.7746] 0.6687 [0.6588, 0.6785] 0.6587 [0.6492, 0.6683] 
3160 0.783 [0.7745, 0.7745] 0.6687 [0.6589, 0.6784] 0.6586 [0.6491, 0.6682] 
3170 0.783 [0.7745, 0.7745] 0.6687 [0.659, 0.6784] 0.6586 [0.6491, 0.6681] 
3180 0.7831 [0.7746, 0.7746] 0.6687 [0.659, 0.6785] 0.6585 [0.6491, 0.668] 
3190 0.7831 [0.7746, 0.7746] 0.6688 [0.6591, 0.6785] 0.6585 [0.649, 0.6679] 
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3200 0.7832 [0.7747, 0.7747] 0.6688 [0.6591, 0.6785] 0.6585 [0.6491, 0.668] 
3210 0.7833 [0.7748, 0.7748] 0.6688 [0.6591, 0.6785] 0.6583 [0.6489, 0.6677] 
3220 0.7831 [0.7747, 0.7747] 0.6687 [0.659, 0.6784] 0.6582 [0.6487, 0.6676] 
3230 0.7831 [0.7745, 0.7745] 0.6687 [0.659, 0.6785] 0.6582 [0.6487, 0.6677] 
3240 0.783 [0.7744, 0.7744] 0.6688 [0.659, 0.6786] 0.6581 [0.6487, 0.6675] 
3250 0.783 [0.7745, 0.7745] 0.6689 [0.659, 0.6787] 0.658 [0.6487, 0.6673] 
3260 0.7828 [0.7744, 0.7744] 0.6688 [0.659, 0.6786] 0.6579 [0.6485, 0.6672] 
3270 0.7827 [0.7742, 0.7742] 0.6688 [0.659, 0.6786] 0.6578 [0.6485, 0.6672] 
3280 0.7826 [0.774, 0.774] 0.6688 [0.659, 0.6786] 0.6578 [0.6485, 0.6672] 
3290 0.7828 [0.7742, 0.7742] 0.6687 [0.6589, 0.6785] 0.6578 [0.6485, 0.6672] 
3300 0.7827 [0.774, 0.774] 0.6688 [0.6589, 0.6786] 0.6577 [0.6485, 0.667] 
3310 0.7825 [0.7738, 0.7738] 0.6689 [0.659, 0.6787] 0.6576 [0.6483, 0.6669] 
3320 0.7824 [0.7736, 0.7736] 0.6689 [0.6591, 0.6788] 0.6575 [0.6482, 0.6668] 
3330 0.7823 [0.7734, 0.7734] 0.669 [0.6592, 0.6788] 0.6575 [0.6482, 0.6669] 
3340 0.7822 [0.7733, 0.7733] 0.669 [0.6592, 0.6788] 0.6574 [0.6481, 0.6668] 
3350 0.7823 [0.7735, 0.7735] 0.6689 [0.659, 0.6788] 0.6574 [0.6481, 0.6667] 
3360 0.7823 [0.7734, 0.7734] 0.6688 [0.6587, 0.6788] 0.6574 [0.6481, 0.6666] 
3370 0.7823 [0.7732, 0.7732] 0.6688 [0.6587, 0.6789] 0.6573 [0.648, 0.6666] 
3380 0.7822 [0.7732, 0.7732] 0.6688 [0.6587, 0.6788] 0.6573 [0.6481, 0.6665] 
3390 0.782 [0.7729, 0.7729] 0.6688 [0.6588, 0.6788] 0.6574 [0.6481, 0.6666] 
3400 0.782 [0.7729, 0.7729] 0.6687 [0.6587, 0.6787] 0.6573 [0.648, 0.6665] 
3410 0.7821 [0.773, 0.773] 0.6687 [0.6586, 0.6788] 0.6572 [0.648, 0.6664] 
3420 0.7822 [0.7731, 0.7731] 0.6686 [0.6586, 0.6786] 0.6573 [0.648, 0.6665] 
3430 0.7822 [0.773, 0.773] 0.6685 [0.6585, 0.6785] 0.6572 [0.6479, 0.6665] 
3440 0.7823 [0.7731, 0.7731] 0.6685 [0.6586, 0.6785] 0.6573 [0.648, 0.6667] 
3450 0.7824 [0.7732, 0.7732] 0.6685 [0.6586, 0.6785] 0.6572 [0.6479, 0.6665] 
3460 0.7823 [0.7731, 0.7731] 0.6685 [0.6586, 0.6785] 0.6572 [0.6479, 0.6665] 
3470 0.7823 [0.7731, 0.7731] 0.6684 [0.6585, 0.6784] 0.6572 [0.6479, 0.6665] 
3480 0.7822 [0.773, 0.773] 0.6683 [0.6584, 0.6782] 0.6573 [0.648, 0.6666] 
3490 0.7822 [0.7731, 0.7731] 0.6683 [0.6584, 0.6783] 0.6574 [0.6482, 0.6666] 
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3500 0.7822 [0.7729, 0.7729] 0.6684 [0.6586, 0.6783] 0.6572 [0.648, 0.6664] 
3510 0.782 [0.7728, 0.7728] 0.6684 [0.6586, 0.6783] 0.6571 [0.6478, 0.6664] 
3520 0.7819 [0.7728, 0.7728] 0.6683 [0.6584, 0.6782] 0.6572 [0.648, 0.6665] 
3530 0.782 [0.7729, 0.7729] 0.6682 [0.6583, 0.6781] 0.6571 [0.6479, 0.6664] 
3540 0.782 [0.7728, 0.7728] 0.6683 [0.6584, 0.6782] 0.6573 [0.648, 0.6665] 
3550 0.7821 [0.7727, 0.7727] 0.6683 [0.6583, 0.6782] 0.6572 [0.648, 0.6665] 
3560 0.7821 [0.7727, 0.7727] 0.6681 [0.6582, 0.678] 0.6573 [0.648, 0.6666] 
3570 0.7819 [0.7726, 0.7726] 0.6682 [0.6583, 0.6781] 0.6571 [0.6479, 0.6664] 
3580 0.7818 [0.7725, 0.7725] 0.6681 [0.6583, 0.678] 0.6571 [0.6479, 0.6664] 
3590 0.7817 [0.7724, 0.7724] 0.6681 [0.6582, 0.6781] 0.6571 [0.6479, 0.6664] 
3600 0.7816 [0.7722, 0.7722] 0.6682 [0.6582, 0.6781] 0.6571 [0.6479, 0.6663] 
3610 0.7817 [0.7723, 0.7723] 0.6681 [0.6581, 0.6781] 0.6571 [0.6479, 0.6664] 
3620 0.7816 [0.7723, 0.7723] 0.6681 [0.6581, 0.6781] 0.6572 [0.6479, 0.6665] 
3630 0.7816 [0.7723, 0.7723] 0.6681 [0.6581, 0.6781] 0.6571 [0.6478, 0.6664] 
3640 0.7818 [0.7724, 0.7724] 0.6681 [0.6581, 0.6781] 0.6571 [0.6478, 0.6664] 
3650 0.7817 [0.7724, 0.7724] 0.668 [0.658, 0.678] 0.6572 [0.6478, 0.6666] 
3660 0.7817 [0.7723, 0.7723] 0.668 [0.658, 0.6779] 0.6574 [0.648, 0.6667] 
3670 0.7818 [0.7724, 0.7724] 0.6679 [0.658, 0.6779] 0.6574 [0.6481, 0.6667] 
3680 0.7817 [0.7723, 0.7723] 0.6679 [0.658, 0.6778] 0.6574 [0.648, 0.6668] 
3690 0.7817 [0.7721, 0.7721] 0.668 [0.6581, 0.6778] 0.6574 [0.6481, 0.6668] 
3700 0.7817 [0.7721, 0.7721] 0.6679 [0.6581, 0.6778] 0.6575 [0.6481, 0.6668] 
3710 0.7815 [0.772, 0.772] 0.668 [0.6581, 0.6778] 0.6575 [0.6482, 0.6669] 
3720 0.7816 [0.772, 0.772] 0.668 [0.6581, 0.6779] 0.6576 [0.6482, 0.6669] 
3730 0.7815 [0.7719, 0.7719] 0.668 [0.6581, 0.6779] 0.6576 [0.6483, 0.667] 
3740 0.7814 [0.7718, 0.7718] 0.668 [0.6581, 0.6778] 0.6577 [0.6483, 0.667] 
3750 0.7814 [0.7718, 0.7718] 0.6679 [0.658, 0.6778] 0.6577 [0.6484, 0.667] 
3760 0.7813 [0.7717, 0.7717] 0.6679 [0.658, 0.6778] 0.6577 [0.6483, 0.6672] 
3770 0.7813 [0.7716, 0.7716] 0.6679 [0.658, 0.6778] 0.6577 [0.6483, 0.6671] 
3780 0.7814 [0.7718, 0.7718] 0.6679 [0.6581, 0.6777] 0.6578 [0.6484, 0.6672] 
3790 0.7814 [0.7717, 0.7717] 0.6678 [0.6579, 0.6776] 0.6578 [0.6484, 0.6672] 
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3800 0.7813 [0.7716, 0.7716] 0.6678 [0.6581, 0.6776] 0.6578 [0.6484, 0.6673] 
3810 0.7814 [0.7716, 0.7716] 0.6678 [0.658, 0.6776] 0.6579 [0.6484, 0.6674] 
3820 0.7814 [0.7716, 0.7716] 0.6677 [0.6581, 0.6774] 0.658 [0.6485, 0.6674] 
3830 0.7815 [0.7718, 0.7718] 0.6677 [0.658, 0.6773] 0.658 [0.6486, 0.6674] 
3840 0.7816 [0.7719, 0.7719] 0.6676 [0.658, 0.6773] 0.6579 [0.6485, 0.6672] 
3850 0.7816 [0.7719, 0.7719] 0.6675 [0.6578, 0.6773] 0.6579 [0.6485, 0.6673] 
3860 0.7816 [0.7718, 0.7718] 0.6674 [0.6577, 0.6772] 0.658 [0.6486, 0.6673] 
3870 0.7817 [0.772, 0.772] 0.6675 [0.6577, 0.6772] 0.6579 [0.6486, 0.6673] 
3880 0.7817 [0.772, 0.772] 0.6674 [0.6575, 0.6772] 0.6579 [0.6484, 0.6673] 
3890 0.7818 [0.772, 0.772] 0.6674 [0.6576, 0.6772] 0.6577 [0.6483, 0.6672] 
3900 0.7817 [0.772, 0.772] 0.6674 [0.6576, 0.6771] 0.6577 [0.6481, 0.6672] 
3910 0.7816 [0.7718, 0.7718] 0.6673 [0.6574, 0.6771] 0.6577 [0.6482, 0.6672] 
3920 0.7817 [0.7719, 0.7719] 0.6672 [0.6574, 0.677] 0.6576 [0.6481, 0.6671] 
3930 0.7816 [0.7719, 0.7719] 0.6671 [0.6573, 0.6769] 0.6577 [0.6482, 0.6671] 
3940 0.7817 [0.772, 0.772] 0.6672 [0.6574, 0.677] 0.6576 [0.6481, 0.6671] 
3950 0.7816 [0.772, 0.772] 0.6671 [0.6573, 0.6769] 0.6575 [0.648, 0.6671] 
3960 0.7816 [0.7719, 0.7719] 0.6671 [0.6573, 0.677] 0.6576 [0.648, 0.6672] 
3970 0.7816 [0.7719, 0.7719] 0.6671 [0.6572, 0.677] 0.6576 [0.648, 0.6672] 
3980 0.7816 [0.7719, 0.7719] 0.6671 [0.6571, 0.677] 0.6576 [0.648, 0.6672] 
3990 0.7816 [0.7719, 0.7719] 0.667 [0.657, 0.677] 0.6575 [0.6479, 0.667] 
4000 0.7816 [0.7719, 0.7719] 0.667 [0.657, 0.677] 0.6575 [0.6479, 0.667] 
4010 0.7815 [0.7717, 0.7717] 0.667 [0.6571, 0.6769] 0.6574 [0.6478, 0.6669] 
4020 0.7815 [0.7718, 0.7718] 0.667 [0.657, 0.677] 0.6574 [0.6478, 0.6669] 
4030 0.7814 [0.7717, 0.7717] 0.667 [0.657, 0.677] 0.6574 [0.648, 0.6668] 
4040 0.7814 [0.7717, 0.7717] 0.667 [0.657, 0.677] 0.6574 [0.6479, 0.6668] 
4050 0.7812 [0.7715, 0.7715] 0.667 [0.657, 0.677] 0.6572 [0.6478, 0.6667] 
4060 0.7813 [0.7715, 0.7715] 0.6669 [0.6568, 0.6769] 0.6572 [0.6477, 0.6667] 
4070 0.7811 [0.7714, 0.7714] 0.6668 [0.6568, 0.6768] 0.6572 [0.6477, 0.6667] 
4080 0.7811 [0.7714, 0.7714] 0.6667 [0.6567, 0.6767] 0.6571 [0.6475, 0.6666] 
4090 0.7811 [0.7714, 0.7714] 0.6665 [0.6566, 0.6765] 0.657 [0.6476, 0.6665] 
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4100 0.7812 [0.7715, 0.7715] 0.6664 [0.6565, 0.6764] 0.657 [0.6476, 0.6665] 
4110 0.7811 [0.7715, 0.7715] 0.6664 [0.6564, 0.6764] 0.6571 [0.6477, 0.6666] 
4120 0.7812 [0.7715, 0.7715] 0.6664 [0.6565, 0.6764] 0.657 [0.6475, 0.6665] 
4130 0.7813 [0.7716, 0.7716] 0.6664 [0.6564, 0.6764] 0.657 [0.6475, 0.6665] 
4140 0.7814 [0.7717, 0.7717] 0.6664 [0.6564, 0.6763] 0.657 [0.6475, 0.6665] 
4150 0.7813 [0.7716, 0.7716] 0.6663 [0.6562, 0.6763] 0.6571 [0.6476, 0.6666] 
4160 0.7813 [0.7716, 0.7716] 0.6662 [0.6562, 0.6763] 0.6572 [0.6477, 0.6666] 
4170 0.7812 [0.7715, 0.7715] 0.6662 [0.6561, 0.6762] 0.6571 [0.6476, 0.6666] 
4180 0.7812 [0.7715, 0.7715] 0.6662 [0.6562, 0.6762] 0.6572 [0.6476, 0.6667] 
4190 0.7811 [0.7714, 0.7714] 0.666 [0.6561, 0.676] 0.6571 [0.6476, 0.6667] 
4200 0.7812 [0.7715, 0.7715] 0.666 [0.656, 0.6759] 0.6571 [0.6475, 0.6667] 
4210 0.7812 [0.7715, 0.7715] 0.6659 [0.6559, 0.6758] 0.6571 [0.6474, 0.6667] 
4220 0.7813 [0.7716, 0.7716] 0.6659 [0.6559, 0.6758] 0.6571 [0.6474, 0.6667] 
4230 0.7813 [0.7717, 0.7717] 0.6658 [0.6559, 0.6758] 0.657 [0.6473, 0.6667] 
4240 0.7812 [0.7716, 0.7716] 0.6658 [0.6559, 0.6758] 0.657 [0.6473, 0.6667] 
4250 0.7813 [0.7717, 0.7717] 0.6658 [0.6559, 0.6757] 0.6569 [0.6472, 0.6665] 
4260 0.7812 [0.7716, 0.7716] 0.6656 [0.6557, 0.6756] 0.6568 [0.6472, 0.6665] 
4270 0.7814 [0.7717, 0.7717] 0.6656 [0.6557, 0.6756] 0.6568 [0.6472, 0.6664] 
4280 0.7814 [0.7717, 0.7717] 0.6656 [0.6557, 0.6756] 0.6568 [0.6472, 0.6665] 
4290 0.7813 [0.7716, 0.7716] 0.6656 [0.6557, 0.6755] 0.6569 [0.6473, 0.6665] 
4300 0.7812 [0.7715, 0.7715] 0.6656 [0.6557, 0.6755] 0.657 [0.6474, 0.6666] 
4310 0.7813 [0.7717, 0.7717] 0.6656 [0.6557, 0.6755] 0.657 [0.6474, 0.6666] 
4320 0.7814 [0.7717, 0.7717] 0.6655 [0.6556, 0.6755] 0.6571 [0.6475, 0.6668] 
4330 0.7814 [0.7718, 0.7718] 0.6654 [0.6555, 0.6753] 0.6569 [0.6472, 0.6665] 
4340 0.7814 [0.7717, 0.7717] 0.6654 [0.6555, 0.6753] 0.6569 [0.6473, 0.6666] 
4350 0.7812 [0.7715, 0.7715] 0.6655 [0.6556, 0.6754] 0.6569 [0.6472, 0.6666] 
4360 0.7813 [0.7717, 0.7717] 0.6655 [0.6556, 0.6754] 0.6569 [0.6472, 0.6665] 
4370 0.7814 [0.7717, 0.7717] 0.6655 [0.6556, 0.6754] 0.6568 [0.6471, 0.6665] 
4380 0.7815 [0.7718, 0.7718] 0.6655 [0.6556, 0.6754] 0.6568 [0.6471, 0.6665] 
4390 0.7814 [0.7716, 0.7716] 0.6655 [0.6556, 0.6754] 0.6568 [0.6471, 0.6664] 
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4400 0.7814 [0.7716, 0.7716] 0.6654 [0.6554, 0.6753] 0.6567 [0.6471, 0.6664] 
4410 0.7814 [0.7716, 0.7716] 0.6654 [0.6555, 0.6753] 0.6569 [0.6472, 0.6665] 
4420 0.7813 [0.7714, 0.7714] 0.6652 [0.6553, 0.6752] 0.6569 [0.6473, 0.6666] 
4430 0.7812 [0.7714, 0.7714] 0.6653 [0.6553, 0.6752] 0.6569 [0.6472, 0.6665] 
4440 0.7813 [0.7716, 0.7716] 0.6651 [0.6551, 0.6751] 0.6568 [0.6471, 0.6665] 
4450 0.7814 [0.7716, 0.7716] 0.6651 [0.655, 0.6751] 0.6567 [0.647, 0.6664] 
4460 0.7814 [0.7716, 0.7716] 0.665 [0.655, 0.675] 0.6567 [0.647, 0.6664] 
4470 0.7813 [0.7716, 0.7716] 0.665 [0.6549, 0.6751] 0.6566 [0.6471, 0.6662] 
4480 0.7813 [0.7715, 0.7715] 0.665 [0.6549, 0.6751] 0.6565 [0.647, 0.6661] 
4490 0.7814 [0.7716, 0.7716] 0.6649 [0.6549, 0.675] 0.6564 [0.6467, 0.6661] 
4500 0.7813 [0.7715, 0.7715] 0.6649 [0.6548, 0.6749] 0.6565 [0.6467, 0.6662] 
4510 0.7814 [0.7715, 0.7715] 0.6648 [0.6548, 0.6748] 0.6564 [0.6468, 0.6661] 
4520 0.7814 [0.7714, 0.7714] 0.6647 [0.6546, 0.6747] 0.6564 [0.6466, 0.6662] 
4530 0.7814 [0.7714, 0.7714] 0.6646 [0.6546, 0.6747] 0.6564 [0.6465, 0.6663] 
4540 0.7812 [0.7712, 0.7712] 0.6645 [0.6544, 0.6746] 0.6564 [0.6465, 0.6663] 
4550 0.7813 [0.7713, 0.7713] 0.6645 [0.6545, 0.6746] 0.6563 [0.6464, 0.6662] 
4560 0.7814 [0.7713, 0.7713] 0.6645 [0.6545, 0.6746] 0.6562 [0.6463, 0.6661] 
4570 0.7813 [0.7712, 0.7712] 0.6646 [0.6546, 0.6746] 0.6562 [0.6463, 0.6662] 
4580 0.7812 [0.7711, 0.7711] 0.6646 [0.6546, 0.6747] 0.6564 [0.6465, 0.6663] 
4590 0.7812 [0.7711, 0.7711] 0.6646 [0.6546, 0.6746] 0.6564 [0.6465, 0.6663] 
4600 0.7812 [0.7711, 0.7711] 0.6647 [0.6547, 0.6746] 0.6563 [0.6464, 0.6662] 
4610 0.7811 [0.7709, 0.7709] 0.6646 [0.6546, 0.6746] 0.6562 [0.6464, 0.666] 
4620 0.781 [0.7708, 0.7708] 0.6646 [0.6546, 0.6747] 0.6562 [0.6464, 0.666] 
4630 0.7809 [0.7707, 0.7707] 0.6645 [0.6545, 0.6746] 0.6562 [0.6464, 0.666] 
4640 0.7809 [0.7706, 0.7706] 0.6645 [0.6545, 0.6746] 0.6562 [0.6465, 0.666] 
4650 0.7808 [0.7706, 0.7706] 0.6644 [0.6544, 0.6744] 0.6561 [0.6464, 0.6659] 
4660 0.7809 [0.7706, 0.7706] 0.6644 [0.6544, 0.6744] 0.6562 [0.6464, 0.666] 
4670 0.7809 [0.7705, 0.7705] 0.6643 [0.6544, 0.6743] 0.6561 [0.6464, 0.6658] 
4680 0.7808 [0.7704, 0.7704] 0.6644 [0.6545, 0.6743] 0.6561 [0.6464, 0.6658] 
4690 0.7809 [0.7705, 0.7705] 0.6644 [0.6545, 0.6743] 0.656 [0.6464, 0.6657] 
 199 
4700 0.7809 [0.7707, 0.7707] 0.6644 [0.6545, 0.6743] 0.6562 [0.6465, 0.6658] 
4710 0.781 [0.7708, 0.7708] 0.6645 [0.6546, 0.6744] 0.6562 [0.6466, 0.6658] 
4720 0.7809 [0.7707, 0.7707] 0.6645 [0.6545, 0.6744] 0.6562 [0.6465, 0.6658] 
4730 0.7808 [0.7706, 0.7706] 0.6644 [0.6545, 0.6743] 0.6561 [0.6466, 0.6656] 
4740 0.7808 [0.7705, 0.7705] 0.6644 [0.6545, 0.6743] 0.6561 [0.6466, 0.6657] 
4750 0.7807 [0.7703, 0.7703] 0.6643 [0.6545, 0.6742] 0.656 [0.6464, 0.6656] 
4760 0.7804 [0.77, 0.77] 0.6643 [0.6544, 0.6742] 0.6559 [0.6463, 0.6655] 
4770 0.7804 [0.7699, 0.7699] 0.6642 [0.6543, 0.6741] 0.6559 [0.6462, 0.6656] 
4780 0.7804 [0.7699, 0.7699] 0.6642 [0.6543, 0.6741] 0.656 [0.6462, 0.6657] 
4790 0.7802 [0.7697, 0.7697] 0.6641 [0.6542, 0.674] 0.656 [0.6462, 0.6657] 
4800 0.7802 [0.7698, 0.7698] 0.6642 [0.6542, 0.6741] 0.656 [0.6462, 0.6657] 
4810 0.7804 [0.77, 0.77] 0.6641 [0.6541, 0.674] 0.656 [0.6462, 0.6657] 
4820 0.7803 [0.7699, 0.7699] 0.6641 [0.6542, 0.674] 0.6561 [0.6463, 0.6658] 
4830 0.7803 [0.7699, 0.7699] 0.664 [0.6541, 0.674] 0.6562 [0.6464, 0.6659] 
4840 0.7802 [0.7698, 0.7698] 0.664 [0.6541, 0.6739] 0.6562 [0.6464, 0.6661] 
4850 0.7803 [0.7698, 0.7698] 0.664 [0.6541, 0.6738] 0.6563 [0.6464, 0.6661] 
4860 0.7804 [0.7699, 0.7699] 0.6639 [0.6541, 0.6738] 0.6562 [0.6463, 0.6661] 
4870 0.7803 [0.7698, 0.7698] 0.6639 [0.654, 0.6737] 0.6563 [0.6465, 0.6662] 
4880 0.7803 [0.7697, 0.7697] 0.6638 [0.6539, 0.6738] 0.6563 [0.6464, 0.6661] 
4890 0.7804 [0.7698, 0.7698] 0.6638 [0.6539, 0.6737] 0.6564 [0.6466, 0.6662] 
4900 0.7804 [0.7697, 0.7697] 0.6638 [0.6539, 0.6738] 0.6563 [0.6466, 0.6661] 
4910 0.7804 [0.7696, 0.7696] 0.6638 [0.6539, 0.6737] 0.6562 [0.6465, 0.6658] 
4920 0.7803 [0.7695, 0.7695] 0.6638 [0.6539, 0.6738] 0.6561 [0.6465, 0.6658] 
4930 0.7803 [0.7695, 0.7695] 0.6638 [0.6539, 0.6737] 0.6562 [0.6466, 0.6658] 
4940 0.7802 [0.7694, 0.7694] 0.6639 [0.654, 0.6738] 0.6561 [0.6464, 0.6657] 
4950 0.7802 [0.7693, 0.7693] 0.6639 [0.654, 0.6738] 0.656 [0.6464, 0.6657] 
4960 0.7801 [0.7691, 0.7691] 0.6639 [0.654, 0.6738] 0.656 [0.6463, 0.6657] 
4970 0.7798 [0.7688, 0.7688] 0.6639 [0.6539, 0.6738] 0.6559 [0.6462, 0.6656] 
4980 0.7797 [0.7687, 0.7687] 0.6638 [0.6538, 0.6737] 0.6559 [0.6463, 0.6655] 
4990 0.7798 [0.7687, 0.7687] 0.6637 [0.6538, 0.6737] 0.656 [0.6464, 0.6655] 
 200 
5000 0.7798 [0.7688, 0.7688] 0.6637 [0.6537, 0.6736] 0.656 [0.6464, 0.6655] 
 
